









New Methodology for the Synthesis of Chiral, 
Non-Racemic α-Tertiary Amine Centres: 
Application to the Synthesis of the Marine 
Alkaloid Lepadiformine 
 
A thesis submitted to the 
University of Cape Town 
In fulfilment of the requirements of the  





Supervisor: Professor Roger Hunter 
Department of Chemistry 
University of Cape Town 
Rondebosch, 7701 
Cape Town         July 2016 
The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
Published by the University of Cape Town (UCT) in terms 












I declare that “New Methodology for the Synthesis of Chiral, Non-Racemic α-Tertiary Amine 
Centres: Application to the Synthesis of the Marine Alkaloid Lepadiformine” is my own work 
and that all sources that I have used or quoted have been indicted and acknowledged by 
means of complete references. I authorise the University to reproduce for the purpose of 






The development of new methodology for the synthesis of a chiral, non-racemic quaternary carbon 
bearing an α-nitrogen (an α-tertiary amine or ATA) continues to be an active area of modern 
research in current synthetic organic chemistry. As a privileged biological scaffold, ATAs are 
widespread amongst bioactive natural products, providing an inspiration in their complex 
architecture to synthetic chemists in drug discovery programmes. 
Three experimental endeavours comprise this project, which are presented as separate sections of 
Chapter 2. The first part focuses on new methodology for all-carbon quaternization based on an 
auxiliary-based diastereoselective alkylation of an auxiliary-malonate, in which an imidazolidinone 
auxiliary provided excellent facial selectivities in the alkylation in conjunction with KHMDS as the 
base. Five derivatives were generated in high yields (>85 %) and selectivities (dr >95:5). Extension of 
the methodology to generate ATAs using the auxiliary-malonate system forms the basis of the 
second section. This was achieved via a modified Curtius rearrangement protocol performed on 
quaternary carboxylic acids, in turn obtained from a chemoselective cleavage of a PMB ester 
malonate-auxiliary system. The ATA products were obtained in high yields and with retention of 
stereoselectivity, and following the non-destructive removal of the auxiliary by methanolysis, 
produced enantioenriched α,α-disubstituted alanine and phenylalanine methyl esters. Additional 
steps on other suitable derivatives furnished quaternary proline and lysine derivatives, all in high 
ees (96 – 98 %). The methodology offers a general approach to the production of enantioenriched 
ATAs, and in particular, access to both natural and unnatural α,α-disubstituted amino acids. 
Application to an attempted synthesis of lepadiformine is described in the final section, whereby the 
ATA of the alkaloid is constructed in an acyclic form employing the newly developed methodology. 
Reductive (non-destructive) removal of the auxiliary provided an amino alcohol derivative that was 
further elaborated via a sequence involving ring-closing metathesis, hydrogenation, hydroxyl group 
oxidation and Grignard addition to afford a functionalised A-ring of lepadiformine A, with key 
functionality in place for elaboration to the target. However, dehydration of the tertiary alcohol 
from the Grignard step, although successful in a related model study, led to problems, bringing the 
total synthesis endeavour to a close. In spite of this setback, the divergent nature of the approach 
allows for new designs in the synthetic plan, particularly regarding the order of which the 
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Chapter 1: Introduction 
 
Following an overview of general concepts in asymmetric synthesis this review will highlight 
approaches to the synthesis of tertiary amines in which the categorisation is disconnection-based, 
rather than methodology focused. 
1.1 Chiral α-Tertiary Amines 
The α-tertiary amine (ATA), i.e a tetrasubstituted carbon atom bonded to three carbon and one 
nitrogen substituents is a structural motif prevalent in numerous alkaloid natural products1 and 
other biologically active molecules, and as such of great interest to the synthetic organic chemist. 
Fig. 1 shows a selection of alkaloids and drugs featuring the ATA functionality. 
 
Figure 1 A selection of alkaloids and drugs bearing the ATA motif. 
Similarly, small molecules such as α,α-disubstituted amino acids, both proteogenic and non-
proteogenic, also presenting the motif, have found increasing applications in biochemical research 
and drug discovery,2,3 spurring extensive exploration into the development of dependable and 
flexible methods for their construction. For the most part, structures bearing fully substituted 
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carbon centres need to be generated in enantiopure form as this is imperative to their function, 
creating an additional dimension of difficulty to the task of creating them. Although progress in this 
field over the last 10 years has been immense, the synthetic challenge is far from completely solved 
and new methodologies continue to emerge.   
1.2 The Synthesis of Enantiopure Compounds  
The generation of enantiopure compounds can be achieved by chiral resolution of a mixture of 
enantiomers, or by asymmetric synthesis via enantioselective catalytic processes or 
diastereoselective auxiliary-controlled approaches (see Fig. 2). This review will only discuss 
asymmetric synthesis approaches.  
 
Figure 2 Available strategies for production of enantiopure compounds. 
1.2.1 Catalytic Enantioselective Synthesis 
Enantiocatalytic asymmetric synthesis is a field of organic chemistry that has experienced massive 
growth and maturity over the last 15 years,4 and in which the drive has largely come from the ever-
growing demand for chirally pure compounds in the pharmaceutical industry and others. It involves 
the use of a chiral catalyst in an enantioselective process, in which target molecules can be 
synthesized without the need for extra steps that are involved in auxiliary formation, attachment 
and removal. Although the catalysts often also require synthesis, catalyst molecules and complexes 
are used at much less than stoichiometric amounts, and are at times reusable for a number of cycles, 
making them cost-effective. The factors determining the efficiency of a chiral catalyst include: 
 A high turn-over frequency (TOF), meaning that it should be capable of catalyzing high 
numbers of transformations quickly and with minimal loss of activity; 
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 Effectiveness at low catalyst loading; 
 The ability to deliver products in high ees.  
 A degree of re-usability and ease of separation from the products 
Metal catalysts with chiral organic ligands, chiral organic catalysts (organocatalysis) and biocatalysts 
are the main categories, and a general overview of each of these will be given in the following 
section.   
Metal-ligand catalysis 
The discovery of the very first metal-ligand catalytic asymmetric process for asymmetric 
hydrogenation in 1966 by Noyori and Nozaki5 marked the birth of asymmetric catalysis from which 
all further advances and variations have stemmed. Following on from there, asymmetric 
hydrogenation was pursued by a number of research groups, which resulted in the rapid generation 
of various ligands and a steady improvement in ees, as well as discoveries for broader application. 
Today, many of these processes display high enantioselectivities and catalyst efficiencies, making 
them suitable for industrial applications, asymmetric hydrogenation/reduction and epoxidation 
being predominant in industry.  
Metal-ligand catalysts are generated by complexation of a chiral ligand to the metal, which creates a 
chiral environment for the reaction to take place and which generally proceeds by further 
complexation of the substrate/ reagent to the metal or ligands or both. The ligands, therefore, must 
encompass the correct functionality suited to the reaction in order to provide high reactivity, as well 
as suitable three-dimensional scaffolds to induce high stereoselectivities. Over the years metal-
ligand catalysis has been successfully applied to virtually every reaction class, encompassing a larger 
variety of transformations than other forms of catalysis and employing numerous transition metals 
and thousands of chiral ligands. Among the myriad of ligands, there are several compound classes 
which have proven to have general applicability and versatility, and these are termed privileged 
ligands.6 Fig. 3 shows some of the most important of these classes. With a relatively small number of 
catalytically useful metals available, the advancement of the field is largely dependent on developing 




Figure 3 Privileged chiral ligands 
Regarding ATA synthesis, examples of successful metal-ligand transformations include aziridinations, 
electrophilic aminations, electrophilic and nucleophilic alkylations of α-amino esters, additions to 
ketimines and Steglich rearrangements among others. Selected examples of these will be covered in 
the relevant section pertaining to each transformation. A downside to metal-ligand catalysis is the 
considerable cost, toxicity and scarcity of commonly used metal salts (eg Rh, Ru, Ir), which has 
prompted many researchers to investigate catalytic processes based on non-precious metals, such as 
Co, Fe and Cu.7  
Organocatalysis 
Notwithstanding the efficiency of metal-ligand catalysis, in recent years focus and effort has shifted 
to organocatalysis, particularly in the pharmaceutical context, as there is no contamination of final 
targets with traces of heavy metals. Organocatalysis involves the use of a small organic molecule like 
proline to promote the catalysis, and these are invariably stable to moisture and air. Although the 
green chemistry advantage of organocatalysis over metal-ligand type is undeniable, the field is not 
without its drawbacks. Organocatalysis reactions generally require much higher catalyst loadings and 
tend to be less general than that of metal-ligand catalysis. Furthermore, their activity and selectivity 
is often intrinsically connected to substrate structure, with small nuances leading to marked 
differences in results, in which there are limitations in terms of reaction classes due to specific 
mechanisms of action.  
Although having its origins back in the twentieth century, particularly through the industrially-driven 
Hajos-Parrish-Eder-Sauer-Wiechert aldol reaction of the 1970s,8–10 the birth of organocatalysis as we 
understand it today is usually taken to be only about fifteen years ago following seminal work by 
MacMillan, Barbas and List.11–13 Since then, the field of organocatalysis has exploded and continues 
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to draw massive amounts of interest from researchers. The central idea is to create organic 
molecules capable of facilitating reactions in which selectivities are comparable to that of enzymatic 
processes, in effect bringing laboratory processes ever closer to mimicking nature. There are a 
number of different mechanisms by which this can be achieved: 14 
 Covalent reactive intermediates in which proline and its derivatives as well as 
imidazolidinone-type catalysts are the main examples (Fig. 4) 
 Transition-state stabilization via weak interactions such as hydrogen bonding. A good 
example is Jacobsen’s15 thiourea scaffold as well as a chiral phosphoric acid (Fig. 4).16 Much 
like how enzymes function, a prochiral molecule is affixed to the catalyst whose asymmetry 
creates a local chiral environment to the functional site thereby favouring a facial selectivity.  
 Chiral phase-transfer catalysts (CPTCs). The CPTC forms an ion pair to facilitate the transfer 
of an ion or molecule from one reaction phase to another. Here, enantiomerically enriched 
quaternary ammonium salts are the most commonly used CPTC, particularly those derived 
from the cinchona alkaloids (Fig. 4). 
 
 
Figure 4 Examples of Organocatalysts and their mechanisms of operation 
 
As is evident from Fig. 4, by far the most prevalent chemotype of organocatalysts are chiral amines; 
hence the field of organocatalysis is often simply termed aminocatalysis. Proline and its derivatives 
feature prominently as a sub-class, with numerous applications for asymmetric transformations 
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involving carbonyls. There are two distinct activation modes in aminocatalysis pertaining to carbonyl 
functionalizations: iminium-ion catalysis and enamine catalysis.17 These two different pathways 
allow for both electrophilic and nucleophilic processes (Scheme 1). 
 
Scheme 1 Two activation modes of aminocatalysis 
Furthermore, opposite stereoselectivities can be achieved via enamine catalysis depending on the 
type of catalyst involved. In the H-bond directed mode, the approach of the electrophile is 
influenced by a H-bond donor atom on the catalyst, which effectively pulls the electrophile to add 
from the same face as the pendant chiral group in the preferred E, s-trans configuration. If no H-
bond donor is present, the chiral group acts as a steric block, thereby promoting the electrophile 
approach from the opposite face- hence this is termed the steric model. These concepts are 
depicted in Fig.5 with Proline and one of the Hayashi--Jørgensen diarylprolinol silyl ether catalysts as 
representative examples. 
 
Figure 5 Enamine catalysis modes of chiral induction 
 
The construction of ATAs by aminocatalysis via both covalent and non-covalent mechanisms has 
become hugely popular, with impressive results across the spectrum of available transformations, 
and these will be covered in the chemistry section on ATAs.  
 
Biocatalysis18 
Asymmetric biocatalysis refers to the use of an enzyme or whole cell to affect a stereoselective 
process. The specificity of an enzyme for only one of the two possible stereoisomers means that half 
of the starting material is lost in the process. Hence, their application in asymmetric syntheses of 
natural products is most prevalent in the early stages. The counterpoint of that is the lesser need for 
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protecting group manipulation, allowing for shorter syntheses. Reaction class applicability is limited 
to enzymatic processes but their high specificity, efficiency and need for mild (usually aqueous) 
reaction conditions make them amenable to industrial processes. Most often, enzymes applied to 
desymmetrizations and chiral resolutions in the context of amino acid synthesis, involve selective 
hydrolytic enzymes such as lipases, amidases, proteases and esterases.  However, their successful 
application become increasingly difficult when quaternary centres are adjacent to the site of action. 
1.2.2 Auxiliary-controlled diastereoselective synthesis19 
This approach involves the coupling of suitable non-chiral synthetic precursors to a chiral auxiliary 
prior to a diastereoselective reaction, generating enantio-enriched or enantiopure products after 
removal of the auxiliary. The use of chiral auxiliaries in enantioselective syntheses is widespread and 
can be applied to numerous reactions. In general, the following three criteria determine the 
efficiency of an auxiliary: 
 The ease of preparation and attachment. 
 The auxiliary should induce a highly selective process and allow for a strong bias of 
diastereofacial selectivity in the bond being formed.  
 A mild and non-destructive removal of the auxiliary must proceed without product 
racemization.  
A plethora of auxiliaries exist today that fulfil the above criteria and some prominent ones are shown 
in Fig 6. Generally, these are derived from inexpensive, chiral natural sources and allow for a high 
degree of diastereoselectivity. The fact that these processes obviate the use of the auxiliary in 
stoichiometric quantities is a disadvantage, lessened however, if recovery in good yield is possible at 
the end of a process. Asymmetric alkylations, aldol and Diels-Alder reactions are examples where 





Figure 6 Examples of chiral auxiliaries successfully applied in asymmetric synthesis. 
Application of these methodologies will now be discussed for the construction of ATAs, in which the 
emphasis is on the disconnection and functional group manipulation. 
1.3 Categories of Asymmetric ATA Syntheses 
As a preamble to the research carried out in the ATA methodology part of the thesis It was decided 
to illuminate the area by following a disconnection approach focusing on two major classifications 
for ATA synthesis: one where the quaternary centre comes about from a final C-C bond formation 
(blue in Scheme 2) with the amino group as part of the substrate, and the other where the amino 
group is installed in the final step (red in Scheme 2). These 2 categories can be further sub-divided 
into processes involving either electrophilic or nucleophilic nitrogen functionality. Cycloadditions 
and rearrangements have been classed separately. The chapter sub-headings (sections) in the thesis 
corresponding to these various sub-types are given in blue in Scheme 2. Selected lepadiformine 
syntheses will be reviewed according to the type of transformation employed to generate the ATA of 





Scheme 2 Classification of ATA synthesis based on the type of bond formed to create the ATA. 
1.4 C-C Bond Formation via an Electrophilic N-α-Carbon 
The classification where a C-C bond is formed last via an iminium species covers some of the most 
commonly practiced methods for ATA construction, such as the Strecker and Mannich reactions, the 
aza-Prins reaction as well as N-acyliminium chemistry. Aziridine ring-opening reactions are another 
example, however these will not be covered.  
1.4.1 Ketimine alkylation 
Nucleophilic addition to a disubstituted imine (ketimine) derived from a ketone precursor is a direct 
way of generating an ATA. However, the electrophilicity of an N-alkyl-substituted imine is lower than 
that of its carbonyl counterpart owing to the electronegativity difference of nitrogen compared to 
oxygen, requiring the use of very reactive nucleophiles. For this reason, electron-withdrawing 
substituents on the N are called for to enhance the electrophilicity, in which case a wider range of 
nucleophiles can be used successfully. Popular examples of activating groups are: N-sulfinyl 
ketimines,20 N-phosphenoyl ketimines,21 N,N-dialkylated hydrazones22 and N-acyl ketimines.23 
Scheme 3 shows a typical sequence of imine formation, alkylation to generate the ATA and removal 
of the nitrogen-bonded group using Ellman’s auxiliary 
 




Asymmetric synthesis involving acyclic ketimines is further hampered by the equilibration of E- and 
Z- imines, a potential deciding factor in the stereo- outcome of the reaction.  
Chiral, removable auxiliaries used for diastereoselective alkylations on imines can either be 
covalently bonded to the N-substituent, the carbonyl carbon of the imine, or even be bonded to the 
nucleophile (See Fig. 4). Alternatively, enantioselective catalytic reactions can be performed on an 
achiral imine.   
 
Figure 7 Known locations for introduction of chiral auxiliaries for reactions on imines. 
Auxiliary-based approaches for the most part utilize the first option in Fig. 4 derived from the 
condensation of an enantiopure amine such as an amino acid or a derivative thereof, with a ketone. 
-Methylbenzylamine, phenylglycinol, and ephedrine derivatives have all been used successfully as 
auxiliaries, although the N-tert-butanesulfinyl chiral sulfonamide auxiliary introduced by Ellman20 in 
1997 is probably the most widely utilized owing to its ease of preparation and removal (by acid) as 
well as high reaction des. As mentioned, though, for acyclic ketimines a potential drawback is that 
the degree of selectivity, in keeping with a Zimmerman-Traxler chelated transition state, is largely 
dependent on the relative steric difference between the 2 substituents on the ketimine. In the 
example shown in Scheme 4,24 the lowest level of stereoselectivity was seen with R1 and R2 as 
methyl and i-butyl even though the steric difference between the two groups is relatively large. In 
this regard, no reactions were done with groups more similar in size, such as R1 = Me, R2 = Et where 
one would have expected even lower selectivities. 
Scheme 4 Alkylation with N-tert-butanesulfinyl ketimines to generate ATAs. 
Regarding application in total synthesis Zhao25 made use of a chiral N-tert-butanesulfinamide as an 
asymmetric inductor for the Zn-mediated allylation of ketimine 1.2 to generate the requisite -




Scheme 5 Reagents and conditions: a) Ti(OEt)4/THF, (R)-tert-butanesulfinamide; b) Zn, allyl bromide/THF. 
The ketone 1.1 was generated in an overall yield of 27 % and 94 % ee from the corresponding γ-ester 
via a Corey-Bakshi-Shibata reduction using a dendrimer-supported prolinol catalyst26 followed by a 
further 3 steps. Condensation with (R)-tert-butanesulfinamide provided the desired ketimine 1.2 as a 
9:1 mixture of separable diastereomers. Direct allylation of 1.2 with organolithium and Grignard 
reagents gave very low yields; however, a Zn-mediated allylation proceeded smoothly, giving the 
ATA product 1.3 in excellent yield and diastereoselectivity. The stereoselectivity was rationalized 
using a chelate-controlled, chair-like Zimmerman-Traxler transition-state model where coordination 
of allyl-Zn to the sulfinyl oxygen directs the allylation via axial addition.   
1.4.2 Strecker reaction 
Similarly, the Strecker synthesis involves the addition of cyanide to the C=N bond of an imine to 
generate an α-aminonitrile, which are versatile intermediates for the synthesis of amino acids via 
hydrolysis. Chiral sulfinyl ketimines are commonly utilized but don’t provide high drs when sterically 
similar R1 / R2 groups are present. Ohfune’s27 use of chiral cyclic ketimines in a diastereoselective 
Strecker reaction addresses this problem, providing access to a variety of α,α-disubstituted amino 
acids in high yield and selectivity (Scheme 6). Formation of an ester between an L-or D- amino acid 
and the hydroxyl group of a racemic -acyloxy ketone followed by condensative cyclization with TFA 
generates a stereodefined ketimine 1.4 as a mixture of diastereomers relative to the -acyloxy 
centre. This undergoes a highly diastereoselective anti-addition (relative to the amino acid -
substituent) generating two α-amino nitrile diastereomers 1.5 that can be cleverly resolved via 
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acetonide formation using 2,2-dimethoxypropane and camphorsulfonic acid. Oxidative cleavage of 
the auxiliary with ozone, followed by acidic hydrolysis, gave the quaternized amino acid. 
 Scheme 6 Reagents and conditions: a) 2,2 dimethoxypropane, CSA (0.4 eq); b) H3O
+
; c) i) O3, -78 °C, MeOH; ii) 
HCl (conc.) 100 °C, 16h.  
This methodology can be extended to cases containing the ATA within a cycle, and a number of 
complex natural product syntheses have made use of this approach. An example is the synthesis of 
(+)-LY354740, a metabotropic glutamate receptor agonist as shown in Scheme 7.   
Scheme 7 Reagents and conditions: a) Cu(acac)2, toluene; b) TFA; c) TMSCN, ZnCl, iPrOH, rt, 18h 
Development of an enantioselective version of the Strecker reaction has also been addressed in 
recent years ever since Jacobsen’s first report in 2000,15 in which a urea Schiff base catalyst was 
employed for the enantioselective cyanation of ketimines. Similarly, Shibasaki disclosed a protocol 
employing an efficient bi-functional gadolinium-based catalyst assembly with ligand 1.6 in 200728 for 
the obtainment of Strecker products in very high yield and enantioselectivity as shown in Scheme 8. 
Understandably, a high selectivity in both of the above-mentioned reports were achieved when R1 
was small and R2 large.  The amino acids were isolated as their HCl salts by refluxing the Strecker 




Scheme 8 Shibasaki’s asymmetric Strecker reaction with ketimines 
1.4.3 Mannich reactions 
Nucleophilic addition of enols or enolates onto ketimines to give ATA structures qualifies as a 
Mannich reaction, in which efficient stereoselective examples are rare for acyclic variants and 
require strongly electron-withdrawing groups on the imine to facilitate the reaction. In the synthesis 
of α-trifluoromethylaspartic acid29 (Tfm Asp) using an auxiliary approach, a titanium enolate derived 
from t-Bu acetate reacted with the enantiopure sulfimine to give the desired N-sulfinyl Tfm Asp ester 
1.7 in a yield of 78 % and a de of 92 % (Scheme 9). The authors reported that only titanium enolates 
were reactive. Treating the esters with TFA to remove the sulfinyl and t-Bu groups, followed by 
saponification with KOH gave the Tfm Asp in a yield of 78 % and an ee of 97 %.   
 
Scheme 9 Asymmetric Mannich reaction onto a chiral sulfimine. 
2003 saw the first report on the catalytic enantioselective Mannich reaction of silyl-ketene acetals 
with ketimines by Jørgensen,30 applicable to ATA synthesis. Carrying out Mannich reactions on isatin-
derived ketimine frameworks has become an attractive protocol for generating 3,3 disubstituted 3-
aminooxindoles, an important class of biologically active compounds. Very recently in 2015,31 Liu 
and coworkers disclosed both a diastereo- and enantioselective method for the construction of 
vicinal tetrasubstituted centres via a catalytic asymmetric Mannich reaction of monothiomalonates 
1.8 and isatin N-Boc ketimines, 1.9 using a thiourea catalyst 1.10 (Scheme 10). Only one derivative 
(with the bromo group in the 3 position on the ring) gave the lower dr of 9:1; all others were 




Scheme 10 Catalytic asymmetric Mannich reaction of linear α-substituted monothiomalonates with 
Isatin N-Boc ketimines. 
Shibasaki’s32 formal total synthesis of lepadiformine and total synthesis of cylindricine C features an 
impressive cascade of cyclizations, involving a Mannich addition to form the ATA (Scheme 11). The 
cyclization precursor was generated via an asymmetric organocatalyzed conjugate addition reaction 
between 1.11 and 1.12 (derived from pimelic acid), using a tartrate-derived diammonium salt ((S,S)-
TaDiAS). The tandem Mannich/ aza-Michael sequence was initiated in acidic conditions in which the 
ratio of diastereomers obtained could be influenced by additives. Specifically, no additive resulted in 
a 1:2 ratio of 1.14 to 1.15 and trace amounts of a third diastereomer (64:33:4). Whereas the use of 
Lewis acidic additives produced a dr ratio of 87:7:6. Although only one stereocentre was set by the 
asymmetric conjugate addition, this had a drastic effect on the cyclization cascade. The pyrrolidine 
ring was generated by a transimination, which was followed by an intramolecular Mannich reaction 
to form the second ring and the aza-spirocycle 1.13. The diastereoselectivity of the ensuing aza-
Michael addition step was controlled by additives, which likely aided the enolization of 1.13, 
allowing epimerization at the α-carbonyl carbon. Five additional steps from 1.15 furnished 





Scheme 11 Reagents and conditions: a) (S,S)-TaDiAS, CsCO3, -40 °C; b) CSA, MgCl2, DCE, 50 °C. 
1.4.4 Addition to Hydrazones 
In the same way as with ketimines, nucleophilic addition to the the CN double bond of hydrazones 
gives rise to hydrazines, which can then undergo reductive cleavage to yield chiral amines. The 
example below, reported by Leighton et al in 2004,33 shows the allylation of a ketone-derived 
hydrazone 1.16 with an ephedrine-derived chiral allylsilane 1.17, showcasing the rather rare use of 
reagent-based enantioselectivity (Scheme 12). 
 
Scheme 12 Addition of a chiral allylsilane to an acyclic hydrazine 
Hydrazones and oxime ethers are known to be good radical acceptors because of the stabilization of 
the intermediate radical by the neighbouring heteroatoms. The advantage of radical methodologies 
over nucleophilic additions is the milder reaction conditions necessary, which translates to fewer 
side reactions. Although much progress has been made with aldimine acceptors, asymmetric 
ketimine radical additions are rare. In 2008 Gregory Friestad34 reported the use of a manganese- 
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mediated coupling of an iodide with a hydrazone containing an Evans auxiliary at its terminus. The 
chiral hydrazone 1.18 was prepared by N-amination of an oxazolidinone, followed by condensation 
with methyl pyruvate to afford the hydrazine product in an E/Z ratio of 98:2, the geometrical 
isomers separable by column chromatography. Photolysis of manganese carbonyl [Mn2(CO)10] 
results in homolytic metal-metal bond cleavage, giving rise to two Mn(CO)5 radicals, which abstract 
an iodide atom from the alkyl halide to form the reactive alkyl radical species. The radical addition 
reaction gave a superior dr with i-Pr (1.19b) compared to Et (1.19a) as shown in Scheme 13. 
Reductive N-N bond cleavage to afford the final quaternized product 1.20b was achieved using a 
sequence involving n-BuLi, benzoic anhydride and SmI2/MeOH.  
 
Scheme 13 Reagents and conditions: a) KH; NH2Cl, MTBE; b) p-TsOH, 4Ȧ MS, Toluene, 80 °C; c) R-I, Mn2(CO)10, 
hν, InCl3, CH2Cl2; d)  n-BuLi, Bz2O; e) SmI2, MeOH 
1.4.5 Addition to Nitrones 
Addition of nucleophiles to nitrones is one way to overcome the low reactivity of imines, as the 
polarization of the nitrogen in the nitrone raises the electrophilicty of the α-carbon. However, not 
many examples exist for the generation of quaternary centres. Carda and Marco in 199835 reported 
some advances in this regard, when they disclosed on an acyclic nitrone 1.22 accessed from a silyl-
protected erythrulose acetonide 1.21, which could be alkylated by various Grignard reagents in good 
to excellent drs followed by hydrogenolysis to remove the auxiliary (Scheme 14). The steps to obtain 





Scheme 14 Reagents and conditions:  a) BnNHOH; b) RMgX, THF, -78 °C, 5h; c) RMgX, THF, -78 °C, 5h, then 
Ac2O, rt, 30 min; d) PPTS, aq. MeOH, reflux; e) NaIO4; f) NaClO2; g) CH2N2; h) TBAF, THF; i) NaOH, EtOH; j) H2 (70 
psi) Pd(OH)2. 
Nitrones are also good substrates for cycloaddition reactions and a number of alkaloid syntheses 
have made use of the [3 + 2] nitrone-alkene cycloaddition.36 In their enantioselective approach to 
cylindricines, the Oppolzer group used a (2R)-bornane-10,2-sultam chiral auxiliary 1.23 to provide an 
enantiomerically  pure nitrone  1.24 for the intramolecular nitrone/olefin dipolar cycloaddition 
(Scheme 15).37 Prior to that Weinreb employed a very similar tactic in his racemic synthesis of 
lepadiformine, which consequently led to the elucidation of the  correct structure thereof.38 
Although good stereoselectivity was achieved in Oppolzer’s approach with the use of the chiral 
auxiliary, the regioselectivity of the cycloaddition was poor, producing two regioisomers arising from 
the conformations shown in Scheme #, with the desired isoxazolidine 1.25a formed in a yield of 41 
%. 
Scheme 15 Reagents and conditions: a) 3N HCl; b) DMSO 195 °C; c) i) NaHMDS, THF -78 °C; d) i) 1-chloro-1-
nitrosocyclohexane; ii) conc. HCl; e) PhMe, reflux.  
 
The electron-withdrawing effect of a carbonyl group alpha to an imine greatly enhances the 
electrophilicity of the iminium carbon, allowing for a wider range of nucleophiles to be employed, in 
which alkenes, alkynes, as well as aromatic and heteroaromatic nucleophiles are all effective. 
Similarly, the cyclization of nucleophilic alkenes onto transiently formed N-acyliminium ions is a 
commonly practiced method for creating both C-N and C-C bonds in the same reaction. Weinreb 
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applied N-acyliminium ion/ allylsilane spirocyclization methodology to the racemic synthesis of 
lepadiformine, and in 2002 extended it to an enantioselective version.39 Starting with (S)-
pyroglutamic acid, Cbz-lactam 1.26 incorporating a bulky phenyldimethylsilyl group was synthesized 
in five steps (Scheme 16). Addition of lithio (Z)-allylsilane 1.27 to the lactam carbonyl of 1.26 gave 
adduct 1.28 as a hemiaminal, which was treated with boron trifluoride acetic acid to promote 
iminium ion formation and cyclization. Spirocycle 1.29 was isolated as a single stereoisomer in a 
yield of 52 % due to the pendant phenyldimethylsilyl group blocking one of the faces of the iminium 
ion, promoting addition of the allylsilane to the less hindered face as illustrated in the Scheme.  
 
Scheme 16 Reagents and conditions: a) BF3∙2HOAc, CH2Cl2 
1.4.6 Aza-Prins 
The aza-Prins reaction describes a nucleophilc attack by a diene onto an iminium carbon, usually 
carried out for the purposes of cyclization. Kibayashi et al. employed a similar strategy to Weinreb’s 
by incorporating an aza-Prins cyclization (Scheme 17),40 in their expedient synthesis of lepadiformine 
and the cylindricines. Known (S)-N-Boc-2-pyrrolidinone 1.30 was treated with Grignard 1.31 to 
generate ketone 1.32. Treatment with formic acid promoted spirocyclization onto the in-situ 
generated N-acyliminium ion, along with formation of a formate ester at C-3, furnishing spirocycle 
1.33 in a yield of 88 %. It was noted that conjugated dienes underwent spirocyclization smoothly, 
requiring shorter reaction times compared to non-conjugated olefins. 1.33 was generated with 
complete stereocontrol via 6-exo-trig cyclization onto the less sterically hindered face of the iminium 
ion (opposite the 5-benzyloxymethyl group). Other possible transition states leading to the opposite 
diastereomer were claimed to be disfavoured due to interactions between the N-Boc group and the 




Scheme 17 Reagents and conditions: a) THF, 0 °C; b) HCO2H, toluene/THF (95:5), 0 °C 
In a somewhat similar approach to Kibayashi’s, Hsung achieved a relatively short total synthesis of 
the (+)-cylindricines C-E as well as (-)-lepadiformine via a common intermediate accessed from an 
aza-Prins cyclization, followed by a Wharton rearrangement (Scheme 18).41 Commencing with 
butyrolactam 1.34 (prepared in three steps from (S)-pyroglutamic acid), alkyl lithium addition/ ring 
opening afforded the Boc-protected amino ketone 1.35. Treatment of 1.35 with formic acid led to 
the initial closing of the pyrrolidine ring, followed by aza-Prins cyclization onto the resultant iminium 
ion and trapping of the allylic cation by the formate anion, to give the azaspirocycle 1.36. Removal of 
the formate group and further elaboration of the resultant allylic alcohol gave the epoxy ketone 
1.37, which underwent a Wharton rearrangement, without isolation of the hydrazone intermediate. 
Four steps, including an intramolecular aza-Michael addition furnished (-)-lepadiformine A in an 
overall yield of 7.1 %. The Cyclindricines were accessed via in-situ epimerization at C-5 of derivative 




Scheme 18 Reagents and conditions: a) t-BuLi, THF; b) HCO2H: THF: Toluene (50:3:47), -10 °C; c) NH2NH2, (5 
eq), MeOH, AcOH, -10 °C 
 
Recently, in 2015, Morimoto et al disclosed a facile total synthesis of (-)-lepadiformine A featuring a 
Hg(OTf)2-catalyzed cycloisomerization reaction as a key step, which also involved cyclization onto an 
iminium ion but via a triple bond as the nucleophile source, (Scheme 19).  
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Scheme 19 Reagents and conditions: a) I2, PPh3, imidazole, CH2Cl2, 0 °C to rt; b) NaSO2Ph, DMF, rt; c) i) n-BuLi, 
THF, -78 °C; d) SmI2, THF/MeOH (2:1) -78 °C; e) Hg(OTf)2 (0.2 eq), MeCN, -20 to 0 °C.  
Starting with the hemi-acetal 1.39 and acetylide 1.40, alcohol 1.41 was obtained in 5 steps and high 
overall yield, which was converted to sulfone 1.42 via an iodination/ sulfonylation sequence, and 
acylated with pyrrolidinone 1.43. Thereafter, desulfonylation furnished the ynone 1.44, the 
cyclization substrate containing all the carbons of the lepadiformine structure. Reaction of ynone 
1.44 with mercuric triflate gave the desired spirocycle 1.45 in a 78 % yield with a dr of 13:1 via a 
cascade sequence. The postulated mechanism involves first a 6-exo-dig intramolecular 
oxymercuration with formation of the target pyrrolidine C ring followed by cleavage to an iminium 
ion and an -mercurated ketone that cyclizes to generate the key A/C target spirocycle in a Ferrier-
type reaction with correct absolute and relative stereochemistry. The authors present five possible 
transition states for the cyclization, in which the one leading to the desired product exhibits the least 
amount of steric repulsion between the bulky OBn, Boc and OTBS groups. The stereoselective 
cycloisomerization reaction is a fascinating example of a highly convergent process  that can produce 
complex aza-spirocycles from a linear acyclic derivative in a single step. Conventional steps allowed 
B-ring closure to afford the target in 16 total steps and an impressive 28 % overall yield. 
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1.5 C-C Bond Formation via an N-α-Carbanion 
The next sub-division as formulated in Scheme 2, focuses on alkylation of N-containing enolates in 
which the -carbon has nucleophilic character. There are numerous variations on this theme and a 
selection of these will be covered. The Kazmaier-Claisen rearrangement, although strictly speaking is 
a pericyclic process, involves a nucleophilic α-carbon and as such will also be included here, as will 
the Steglich-Hӧfle rearrangement.  
1.5.1 -Carbanions with Memory of Chirality  
The term in the organic literature “Memory of chirality” (MOC) refers to a process in which an  
intermediate ‘remembers’ the initial configuration of a stereogenic element destroyed in the 
formation of that intermediate and transfers the chiral information to the product, without external 
influence.  
Tertiary aromatic amides with appropriate ortho groups in the aromatic ring possess axial chirality 
(atropisomerism) due to a slow -bond rotation (shown by an arrow in Figure 8), in which the 
relationship between the two conformers about the Ar-CO bond -bond is enantiomeric if R1 and R2 
are achiral, and diastereomeric if R1 or R2 are chiral. 
 
Figure 8 Axial chirality of tertiary aromatic amides 
Kouklovski and Alezra made use of this stereogenicity in the asymmetric synthesis of quaternary α-
alkyl amino acids via a MOC process (Scheme 20).42 An oxazolidinone, 1.46, generated from an 
amino acid, acetone and the appropriate aryl acid chloride, was isolated as a single diastereomer 
due to the axial chirality induced by the amino acid central chirality. Base-mediated enolization, 
though destroying the chiral centre, retained the atropisomer axis resulting ultimately in a highly 
stereoselective alkylation reaction. Very specific reaction conditions and enolization times were 
necessary in order to attain high yields and selectivities, and fine-tuning was necessary for some 
derivatives. Leucine, alanine, phenylalanine and methionine were alkylated via this methodology in 
yields of up 96 % and ees up to 96 %. Recrystallization improved ees to >99 % and these products 




Scheme 20 Reagents and conditions: a) i) dry acetone, Lewis acid M.S 4 Å, rt; ii) 1-naphthoyl chloride, rt; b)i) 
KHMDS-2DME (1.5 eq), THF or Et2O/tol or THF/tol, -78 °C; ii) R
1
X (5 eq).  
In 2014, the protocol was extended to include aldehyde electrophiles for producing enantiopure β-
hydroxy quaternary α-amino acids.43  
1.5.2 Chiral Amino Acid Enolate Equivalents 
However, undoubtedly one of the most prevalent and versatile approaches for the generation of α-
tertiary amine centres involves the diasteroselective alkylation of chiral amino acid enolate 
equivalents. The templates are often glycine-derived Schiff bases, and mostly cyclic. Various 
derivatives of chiral imidazolidinones, oxazinones, bis-lactim ethers and tetrahydropyrazinones have 
been successfully employed. Table 1 below summarizes a selection of reports pertaining to enolate 
alkylation of a range of chiral templates, derived from amino acids or other members of the chiral 
pool, used for the production of quaternary amino acids. Although the template designs are 
structurally different, they all rely on the same basic principle for chiral induction: a high degree of 
facial selectivity achieved by the generation of a rigid enolate with a set geometry, (whether through 
chelation effects or by virtue of being endocyclic) followed by electrophile approach onto the least 
















Table 1 Examples of Diastereoselective Enolate Alkylations Using Chiral Templates 
 
 
The five entries will now be briefly discussed. Entry 1 in Table 1 depicts an interesting approach by 
Wenglowski and Hegedus44 who utilized an Evans-type oxazolidinone 1.47 as the chirality inducer. 
The synthesis of the template 1.50 involved an intermolecular Pd(0)-catalyzed allylic amination 
between the oxazolidinone 1.47 and an allylic carbamate 1.48, followed by ozonolysis and 
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Scheme 21 Regents and conditions: a) Pd(PPh3)4-dppe, DMF, rt; b) O3, Me2S, DCM -78 °C to rt; c) 
cyclohexylamine, MgSO4, DCM; d) RX-KHMDS, THF, -78 °C to – 45 °C; e) HCl-THF 
 
 After some difficulties, the authors reported that best results were achieved when the entire four-
step sequence from 1.49 to the dialkylated aldehyde 1.51 was carried out without purification of the 
intermediates. Alkylation took place via the Z-aza-enolate of 1.50, in which the imine nitrogen and 
carbonyl oxygen were not chelated and the authors put forth the reasoning that such a 
conformation was preferred in order to minimize the dipole interaction between the N- and C=O, 
achieving high drs of >90:10.   
The example in Table 1, entry 2 is Husson’s45 protocol for generating quaternary serine derivatives, 
featuring an expedient synthesis of an oxazolidine alkylation template 1.52 that was achieved via an 
SN2 reaction between (R)-phenylglycinol methyl ether and BrCH2COtBu, followed by a [3 +2] dipolar 
cycloaddition involving paraformaldehyde. Quaternized products were accessed in good yields and 
selectivities via the electrophile approaching anti- to the phenyl group during the alkylation. Acidic 
cleavage of the auxiliary was problematic owing to the presence of the acid sensitive t-Bu ester, and 
the ethyl acetate derivative spontaneously lactonizing under the acidic conditions.  
Ma and Ding used an oxazinone 1.53 obtained from a Strecker product (NaCN addition to an imine 
derived from (R)-phenylglycinol and R1CHO) as a highly efficient alkylation template (Table 1, Entry 
3).46 Electrophile approach resulted in a cis relationship with the phenyl substituent derived from the 
auxiliary (except in the case of methyl bromoacetate), due to alkylation proceeding anti to the N-Bn 
group. Entry 4 in Table 1 is an example of a versatile template developed by Nájera in 2000,47 in 
which highly diastereoselective alkylations of a Val-Ala-derived pyrazinone 1.54 furnished 
quaternized pyraziniones 1.55, which upon acidic cleavage yielded a range of quaternary alanine 
amino acids (Scheme 22). The same template underwent Pd-catalyzed allylation with an allyl 
carbamate, furnishing a variety of allyl-substituted pyrazinones 1.56, likewise hydrolyzed to 




Scheme 22 Reagents and conditions: a) K2CO3 (3 eq.), TBAI (10 mol %), CH3CN, R
1
X, rt; b) Pd(OAc)2 (5 mol %), 
PPh3 (10 mol %), THF, R2OCO2Et, rt; c) i) 6N HCl, 150 °C; ii) propylene oxide, EtOH. 
The final example (Table 1, entry 5) showcases a recent application by Barrett and coworkers48 of 
the Schӧllkopf auxiliary for generating aryl-substituted quaternary amino acids. This ingenious 
methodology achieved an arylation and subsequent alkylation in a one-pot operation (Scheme 23). 
1,4-Dimethoxy-2-benzyne 1.58 was generated via an ortho-metallation and elimination sequence 
using sec-BuLi, whilst in the same pot the bis-lactim template 1.57 was deprotonated, resulting in 
nucleophilic attack of the resultant enolate onto the benzyne. The resultant aryl carbanion then 
underwent proton exchange to afford the more stable template carbanion 1.59, allowing for a 
second alkylation with a range of SN2-reactive electrophiles in good overall yield and selectivity (80-
92 % and drs of 96:4 and > 98:2). Less reactive electrophiles such as n-Bu in the second alkylation 
gave lower yields (50 -71%) but still high drs (95:5 to >98:2). One attractive feature of this 
methodology is that it can access α-arylated quaternary amino acids - these are a difficult target 
class – even if the choice of substituents on the aryl ring is limited. Hydrolysis to the amino acid 
products was problematic, especially for derivatives with two methoxy groups on the ring. Using 
0.5M HCl, the imidate α to the quaternary centre was only partially hydrolysed, giving methyl ester 
dipeptides 1.60. Eventually, acidic hydrolysis with 6M H2SO4 hydrolysed the dipeptide bond but only 
for the less bulky and less substituted derivatives, whilst the others were isolated as valine 




Scheme 23 Reagents and conditions: a) 6M H2SO4, 20 °C, 72h; b) i) 0.5M HCl, THF, 20 °C, 36h; ii) Boc2O, i-
Pr2NEt, CH2Cl2, 20 °C, 48h. 
The obvious drawback of the methodologies depicted in Table 1 is the low atom efficiency, since all 
the templates are destructively removed at the end of the process, and in some cases the synthesis 
of the alkylation template is lengthy (methodologies recycling the auxiliary do exist, but are less 
prolific). For this reason, enantioselective approaches using chiral catalysts have seen increased 
development in recent years, particularly phase-transfer catalysis.3,49 The early quaternary 
ammonium salts such as TADDOL, although efficient, often lacked generality. Maruoka’s C2-
symmetric chiral quaternary ammonium bromide catalyst 1.62, introduced in 2000, proved superior, 
with successful application to a much wider variety of substituents in the stereoselective sequential 
double alkylation of glycine-derived Schiff bases 1.61, as well as alanine-, isobutyl- and phenylglycine 
derivatives and cyclic amino acids (Scheme 24).50,51 Alkylations were carried out using five 
equivalents of cesium hydroxide and 1.2 equivalents of the electrophile, while hydrolysis to the 
quaternary amino acid esters was achieved with 0.5 M citric acid in yields of 58-89 % and ees of 82 
to 99 %. In 2005, the same catalyst was successfully applied to the enantioselective alkylation of 
cyclic α-amino β-ketoesters 1.63.50 Cinchona alkaloid derivatives and copper-salen complexes are 
other examples of salts that have found successful application in the PTC-catalyzed asymmetric 
alkylation of amino-acid derived Schiff bases.  
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Scheme 24 Alkylation of amino-acid derived Schiff bases according to Maruoka et al. 2000 and 2005 
Although PTC catalysis is successful in many instances of N-containing enolate alkylations, the best 
results for asymmetric allylations are generally achieved using chiral palladium complexes. Kozlowski 
et al.52 have reported an ingenious way of creating α-aryl-α-allyl amino acids via a three-component 
coupling of α-iminoesters, Grignard reagents and cinnamyl acetate (Scheme 25). The methodology 
offers an elegant solution to the difficult problem of creating aryl-containing ATAs, particularly for 




Scheme 25 Reagents and conditions: a) R2MgBr, -78 °C, THF to rt; b) 1.65a or 1.65b (4.9 mol %), [ƞ3-
C3H5PdCl]2 (7.5 mol %), -78 °C to rt.; c) Grotjahn catalyst (5 mol %), H2O, CF3COOH, acetone, 75 °C; d) CAN (3 
eq), MeCN/ H2O, -10 °C to rt.  
The enolate generated by the umpolung addition of the alkyl Grignard onto the iminoester 1.64 was 
reported as being far more reactive than if it were created by direct deprotonation, likely due to 
nuances in the degrees of solvation/ aggregation. The use of chiral bisphosphine ligands 1.65a and 
1.65b on palladium (II), rendered the tandem N-alkylation/-allylation of 1.64 enantioselective, and 
a variety of α-aryl-α-allyl amino acid ester derivatives 1.66 were obtained in good yields (72 – 89 %) 
and enantioselectivities (74 – 92 % ee). Both electron-donating and electron-withdrawing aryl 
substituents reacted effectively, although yields were reduced with ortho-substituted aryls. The 
Grignard reagents could also be successfully varied to provide novel and useful N-alkyl, α-aryl-α-allyl 
amino acid variants, although deprotection of the N-alkyl groups lengthened the sequence 
somewhat. Thus N-alkyl amino acid esters were accessed by CAN deprotection of the PMP group. 
Access to the free amine from derivative 1.67 was possible via olefin isomerization using the 
Grotjahn catalyst, which under thermal, acidic conditions isomerized the terminal alkene by two 
carbons to the enamine. The resultant enamine was then hydrolysed in situ under the acidic 
conditions, following which, CAN deprotection furnished the free amine 1.68. The presence of allylic 
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groups allowed for ring closing metathesis methodology, enabling the synthesis of higher ring 
homologues of α-proline.   
Another impressive arylation quaternization methodology developed was reported by the Clayden 
group in 2013.53 A variety of arylated amino acids were generated via an intramolecular process, 
involving an amino acid enolate and an aryl electrophile, bridged by a urea linker. The new C-C bond 
was installed α to the amino acid via the migration of the N-phenyl substituent of the urea onto the 
enolate through an SNAr process. Subsequent cyclization gave rise to hydantoins, which upon 
hydrolysis generated quaternary aryl amino acids. In 2015,54 an asymmetric protocol for this 
transformation using pseudoephedrine as a chiral auxiliary tethered to a range of amino acid 
derivatives (Scheme 26) was disclosed.  
 
Scheme 26 Reagents and conditions: a) LiOH, H2O, THF b) EDC.HCl, HOBt, i-Pr2Net, CH2Cl2, rt; c) i) LDA (2 eq), 
THF, -78 °C; ii) Me3SiCl (2.1 eq) iii) LDA (2 eq) -78 to 20 °C; iv) K2CO3, MeOH; d) NaOH (4M), reflux.  
Ethyl or methyl esters of various amino acids were acylated with appropriate carbamoyl chlorides 
and then coupled to pseudoephedrine after hydrolysis of the ester. The resultant ureas 1.69 were 
treated with LDA and Me3SiCl, to furnish hydantoins 1.70 with regeneration of pseudoephedrine. 
The yields and selectivities of the rearrangement were found to depend on the number of 
equivalents of Me3SiCl, in which 2.1 equivalents was optimal. This stoichiometry suggested the initial 
silylation of the pseudoephedrine hydroxyl, followed by trapping of the urea anion, allowing for an 
intermediate that could undergo deprotonation with further LDA to the reactive enolate species. 
Alanine, methionine, butyrine, n-propylglycine, leucine, lysine, and proline were all arylated with a 
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phenyl and other electron-rich rings. Yields were moderate to good, with high levels of 
stereoselectivity. Results worsened with increasing steric bulk of the amino acid and valine and 
phenylglycine ureas did not react. Electron-deficient rings gave lower yields and much lower 
selectivities, while substrates bearing allyl, benzyl and indolyl- groups on the amino acids did not 
rearrange successfully.  
1.5.3 α-Amidomalonate Carbanions 
The enantioselective alkylation of prochiral α-amino malonates is an uncommon but further 
intriguing approach for accessing ATAs. Of crucial importance is the chemodifferentiation of the 
malonate esters in the end game. Park et al. 55 achieved overall transformation in 2015 with the use 
of  Maruoka’s chiral phase-transfer catalyst 1.62a,  (Scheme 27). The amido-malonates were 
accessed via the diazotization of malonates followed by conversion to a carbenoid that inserted into 
the NH bond of acetamide. Various amido-malonates were tested, arriving at 1.71 as the best 
substrate for α-alkylation, which was then subjected to PTC alkylation using 1.62a with KOH as base. 
Activated benzylic electrophiles gave much better enantioselectivities than activated aliphatic ones, 
while alkylation with unactivated electrophiles was disappointing. A typical endgame post alkylation 
is illustrated for (R)-α-benzylserine in Scheme 27 involving hydrogenolysis to achieve chemoselective 
ester differentiation, azalactone formation, reduction and finally acidic hydrolysis to afford the ATA.  
 
Scheme 27 Regents and conditions: a) p-ABSA, Et3N, CH3CN, 0 °C; b) AcNH2, Rh2(OAc)4, ClCH2CH2Cl, reflux; c) 
1.62a (5 mol %), RX, 50 % KOH, (5 eq), toluene; d) Pd/C, H2, MeOH, rt; e) EtOC(O)Cl, NMM, THF, -10 °C; f) 
NaBH4, THF, H2O, rt; g) 6N HCl, MeOH, reflux.  
1.5.4 α-Aziridinyl Carbanions 
Enantiomerically pure aziridines are useful and versatile building blocks in the synthesis of ATAs in 
which aziridine 2-carboxylates are particularly desirable as intermediates of α,α-disubstituted amino 
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acids. A typical route to aziridine 2-carboxylates is via the aza-Darzens reaction involving the reaction 
of ethyl diazoacetate with an aldimine (Scheme 28). 
 
Scheme 28 Mechanism of the aza-Darzens reaction 
Access to ATAs is, however, not possible via this route as the reaction only works well with 
unsubstituted diazo esters, but not when a group is present α to the ester. This is where electrophilic 
substitution via a carbanion at the -position of the aziridine can provide a solution, which although 
challenging, is possible owing to the acidity of the C-2 proton. The difficulty in alkylation of chirally 
pure aziridine-2-carboxylates stems from their propensity to undergo ring opening and self-
condensation reactions upon enolate formation.56 Normally, only thioesters of aziridin-2-
carboxylates are useful, or a chelating substituent on N is needed in order to stabilize the enolate.57 
Nevertheless, Wulff and co-workers were able to employ a benzhydrol group on nitrogen very 
successfully in the alkylation, and extended the methodology in their synthesis of the LFA antagonist 
BIRT-377 (Scheme 29).58  The generation of the required aziridine 2-carboxylate 1.72 in an 
enantioselective fashion was achieved by employing (S)-VAPOL-B as a catalyst for the asymmetric 
aza-Darzens reaction, which gave the aziridine 1.72 in 87 % yield and 94 % ee. Thereafter, alkylation 
with LDA and a range of electrophiles proceeded with retention of configuration at C-2 to give 
quaternary aziridines 1.73. Primary alkyl iodides gave moderate yields while aldehydes gave 
excellent yields but with no selectivity at the alcohol chiral centre. The benzhydrol group was found 
to be crucial to the reaction and the aziridine also had to be substituted at C-3. Following alkylation, 
quaternary amino acids could be accessed via removal of the benzhydrol group and hydrolytic ring 




Scheme 29 Reagents and conditions a) 1 mol % (S)-VAPOL-B catalyst (prepared by heating 1.74 with triphenyl 
borate in CCl4 at 85 °C), CCl4, rt; b) LDA, -78 °C DME/Et2O (5:1); c) R
2
X, warm to 25 °C; d) BH3Me3N (12 eq), TFA 
(9 eq) CH2Cl2 0 °C to rt; e) Et3SiH (3 eq) TFA, reflux. 
In the past, the generation of chirally pure substituted aziridines was mainly achieved by elaboration 
of acyclic members of the chiral pool, but as the example above shows, asymmetric catalytic 
methods are becoming a popular and more direct strategy.  
1.5.5 α-Amino Nitrile Carbanions 
The use of α-amino nitriles as synthetic equivalents of α-amino carbanions has been practiced for 
decades. They owe their utility to the strong anion stabilizing ability of the nitrile group and provide 
useful precursors and building blocks for many nitrogen containing compounds.  
The enantioselective synthesis of a series of  -aryl, -alkyl amino acids was recently achieved by 
alkylation of a chiral α-aminonitrile 1.77, derived from the Strecker product of an aromatic  aldehyde 
1.76 and the Weinges auxiliary 1.75 as illustrated in Scheme 30.59 The phenyl group of the auxiliary is 
postulated as blocking the rear face of the keteneiminate β-carbon, resulting in frontside attack by 
the electrophile.  
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Scheme 30 Reagents and conditions: a) KCN (1.3 eq), pH 5, H20/MeOH 1:1, rt; b) KHMDS (1.3 eq), R
2
X (1.3 eq), 
THF, -78 °C; c) 12 N HCl -10 to 55 °C; d) Raney-Ni, air, 2M NaOH, 120 °C. 
The Strecker reaction of 2-naphthaldehyde 1.76b and benzaldehyde with KCN gave aminonitrile 
1.77b as a single diastereomer after crystallization. Anion formation with KHMDS and subsequent 
alkylation with a range of electrophiles proceeded smoothly, although the products had to be 
immediately subjected to nitrile hydrolysis and oxidative auxiliary removal. The final quaternary 
amino acids were isolated in yields of 21 – 81 % and in high enantiomeric purities (80 to > 98 %).  
Nitrile-stabilized carbanions (ketene iminates) can also be useful in the construction of complex 
scaffolds through intermolecular alkylation followed by cyclization, and indeed have proven valuable 
in a recent total synthesis of lepadiformine.  Rychnovsky devised a method for diastereoselective 
spirocyclization by generating an α-amino alkyllithium reagent from an α-amino nitrile (Scheme 
31).60 The highlight of this convergent synthesis is the expedient and stereoselective construction of 
all three rings from acyclic precursors. The enantiomerically pure dibromide was prepared from 
aldehyde 1.78 using an enantioselective ketone reduction employing a chiral hydrogen-transfer 
catalyst; Elaboration of the side chain involved an oxidation and a second Nyori-Ikariya reduction, 
followed by alkyne reduction of 1.79 with platinum oxide and removal of the TBS group. SN2 
bromination of the two hydroxyl groups of 1.80 using bromine, PPh3 and triethylamine, generated 
the dibromide in good overall yield. The initial nitrile anion of 1.81 displaces the primary bromide 
and the additional equivalent of base generates a second nitrile anion which then closes the ring in a 
6-exo-tet fashion. Attempts to include the hydroxymethyl side-chain for lepadiformine A on the 




Scheme 31 Reagents and conditions: a) PtO2, H2, (200 psi); b) PPTS, MeOH; c) PPh3, Br2, Et3N; d) LDA (3.5 eq), 
DMPU/THF (1:1)-78 °C to 0 °C. 
1.5.6 Addition of N carbanion to Allenoates 
In 2015, Fu and co-workers61 disclosed a stereoselective protocol for the ϒ-addition of a racemic 
heterocycle 1.82 to a racemic allenoate 1.83 using a chiral phosphine catalyst 1.84 for creating 
enantioselectivity ultimately. The sequence involved a cascade of steps that was initiated by addition 
of the chiral catalyst 1.84 to the allene central carbon in a Michael addition. Thereafter, proton 
exchange with the heterocycle (oxazolone 1.82 in Scheme 32) followed by a second and 
stereoselective Michael addition of the oxazolone carbanion to the vinylphosphonium salt, proton 
transfer and phosphine elimination (regeneration) furnished the -addition product 1.85. Acid 
hydrolysis allowed access to a range of α,α-disubstituted amino acids in good yields, 
diastereoselectivity and enantioselectivity (Scheme 32). 
Scheme 32 Reagents and conditions: a) 5-10 mol % 1.84, 10 % 2-chloro-6-methylphenol, i-Pr2O, 0°C; b) 1 M 
HCl, 80 °C.  
It is impressive, starting with relatively simple racemic substrates, that two stereocenters could be 
generated with good relative and absolute selectivities, one being a quaternary centre. Furthermore, 
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the protocol proved to be rather general, tolerating various functionalities in both the allenoate and 
the oxazolone. The one drawback, though, was that the reaction failed with R2 = aryl. This problem 
was overcome by employing an imidazolone template 1.86 instead of an oxazolone. Aryl groups 
stabilize the conjugate base of the nucleophile through resonance, thereby decreasing its 
nucleophilic potential and reactivity. However, substitution of the electron-withdrawing oxygen with 
nitrogen provided, through its resonance releasing effect, a desired increase in nucleophilicity. 
Indeed, good yields and selectivities were obtained with various aryl- substituted nucleophiles, 
providing 2-amino-3,5-dihydro-4H-imidazol-4-one adducts 1.87, which are valuable targets in their 
own right aside from being precursors of α,α-disubstituted amino acids (Scheme 33).  
Scheme 33 Reagents and conditions: a) 10 mol % 1.87, 10 % 2-fluoro-6-methoxyphenol, toluene, 10°C. 
The methodology provides a class of compounds which could undergo a range of transformations to 
yield interesting and complex molecules by manipulating different functionalities.  
1.5.7 Rearrangements involving an N-α carbanion 
Kazmaier-Claisen Rearrangement 
In this variant of the ester-enolate Claisen Rearrangement, a chelated metal enolate of N-protected 
amino acid allyl esters 1.88 undergoes a Claisen rearrangement at room temperature (Scheme 34). 
Metal salts such as MnCl2 are added in order to chelate the enolate, setting the enolate geometry to 
ensure high diastereoselectivity in the rearrangement.  
Scheme 34 Reagents and conditions: a) i) LDA (4 eq), MnCl2 (1.2 eq) THF -78 °C to rt.     
Kim et al62 incorporated a cyclic amino acid α to the allylic ester to bring about a combination of the 
Kazmaier and Ireland-Claisen rearrangements stereoselectively, generating the ATA required for 
their Formal total synthesis of lepadiformine (Scheme 35). In the Ireland-Claisen version, the allyl 
ester of a carboxylic acid is converted to its silyl-stabilized enolate (silyl ketene acetal), which 
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rearranges at temperatures below 100 °C to ultimately give chain-extended carboxylic acids. Their 
synthesis began with (S)-pyroglutamic acid, which was converted to acid 1.89 in 8 known steps, 
followed by production of the allylic ester 1.91 via a DCC coupling procedure with allylic alcohol 
1.90a and in their revised synthesis 1.90b. The rearrangement proceeded upon the treatment of 
1.91a and b with LHMDS and TBSCl via a chair-like transition state in which selective formation of 
the (Z)-silyl ketene acetal was crucial to the stereoselectivity of the reaction, ultimately furnishing 
the desired products 1.92a and b both in a ratio of 10:1. Presumably, chelation of the lithium by the 
nitrogen and the oxygen of the enolate ensured selectivity for the (Z)-configuration. Further in the 
synthesis, ring-closing metathesis brought about ring closure at the spirocyclic junction, and simple 
functional group manipulation generated the Weinreb intermediate 1.93, a common intermediate in 
the total enantioselective synthesis of (-)-lepadiformine.  
Scheme 35 Reagents and conditions: a) DCC, DMAP, CH2Cl2, rt; b) LiHMDS, TBSCl, THF, -78 °C to rt; c) 
TMSCHN2, MeOH, rt; d) TFA/ CH2Cl2 (3:5), 0 °C to rt; e) L-Selectride, THF, -78 °C; f) NaCNBH3, MeOH, -78 °C; g) 
LiAlH4, THF, -78  to 0 °C; h) MsCl, Et3N, Et2O, 0 °C; i) allylMgBr, CuI, THF, - 78 °C to rt. 
38 
 
In their revised and more concise synthesis of lepadiformine and Fasicularin published in 2014, the 
key step was a stereoselective reductive amination of a common intermediate, giving rise to 
indolizidines 1.95 and 1.96 (Scheme 35), precursors of lepadiformine and Fasicularin respectively.63 
A more complex rearrangement product 1.92b was devised and synthesized from a known ketone 
and arrived at as before, via the Claisen rearrangement protocol. An iminium salt 1.94 was 
generated by treatment of 1.92b with TFA, removing both the Boc and ketal groups. Based on their 
in-depth model studies for the reductive amination, they were able to generate either stereoisomer 
of the indolizidine product in high selectivities depending on the reagent employed in the reductive 
amination step. The alkaloids were accessed via an aziridine-mediated carbon homologation from a 
hydroxymethyl to a homoallyl group and an additional three steps in the case of (-)-lepadiformine.  
Steglich-Hӧfle rearrangement 
The rearrangement of an O-acylated azalactone 1.97 into the corresponding C-acylated oxazinone 
1.99 offers a practical entry into quaternary oxazolones as precursors of α-alkylated α-amino 
malonic acids. Since the mechanism involves an acyl transfer, the reaction is typically catalyzed by 
DMAP, whose chiral derivatives have been developed for asymmetric transformations. The first 
example of an asymmetric catalytic Steglich-Hӧfle rearrangement was reported in 1998 by Ruble and 
Fu64 who utilized a planar chiral, ferrocene-derived 4-(pyrrolidino)pyridine catalyst 1.98 to access 
products in yields of 93-95 % and ees of 88-92 % (Scheme 36). More recently, Seidel65 disclosed a 
dual-catalysis approach for the asymmetric Steglich rearrangement, which was incidentally also 
applicable to azalactone addition to isoquinolines. The use of an isoquinoline instead of DMAP as a 
nuceophilic activator generated the intermediate 1.100 which made it possible for the incorporation 
of the isoquinoline into the product (mechanism shown in red), providing entry into highly 
functionalized α,β-diamino acid derivatives 1.102. No further transformations of the derivatives 
were reported in the account however. 
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Scheme 36 Reagents and conditions: a) 1.101 (10 mol %), mesityline/ pentane (1:2), 4 Å MS, -15 to -
35 °C; b) 1.101 (20 mol %), DMAP (20 mol %), PhMe, 4 Å MS, -78 °C.  
1.6 C-N Bond Formation via an Electrophilic Nitrogen  
1.6.1 Electrophilic amination with an azodicarboxylate 
Aminating enolates with a suitable electrophilic nitrogen source is one of the simplest and quickest 
ways to generate ATAs in which azodicarboxylates, N-hydroxycarbamate, nitrosobenzene, NH2-LG 
(LG = leaving group) and azidoiodane reagents have been used. Although diastereoselective 
auxiliary-based approaches using electrophilic amination for synthesizing α-secondary amines is 
common, their use in ATA generation is rare, the work of Castellanos et al in 2002 being 
noteworthy.66 In their route, lithium enolates of D- or L- asparagine-derived 
tetrahydropyrimidinones 1.103 were aminated with di-tert-butyl azodicarboxylate (DBAD) in yields 
of 80 to 85 % and drs of up to 87:13. A further three steps including destructive removal of the 
auxiliary, (a disadvantage) gave enantiopure α,α-dialkyl amino acids (Scheme 37).  In the amination 
reaction, the bulky amino acid side chain blocks one of the faces of the enolate, ensuring 
electrophile approach from the opposite face.  
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Scheme 37 Reagents and condition: a) LDA, THF, -78 °C b) RX, -30 °C; c) LDA, THF, -78 °C, 2h. 
By contrast, catalytic approaches are far more prolific.67 The first catalytic asymmetric electrophilic 
amination was reported by Evans68 back in 1997 who utilized a chiral magnesium bis (sulfonamide) 
complex to activate aryl carboximides toward reaction with DBAD to generate α-secondary amines. 
Azodicarboxylates are the most widely used aminating reagent due to their high electrophilicity and 
ease of steric bulk manipulation which has a bearing on enantioselectivity. Di-tert-butyl or dibenzyl 
azodicarboxylates are favoured, because the products they yield can easily be transformed into 
amines via removal of the Boc or Cbz group and cleavage of the N-N bond. Unfortunately, their 
electrophilicity is much lower than that of azodicarboxylates with smaller ester groups, creating the 
need for further activation of the nucleophile. Different activation models for reactions with 
azodicarboxylates will be covered in the following section where the sub-sections focus on the 
nucleophilic partner. 
1.6.1.1 Aldehyde Enamines 
The use of chiral amine catalysts to generate chiral enamines from α-substituted prochiral aldehydes 
has been successful in many instances. The scope of enamine strategies can be limited, particularly 
for acyclic variants where selectivity depends on controlling E or Z-enamine selectivity.  
Proline and its derivatives have been used extensively for enamine-based approaches, as well as 
primary amines derived from a range of sources such as amino acids. Similarly, the Cinchona alkaloid 
framework, where additional H-bonding interactions can come into play, has also been intensely 




Scheme 38 Chiral amines used for enamine activation towards electrophilic amination with 
azodicarboxylates. 
Barbas et al69 employed the proline derived tetrazole 1.104 in their enantioselective total synthesis 
of BIRT-377, which delivered the product in 95 % yield and 80 % ee, effectively raised to 99 % by 
recrystallization. A further seven steps delivered BIRT-377 in an impressive overall yield of 76 %. In 
2011, Wang and co-workers70 discovered that the simple primary amino acid 1.105 was a potent 
catalyst for amination of branched benzaldehydes with diethyl azodicarboxylate (DEAD) or isopropyl 
azodicarboxylate.70 The use of 20 mol % of the HCl salt of 1.105, furnished the desired products in up 
to 99 % yield and 97 % ee. Lu et al71 employed the cinchona alkaloid variant 1.106, also possessing a 
primary amine for the same transformation, in conjunction with 20 mol % of (-)-camphorsulfonic 
acid [(-)-CSA] and DBAD as the aminating reagent. The efficiency of the reaction was highly 
dependent on the chirality match between the amine and the CSA, with lower selectivities and yields 
observed when (+)-CSA was used.  A further three operations gave the protected amino acids in 
good yields (Scheme 39).  
 
Scheme 39 Reagents and conditions: a) NaClO2, H2O2; b) TMSCNH2; c) SmI2 
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Although the enamine activation strategy is successful for the amination of simple α-branched 
aldehydes with azodicarboxylates leading to ATAs ultimately, ketone counterparts cannot be 
activated in this way due to a decreased reactivity and increased steric bulk. Employing a chiral 
Brønsted base or organosuperbase to abstract the α-proton in this case is a good way of overcoming 
the low acidity of the α-proton and prime α-branched ketones toward reaction with 
azodicarboxylates.72 
1.6.1.2 Ketone activation 
In a different approach for ketone activation, Toste and Yang73 disclosed an asymmetric amination 
protocol of branched cyclic ketones involving catalysis by a chiral phosphoric acid 1.107 (Scheme 
40). Both alkenyl and aryl 2-substituted cyclic ketones could be directly aminated using DBAD and 10 
mol % of the catalyst. Various substituted aryls at the α-position of the cyclohexanone were 
tolerated, including electron neutral, electron-donating and electron-withdrawing groups attached 
to the aromatic ring. A broad scope was also achieved with respect to alkenyl substituents on the 
cyclohexanone.  
 
Scheme 40 Reagents and conditions: a) 1.107 (10 mol %), 5 Å MS, 45 °C, ‘neat’ 
1.6.1.3 Ketenes and Lewis Base Catalysis  
Ketenes are excellent substrates for ionic [2+2] cycloaddition reactions with diazo compounds once 
nucleophilically activated, providing entry into highly substituted cyclic compounds, such as the 
versatile aza-β-lactams in particular. Berlin and Fu74 were the first to report on this type of 
enantioselective reaction by employing a chiral, planar DMAP type catalyst 1.108. The resulting 
lactams could be converted to hydantoins, or α,α-disubstituted amino acids (Scheme 41). For this 
type of transformation, so far only aryl ketenes have been reported. 
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Scheme 41 Reagents and conditions: a) 1.108 (5 mol %), CH2Cl2, -20 °C; b) K2CO3, MeOH; c) pyridine then TFA; 
d) SmI2, MeOH; e) conc. HCl. 
1.6.1.4 Stabilised enolates  
Apart from favourable reactivity, this type of substrate is ‘popular’ as it provides an easily 
functionalizable handle on the aminated adduct. Furthermore, a better chelation control in chiral 
metal complex-catalysed reactions can be achieved as in the case of using two carbonyl groups.. 
Since Jørgensen’s first account of α-amination of β-keto esters in 2003,75 an impressive body of work 
has been published using dicarbonyls with differing activation models, two of which will be discussed 
below.  
Chiral Lewis acid activation  
Chiral ligands complexed to a Lewis acid effectively catalyse amination of carbonyls and many 
examples are found in the literature. A notable example Is that of Kim et al,76 who developed a 
BINAP derived chiral palladium(II) complex 1.109, stable to air and moisture which was capable of 
catalysing a wide range of β-keto esters in excellent yields and enantioselectivities (Scheme 42). 
Apart from a low catalyst loading (5 mol %), the catalyst could also be bound to an ionic liquid and 
recycled 5 times without loss of activity. The same catalyst was found to be efficient in the α-
amination of α-cyano ketones.  
Scheme 42 Reagents and conditions: a) 1.109 (5 mol %), MeOH, rt. 
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Chiral Lewis base catalysis 
Carrying out the amination via a chiral enolate derived from a chiral Brønsted bases was first 
reported by Jørgensen. Multifunctional catalysts with one or multiple H-bond donor sites which 
serve to anchor the enolate, gave very good results when in co-operation with tertiary amines bases 
present on the same molecule. Hydroxyl and thiourea moieties are common H-bond donor sites, and 
catalysts based on the cinchona alkaloids are also an obvious example. Other motifs have also 
proven effective such as Takemoto’s bifunctional tertiary amine catalyst 1.110, which incorporated 
2-aminoquinazoline as the H-bond donor, and owing to its conformational rigidity was capable of 
inducing highly asymmetric aminations (81-94 % ee)(Scheme 43). 77   
 
Scheme 43 Chiral Lewis base catalysis for asymmetric amination of β-keto esters 
1.6.2 Electrophilic Azidations  
Organoazides are highly desirable targets in organic synthesis as they can engage in many types of 
transformations such as simple reduction to the amino group, generation of nitrenes, cascade 
reactions and can play the role of triggering rearrangement and cycloaddition reactions. Developing 
stereoselective azidation reactions is therefore an important endeavour in synthetic chemistry. 
While nucleophilic azidation reagents such as sodium azide are well known for azide introduction, 
electrophilic azidations have only come to the fore relatively recently as the traditional reagents are 
toxic and explosive. Sulfonyl azides are widely used, but generally give best results with strongly 
nucleophilic lithium enolates.78 Furthermore, dicarbonyls often suffer from competing diazo transfer 
and rearrangement reactions.79 The creation of an umpolung azide in-situ is a way of overcoming 
this hurdle and can be done by using strong oxidizing agents, exemplified by the sodium azide and 
IBX protocol.80 However, in these pathways the active azidation reagent is still a mystery or highly 
unstable and as such cannot be isolated, making progress on asymmetric induction mechanistic 
thinking difficult. In contrast, the superior stability of the benziodoxol-based hypervalent iodine 
reagents introduced by Zhdankin in 1994,81 allow for the development of catalytic asymmetric 
methodology with greater ease.  
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Gade et al82 reported on the first enantioselective azidation of cyclic β-keto esters 1.111 and 
oxindoles 1.116 catalysed by Iron salts combined with chiral pincer ligands 1.113 (‘boxmi”) (Scheme 
44) in 2013. For the enantioselective azidation of β-keto esters, the best results were obtained with 
in-situ formation of the catalyst (generated by mixing the iron (II) chloride complex 1.114 and silver 
benzoate 1.115), without the need for removal of silver chloride. Bulky ester substituents were 
necessary for good enantioselectivities and cyclic six-membered rings could only be obtained with 
moderate selectivities; the protocol was unfortunately not effective for acyclic ketoesters. 3-
aryloxindoles were also successfully azidated in high yields and selectivities, regardless of the nature 
and position of oxindole substituents. 
 
Scheme 44 Reagents and conditions: a) 1.114 (10 mol %), 1.115 (10 mol %), 1.112 (1.5 eq), Et2O, rt; b) 
Fe(OOCEt)2 (10 mol %), 1.113 (10 mol %), 1.112 (1.5 eq),  Et2O, rt. 
Hartwig and Sharma83 utilized a very similar azidation reagent 1.117 in a metal-catalysed azidation of 
tertiary C-H bonds, using tridentate nitrogen ligands of the pybox family 1.118 (Scheme 45). Because 
the methodology is mild and selective for the tertiary C-H site, it allowed for late-stage azidation of 
complex structures without the use of excess amounts of valuable material. Furthermore, it 
tolerated aqueous conditions and a variety of functional groups such as esters, carboxylic acids, 
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amides and protected alcohols. In cases with multiple tertiary C-H sites, the regioselectivity of the 
reaction was such that azidation took place at the more electron- rich site, and this held true for 
cyclic substrates as well. When applied to  more complex systems with several functional groups and 
strained rings, which could react or influence azidation preference, selectivity was still excellent (5:1 
to 11:1:1) and yields were moderate to good (24 -80 %). In terms of stereoselectivity in ring systems, 
axial azide attack was favoured, thus even when a mixture of diastereomers was reacted, the result 
was one major azide product. 
Scheme 45 Selected examples of tertiary C-H bond azidations 
1.7 C-N Bond Formation via a Nucleophilic Nitrogen  
Forming the C-N bond in the last step of ATA generation by action of a nucleophilic nitrogenous 
reagent is fairly uncommon, the aza-Michael and SN2 reactions at a quaternary carbon being 
representative examples. 
1.7.1 Aza-Michael Addition 
The aza-Michael addition is one of the most versatile and direct ways to create the C-N bond and 
access useful β-amino carbonyl compounds and heterocycles, owing to the broad variety of 
nucleophiles, acceptors and catalysts that can be employed. Enals, enones, conjugated esters, nitro 
olefins and vinyl sulfones are all appropriate Michael acceptors, whilst moderate nitrogen 
nucleophiles such as sulphonamides, carbamates, oximes, hydrazines, azides or nitrogen-containing 
heterocycles can participate as Michael donors. Furthermore, both basic (aminocatalysis) and acidic 
catalysis can be employed.84  As such, it features prominently in organic synthetic chemistry and in 
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numerous total syntheses of natural products. The intramolecular version in particular, provides a 
reliable way to construct heterocycles, often with a high degree of diastereoselectivity. Shibasaki 
took advantage of it in his total synthesis of lepadiformine (vide supra), as did a number of 
cylindricine syntheses,85–87 a recent one of which will be covered in section 1.10. Asymmetric aza-
Michael-initiated domino reactions can be highly effective, offering an expedient construction of 
complex heterocycles.88 Access to enantioenrinched aziridines bearing a quaternary carbon has been 
achieved via an organocatalyzed aza-Michael initiated ring closing reaction (leaving group present on 
the nitrogen), hence the ATA is not directly set by the aza-Michael. These derivatives were further 
proliferated to α,α-disubstituted amino acids via regioselective ring-opening reactions.89 However, 
as prolific as it is for the construction of asymmetric α-secondary amines, applicability rarely extends 
to ATAs. The limitation in the context of stereoselectivity for ATAs, lies in the difficulty in controlling 
the cis/trans geometry at the double bond terminus of the disubstituted enone or enal. Hence, it is 
yet to be developed as a general approach for asymmetric ATA construction.  
1.7.2 SN2 with NaN3 
The generally accepted dogma of SN2 reactions being unable to accesss quaternary centres from 
tertiary halides as taught in most undergraduate courses is apparently not entirely true. In 2012 
Shibatomi et al90 demonstrated that chlorinated β-keto esters could then be displaced in an SN2 
reaction with a variety of nucleophiles, including sodium azide, providing access to the ATA in 
enantioenriched form. To achieve enantioselective chlorination, a number of chiral ligands were 
tested for chelation to copper (II), coupled with NCS as a chlorinating reagent. Spirooxazoline ligand 
containing a quinolone backbone 1.119 gave the best selectivities and yields, with a reaction scope 
that extended to both cyclic and acyclic variants as well as aliphatic and aromatic esters (Scheme 
46). One requirement for high selectivity was the presence of a bulky ester group in the substrate. α-
Alkyl malonates could also be chlorinated in good to high selectivities.  
 
Scheme 46 Reagents and conditions: a) 1.119 (12 mol %), Cu(OTf)2, benzene, rt. 
Simple SN2 substitution of quaternary chlorinated derivatives 1.120 proceeded smoothly with 
sodium azide, the product of which could in turn be reduced to a free amine, thereby delivering 
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ATAs without any alteration in enantiopurity of the derivatives (Scheme 47). The SN2 mechanism was 
supported by X-ray crystallographic data which revealed an inversion of configuration at the 
quaternary carbon.  
 
Scheme 47 SN2 displacement of chlorinated β-keto esters with NaN3 to generate quaternary azides 
1.7.3 SN2 via Mitsunobu  
The Mitsunobu approach to ATAs from the corresponding tertiary α-hydroxy esters has been 
achieved with HN3 as the nucleophile, following which azide reduction and ester hydrolysis furnishes 
quaternary amino acids.91 Craig and Caldwell were able to apply this principle using a SES-protected 
primary amine intermediate (SES = 2-(trimethylsilyl)ethylsulfonyl) for an early construction of the 
ATA of lepadiformine via an epoxidation-aziridination sequence (Scheme 48).92 Starting from the 
substituted cyclohexanone 1.121, a substrate-controlled stereoselective epoxidation delivered the 
epoxide 1.122 in a yield of 96 % and almost perfect diastereoselectivity. The high levels of selectivity 
observed were a result of the bulky acetal side chain positioned equatorially, and the approach of 
the Corey sulfoxonium ylide equatorial onto the ketone carbonyl. The epoxide was then opened with 
the anion of SESNH2 to afford amino alcohol 1.123, which underwent a modified Mitsunobu reaction 
to give the ATA as the spiroaziridine 1.124 with complete inversion of configuration. The aziridine 
was opened by the -sulfonyl carbanion of methyl phenyl sulfone (step d)) to give the precursor 
1.125 for the crucial cyclization tandem reaction. Conversion to the dilithio dianion (- to sulfonyl 
and on N) and reaction of it with 2-benzyloxyethanal led to addition of the carbanion, and the 
ensuing alkoxide was activated in-situ with benzoyl chloride, resulting in the elimination to the vinyl 
sulfone intermediate 1.126. This then underwent formation of the N-SES protected pyrrolidine 1.127 
via a 5-endo-trig cyclization. From here one could proceed to the target alkaloid. Interestingly, 5-
endo-trig cyclizations are disfavoured according to Baldwin’s rules,93 and the clever use of the 




Scheme 48 Reagents and conditions: a) Me3S(O)I, NaH, DMSO; b) SESNH2, K2CO3, DMF; c) 1,1'-
(azodicarbonyl)dipiperidine  (ADDP), PMe3, THF; d) PhSO2Me, n-BuLi, THF; e) i) n-BuLi; ii) PhCOCl. 
1.8 Radical Azidation94 
Radically mediated processes provide an efficient, mild and often general method for azide 
introduction. This next section will briefly present the advances in the generation of ATAs via radical 
protocols. 
Improving on the carboazidation of alkenes, Renaud utilized α-iodoketones 1.128 for radical 
carboazidation to generate α-tertiary azide 1.129, with functionalized substituents such as esters 
and protected hydroxyls for providing a facile entry into substituted pyrrolidines 1.130 (Scheme 49).  
 
Scheme 49 Radical carboazidation of α-iodoketones 
This provided a solution to ATA generation in natural products such as monomorine I, cylindricine C 
and lepadiformine. However, the methodology is not without drawbacks, with the main one being 
the use of organotin reagents and the need to use a three-fold excess of arylsulfonyl azide.  
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Refining his α-iodoketone methodology, Renaud developed a single reagent for both alkene addition 
as well as the azide source in the form of ethoxycarbonylmethylsulfonyl azide 1.131 in which SO2 is 
expelled during the addition. A sun lamp provided the energy necessary for the radical initiation with 
di-tert-butyldiazine. Thus far the methodology is applicable to monosubstituted alkenes giving rise to 
tertiary azides, whilst quaternary azides are generated for cyclic structures only; azidation on 
disubstituted alkene groups leading to open chain quaternary azides has not been reported (except 
when both groups on the alkene are methyl groups). To illustrate its utility, Renaud employed 
desulfitative carboazidation to construct an azaspirocentre, and applied this to the total synthesis of 
(±)-lepadiformines A and C (Scheme 50).95,96  
 
Scheme 50 Reagents and conditions: a) H2 (50 bar), Pd/CaCO3 (cat.), EtOH, 100 °C; b) Me2AlCl (2 eq), DCE, 
reflux; c) 
Methylenecyclohexanes 1.132a and b were subjected to the carboazidation reaction with the 
sulfonyl azide 1.131 to afford the azido esters 1.133a and b as a 3:2 mixture of separable trans/cis 
isomers. Azide reduction, followed by stereoselective reductive amination, gave a 10:1 mixture of 
azadecalin diastereomers 1.134a and b.  Lactamazation gave the tricyclic lactams 1.135a and b, a 
common intermediate for both (±)-lepadiformine A and C. The ingenuity of the methodology lies in 
the fact that both the alkyl radical and the azido group are present in the same reagent making the 
process efficient and atom-economical.   
1.9 Molecular Rearrangements  
A practical alternative to direct ATA synthesis is to make use of molecular rearrangements, in which 
the quaternization takes place with a surrogate group. The amino moiety can be generated after 
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rearrangement to a quaternary carbon, or the rearrangement itself generates the ATA. A crucial 
feature of many rearrangements is a well-defined transition sate that leads to high levels of 
stereospecificity and/or selectivity.97 Furthermore, the fact that these are atom-economic processes 
by nature, adds to their efficacy as successful synthetic methodologies. Steglich, Curtius and Schmidt 
rearrangements can be classified as [1,2] sigmatropic, whilst the Overman and cyanate to isocyanate 
rearrangements are [3,3] sigmatropic processes. [2,3] Sigmatropic rearrangements are generally less 
common for the construction of ATAs, particularly stereoselectively, successful examples being the 
aza-Wittig rearrangement98 and sulfide rearrangement.99  
1.9.1 Curtius rearrangement  
This rearrangement reaction dates back to 1890,100 when Theodor Curtius noted the decomposition 
of an acyl azide with loss of nitrogen gas, giving rise to aniline following the hydrolysis of the 
intermediate isocyanate. The azides were generated from the reaction of acid chlorides or mixed 
anhydrides with sodium azide. Since then it has become a valuable and much used tool in the 
synthetic chemist’s arsenal for the generation of amines from appropriate carboxylic acids. Trapping 
of the isocyanate with a variety of nucleophiles is a widely used method for the synthesis of amine 
derivatives (Scheme 51).  
 
Scheme 51 Curtius rearrangement 
Reaction of the intermediate isocyanate with an alcohol gives rise to carbamates, whilst amine 
interception yields ureas. Achieving the transformation from carboxylic acid to carbamate without 
the need to isolate acyl azides has become possible in recent years with the introduction of 
diphenylphosphoryl azide (DPPA) as the azidating reagent. The rearrangement is known to proceed 
with retention of configuration when a chiral centre is present α to the carboxylic acid and as such is 
highly applicable for the asymmetric generation of ATAs, provided the stereocentre is set in the 
precursor. A report by the Back group in 2009,101 implemented biocatalysis in conjunction with the 
Curtius rearrangement in order to access a range of quaternary acids in generally high yields and 
selectivities. Pig liver esterase was used to desymmetrize a series of quaternary malonates and the 
resultant quaternary carboxylic acids were subjected to a Curtius rearrangement. As with most 
biocatalysed processes, the degree of selectivity was related to the steric differences between the 
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two substituents on the malonate. The protocol was successfully applied to the enantioselective 
total synthesis of (-)-Virantmycin (Scheme 52).  
Scheme 52 Reagents and conditions: a) i) DPPA, DMAP, Et3N, toluene, reflux; ii) NaBH4, THF, rt. 
1.9.2 Schmidt rearrangement 
The Schmidt rearrangement is similar to the Curtius rearrangement except originally involved 
formation of the azide from a carboxylic acid and hydrazoic acid (HN3) and involves acid catalysis in 
the rearrangement, rather than direct thermal treatment. Intramolecular Schmidt reactions are 
particularly useful in alkaloid syntheses in which the principle can be extended to an alkyl azide 
decomposing with nucleophilic interception by a carbonyl function to give amides and lactams with 
ring expansion ultimately. Fused lactams can be accessed via 3-azidopropylketones, but 
stereocontrol is often awkward for this type of conversion. Aube overcame this difficulty to effect 
good stereoselectivity by careful consideration of transition states and reaction rates when he 
described a facile method for applying this to the racemic synthesis of lepadiformines A and C 
respectively, Scheme 53.102  
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Scheme 53 Reagents and conditions: a) TiCl4, CH2Cl2, 0 °C; b) TiCl4, CH2Cl2, 40 °C; c) Ac2O, pyr, DMAP, CH2Cl2, 
rt; d) TiCl4, CH2Cl2, rt; e) LiAlH4. 
In his approach, he made use of the Prins reaction in order to deliver the [5,3] spirocyclic keto azide 
necessary for a Schmidt ring expansion reaction. For the lepadiformine syntheses, a variation on the 
Prins reaction was carried out on substrate 1.137a and b that incorporated an azide into the 
appropriate chain, as well as an aldehyde instead of an acetal, reacting with cyclopropane 1.136. 
This gave rise to cyclobutanones 1.138a and b as single diastereomers. Optimal results for the 
Schmidt rearrangement were achieved by protecting the hydroxyl group as an acetate and then 
treating with TiCl4 to deliver the lactams 1.140a and b in excellent yields. Deacetylation, xanthate 
formation and Barton-McCombie deoxygenation furnished lactams 1.135a and b, common 
intermediates of Renaud’s synthesis of the lepadiformines.  
In 2015, Shenvi and Tabor103 accomplished a short, racemic synthesis of the lepadiformine core via a 
stereoselective hydroamination process, also based on a rearrangement, but here of C-B to C-N. 
Starting with a simple achiral amino diene 1.142, sequential amine-directed hydroboration followed 
by oxidative shift of the alkyl onto nitrogen, generated the lepadiformine skeleton 1.146, rendering 




Scheme 54 Reagents and conditions: a) i) BH3̇∙DMS, CH2Cl2, -78 °C to 0 °C; ii) I2, 22 °C; b) I2, NaOMe 
then NaOH, H2O2; c) CBr4, Et3N, PPh3, CH2Cl2; d) MCPBA, CH2Cl2; e) TFA, KCN. 
The amino diene 1.142 was generated in six steps starting with commercially available alcohol 1.141. 
Subjecting 1.142 to optimized hydroboration conditions furnished the borinic imide 1.143, which 
upon treatment with iodine and NaOMe underwent a 1,2 alkyl shift to deliver 1.145 after an 
oxidative work-up in a 10:1 dr. The hydroboration proceeds via a strained transition state, which is 
nonetheless favoured because of the high potential energy of the ammonium borane. The 1,2 alkyl 
shift predominates over competing reactions such as oxidation to an imine, via the strained 
intermediate 1.144, to give rise to the amino alcohol 1.145. For the synthesis of lepadiformine, only 
the installation of the hydroxymethyl chain remained, but this proved to be problematic, prompting 
the authors to investigate their hydroamination sequence with the hydroxymethyl chain 
incorporated in the substrate. Unfortunately, hydroboration was unsuccessful for these types of 
substrates (amino esters, alcohols and ethers were tested, under numerous conditions), likely as a 
result of the formation of borane chelates. Despite this deficiency, hydroamination is certainly a 
powerful methodology on paper for drastically streamlining the syntheses of complex alkaloids.  
1.9.3 [3,3] sigmatropic rearrangements 
[3,3] Sigmatropic rearrangement are commonplace in organic chemistry as one can access regio- and 
stereoselective carbon-carbon or carbon-heteroatom bonds with relative ease. Examples that give 
rise to ATAs include the Kazmeier- Claisen rearrangement described earlier, the rearrangement of a 
cyanate to an isocyanate and the Overman rearrangement.   
Cyanate to an isocyanate rearrangement 
Improving on Holm’s original report, Ichikawa et al104 developed a convenient method for accessing 
the cyanate from the corresponding carbamate, Scheme 55.  
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Scheme 55 Reagents and conditions: a) PPh3, Et3N, CBr4, CH2Cl2, 0 °C; b) O3, DCM, -78 °C; c) NaClO2, 2-
methylbut-2-ene, NaH2PO4, t-BuOH, H2O; d) 6N HCl, reflux.  
Dehydration of the carbamate 1.147 affords a transient allyl cyanate intermediate 1.148, which in 
turn spontaneously rearranges with complete 1,3- transfer of chirality to the isocyanate 1.149a. The 
six- membered transition state allows for 2 possibilities; The 1,3-diaxial strain in transition state B (TS 
B) raises its energy thus the resultant Z- isomer 1.149b is never observed.  As the reaction is 
stereospecific and proceeds under mild conditions, it has served as a key step in generating ATA  
motifs in several total syntheses such as adaline and euphococcinine reported by Spino et al,105 and 
(S)-ketamine by Kiyooka.106 
The Overman rearrangement 
Also termed the aza-Claisen rearrangement, this [3,3] sigmatropic rearrangement involves an 
iminium C=N bond as the π component, providing access to allylic amines from the counterpart 
allylic alcohols (Scheme 56). An allylic trichloroacetimidate 1.150 gives rise to an allylic 
trichloroacetamide 1.151 with clean 1,3-transposition of the alkenyl moiety, proceeding via a chair-
like transition state.  
Scheme 56 Mechanism of the aza-Claisen rearrangement 
Although originally thermally promoted, transition metals have also been shown to be effective. (eg 
Pd and Hg). This is advantageous as it allows for lower temperatures and the use of chiral catalysts 
for stereoselective conversions. The Peters107 group developed several palladacycle catalysts for the 
enantioselective aza-Claisen rearrangement, the optimal being 1.152 (Scheme 57). Excellent ees 
were achieved (96 to 98 %), albeit only for conversions where one of the substituents was bulky, 
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whereas when both were larger than methyl, higher catalyst loadings were necessary and a decrease 
in yields was observed. However, one must control the geometry of the disubstituted alkene 
terminus. 
Scheme 57 Asymmetric aza-Claizen earrangement according to Peters et al. 
1.10 Cycloaddition strategies 
1.10.1 Diels-Alder 
This well-known and much practiced cycloaddition reaction is a very useful and efficient way to 
generate cyclic structures. When adequately substituted dienes and dienophiles are used, molecules 
with a high degree of complexity can be generated in a single step. For the construction of ATAs, aza-
Diels-Alder [4 + 2], 1,3 dipolar cycloadditions of azomethine ylids [3 +2] and formal [2 + 2] can all be 
applied. Unconjugated imines are generally poor dienophiles, but their reactivity towards Diels-Alder 
reactions can be greatly enhanced by protonation. Lygo and co-workers108 used the aza-
intramolecular Diels Alder (aza-IMDA) reaction in a short, protecting group-free synthesis of (±)-






Scheme 58 Reagents and conditions: a) CsCO3, iPr2O, PhCH2-NMe3Br; b) 15 % aq. Citric acid, THF, K2CO3; c) 
CF3CHOH, 60 °C. 
Starting with the commercially available trans-2-nonenal 1.153 and glycine imine 1.154, they 
accessed the cyclic imine ester 1.155 in 6 steps. A wide range of Diels-Alder reaction conditions were 
then performed on this substrate, finally arriving at the optimal set shown in Scheme #. Of the four 
possible diastereomers that could have arisen from the cycloaddition, preferential addition of the 
diene anti to the carboxyl group gave rise to only two products 1.156a and b, resulting from exo and 
endo addition, with a dr of 5:1 in favour of the desired endo-cycloadduct. The major cycloadduct 
possessed the correct relative stereochemistry for three out of four stereocenters of lepadiformine 
A, accessed as a racemate by a further two steps. The generation of two rings and three 
stereocenters, one of which is an azaspirocenter from a linear, achiral precursor in a single step, 
serves as an elegant demonstration of the power of the aza-IMDA reaction.  
The design of an intermediate that can be proliferated to more than one complex natural product 
target is an advantageous feature of any approach. In 2015 Pandey and Janakiram109 formulated the 
synthesis of a bridge-head substituted 7-azabicyclo heptane 1.161 from which a range of ATA 
scaffolds could potentially be accessed by selective bond cleavage on different loci on the molecule, 
and were able to apply it in the total syntheses of both (+)-cylindricines C-E and (-)-lepadiformine A 
(Schemes 59 and 60). The first part of their synthetic endeavour involved the generation of the 
bicyclic ATA intermediate 1.161 in non-racemic form, by the desymmetrisation of compound meso-
1.160. Meso-1.160 was prepared in four steps, starting with a cycloaddition of 1.157 and 1.158 
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followed by selective reduction, nucleophilic substitution with the sodium salt of 1.159 and finally an 
oxidation. The desymmetrisation reaction (via an oxa-Michael addition, substitution of Ts and ketal 
hydrolysis) using (R),(R)-hydroanisoin was carried out on the boc-deprotected analogue of 1.160, to 
give (-)-1.161 in a dr of 9:1 (endo:exo) and as a pure enantiomer. (S),(S)-hydroanisoin afforded the 
opposite enantiomer.  
 
Scheme 59 Reagents and conditions: a) toluene, 55 °C; b) H2-Pd/C; c) NaH; d) m-CPBA. 
Next, the aza-bicycle (-)-1.161 was elaborated to 1.164, the precursor necessary for the cascade 
reaction which would lead to lepadiformine A (Scheme 60).  The fused ring of 1.163 was generated 
by a biphasic Tsuji-Trost cyclization of 1.162, the diastereselectivity of which resulted from allylation 
of the exo-face of the bicyclic framework, preferred due to minimization of steric repulsion with 
protons on the endo-face. To obtain the cylindricines, compound 1.164 was subjected to Dess-
Martin oxidation, which triggered the cascade rearrangement leading to tricycle 1.168. The cascade 
was postulated to proceed via the unstable intermediate 1.165, which underwent a retro-aldol 
fragmentation to 1.166 and due to the acidic medium of the reaction, resulted in boc- deprotection , 
which allowed for the aza-Michael addition to furnish 1.167. The stereoselectivity of the addition 
was likely a result of the trans geometry of the enone, coupled with the influence of the spirocentre, 
directing the addition from underneath. The authors‘ synthetic plan was to terminate the sequence 
at that point so as to access lepadiformine from here and cylindricines via C-5 epimerization of 
1.167; however, epimerization to the energetically more favoured ring junction stereoisomer took 
place spontaneously at the end of the cascade, thus furnishing the requisite intermediate for the 
cylindricines 1.168. For lepadiformine synthesis, the cascade had to be interrupted at the Boc 
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deprotection stage so as to avoid the aza-Michael addition and subsequent epimerization. This was 
accomplished by using AcOH instead of TFA in the oxidation step leading to the retro-aldol, which 
was followed by reduction and subsequent acetylation of the hydroxyl groups to deliver 1.169. Boc-
deprotection, followed by Tsuji-Trost cyclization gave 1.170, from which lepadiformine was accessed 
in two simple steps.  
Scheme 60 Reagents and conditions: a) DMP, CH2Cl2/TFA (3:1), 0 °C; b) DMP, CH2Cl2, AcOH, 0 °C; c) TFA; d) 
[Pd(PPh3)4], K2CO3. 
Another example of a cycloaddition strategy for the synthesis of (±)-lepadiformine is that of Funk 
and Greshock who employed an amidoacrolein cycloaddition.110  
This survey of current strategic approaches for ATA creation highlights the vast amount of progress 
that has been made in this area in recent years, whilst being inclusive of some of the more classical 
methods still applicable today. The examples of lepadiformine syntheses have included a number of 
elegant, efficient and ingenious strategies that utilize a wide range of transformations to achieve 
synthesis of the ATA en route to the target alkaloid.   
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Chapter 2: Studies in Diastereoselective Construction of ATAs and Application 
to Lepadiformine Synthesis 
 
2.1 Direct Approach to the C-ring of Lepadiformine 
The primary objective of the project was the enantioselective total synthesis of lepadiformine and 
within that context, the development of a methodology for the asymmetric construction of the ATA 
motif present in the spiro- ring junction thereof. Because the ATA of lepadiformine and related 
compounds is embedded in the spirocyclic framework, the majority of synthesis strategies32,111 rely 
on inherent constraints of the existing or emerging ring to control the diasteroselectivity of ATA 
formation. Convergent syntheses for its construction involving cycloadditions or spirocyclization 
strategies are thus not straightforward and in this project a divergent approach was adopted based 
on prior construction of the ATA. The strategy was based on a previously reported synthetic route 
developed in this research group by Hunter and Richards in 2003,112 entailing a diastereoselective 
construction of the tricyclic core of the lepadiformines in racemic form (Scheme 61). Key steps in the 
sequence involved 5,5 dialkylation of a tetramate, ring-closing metathesis to produce the A/C 
azaspirocycle, and a stereoselective hydrogenation (2:1) for the trans A/B 1-azadecalin system. 
Although somewhat lengthy, as well as not enantioselective, the advantage of the route was that it 
was amenable to modification into an enantioselective synthesis, the pursuit of which formed the 
basis of this project.  
 
Scheme 61 Reagents and conditions: a) n-BuLi (2 eq), THF, -78 °C, allylBr (1 eq); b) KOH, Bu4NHSO4, BnBr, THF; 
c) n-BuLi (1.2 eq), THF, -78 °C, TMSCl (1.5 eq); d) HC(OMe)3, BF3
.
 OEt2; e) CF3CO2H (1% H2O), 35 °C; f) allylMgCl, 
THF -78 °C to 0 °C; g) RuCl2(PCy3)2=CHPh, CH2Cl2, 40 °C; h) Na, NH3 (liq), -33 °C; i) H2 Pd-C; j) TPAP (5 mol %), 
NMO, CH3CN, powdered MS; k) BrMg(CH2)3OBn (3 eq), THF, 0 °C; l) CuSO4, p-xylene, reflux; m) H2, Pd-C; n) i) 




Scheme 62 Refinement to an enantioselective synthesis  
In order to achieve such a refinement, an asymmetric construction of the pyrrolidine intermediate 
2.1 containing two of the four stereocentres present in (-)-lepadiformine A (including the ATA) was 
targeted. The overall idea is shown in Scheme 62. From the pyrrolidine 2.1, much of the chemistry 
previously developed could be applied in order to arrive at the tricycle 2.2 Improving the 
stereoselectivity of hydrogenation step was certainly crucial, as well as specifically evaluating the 
influence of the protecting groups. The incorporation of the hexyl side-chain was intended according 
to Weinreb’s method,113 involving Grignard addition onto the iminium salt of 2.3, generated form an 
α-amino nitrile intermediate (Scheme 63). Weinreb reported a 3:1 selectivity for the desired epimer, 
arising from the preferential axial attack of the Grignard onto the top face of the imine carbon. 
 
Scheme 63 Reagents and conditions: a) HCl, MeOH, KCN, H2O, Me2CO; b) C6H13MgBr, BF3
.
Et2O, THF. 
Before embarking on new methodology for enantioselective ATA construction, first an attempted 
strategy for the direct synthesis of 2.1 based on a protocol developed by Harwood was explored. 
This methodology involved a diastereoselective 1,3 dipolar cycloaddition of a chiral, stabilized 
azomethine ylid with an aldehyde.  
2.1.1 Azomethine Ylid Cycloaddition Strategy 
Precedent 
In the early 1990s, Harwood et al114–118 reported that an azomethine ylid derived from an 
enantiomerically pure morpholinone and paraformaldehyde underwent a highly diastereoselective 
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1,3-dipolar cycloaddition with a range of alkene and alkyne dipolarophiles, under both thermal and 
catalysed conditions in which for aldehydes other than formaldehyde, the iminium geometry was 
predominantly E- based on the configuration of the iminium ion (Scheme 64). 
 
Scheme 64 Harwood’s 1,3 dipolar cycloaddition protocol for generation of substituted prolines.  
The preferred stereomode for the cycloaddition wrt disubstituted dipolarophiles (with A and B) was 
variable, but for mono-substituted dipolarophiles, endo adducts were produced exclusively, albeit in 
lower yields. Furthermore, the cycloaddition facial selectivity on the dipole proceeded anti to the 
morpholine phenyl group blocking the underneath face. Following reductive cleavage of the chiral 
auxiliary a tetra (or tri-) substituted pyrrolidine could be obtained stereoselectively, Scheme 64. 
This methodology was extended to 3-phenyl substituted morpholinone 2.4, from which phenyl-
substituted proline derivatives could be accessed containing an enantioenriched ATA (Scheme 65). 
In these cases, only endo products were isolated for acyclic dipolarophiles, whilst cyclic ones showed 






   
Scheme 65 Reagents and conditions: a) Pd(OH)2/C, H2, 5 bar, MeOH, TFA 
Based on the latter it was thought that an allylated equivalent might meet our needs in respect of 
lepadiformine. Furthermore, the use of a suitably substituted aldehyde in the ylide generation step 
would give rise to the requisite C-5 substituent on the target pyrrolidine. To this end, the projected 















Scheme 66 Desired sequence leading to 2.13, entailing a diastereoselctive 1,3 dipolar cycloaddition  
The strategy entailed generation of allylated morpholinone 2.8, from which the ylide 2.10 would 
arise by condensation with aldehyde 2.9, followed by cycloaddition with phenyl vinyl sulfone.  A 
sulfone group was an attractive functionality for dipolarophile activation in this case, due to its 
electron-withdrawing nature, coupled with the fact that it would likely be removeable at the end of 
the process reductively. For the purposes of lepadformine synthesis, endo/ exo selectivity and the 
regioselectivity for the cycloaddition were inconsequential, as the sulfonyl group would be removed, 
and in the Scheme it is represented as being derived from an exo mode (often sulfonyl goes exo in 
view of steric strain in the transition state); however, of crucial importance would be the level of 
diastereoselectivity of the cycloaddition controlling the configurations at the quaternary and C-5 
centres in the final product.  These would be governed by the degree of facial selectivity for the 
approaching dipolarophile, and the configuration of the iminium salt. Based on Harwood’s 
observations, the dipolarophile was anticipated to approach from the face opposite the phenyl on 
the morpholinone, which would deliver the adduct 2.11 as the major product. If successful, the 
methodology would provide rapid access to the desired substituted proline derivative 2.13 in 
appropriate diastero- and enantio form for lepadiformine, following template degradation and 
removal of the sulfone moiety.   
To this end, the synthesis of the morpholinone 2.8 began with reduction of (S)-phenylglycine with 
LiAlH4 to afford (S)-phenylglycinol 2.14 in good yield and without racemization, as judged by the 
agreement of the []D value to that of literature reported value. [α]𝐷
20  = -49.0 (CHCl3, c = 1.0); lit
119  
[α]𝐷
20  = -49.3° (CHCl3, c = 1);  (Scheme 67). Glycinol 2.14 was then condensed with phenyl 2-
bromoacetate to give the morpholinone product 2.15 in modest yields of 30 – 40 % after column 
chromatography. This was established as being due to dimerization, which necessitated immediate 
protection of the condensation adduct 2.15 with Boc anhydride, avoiding aqueous work-up and 




Scheme 67 Reagents and conditions: a) LiAlH4 (1 eq), THF, reflux; b) Phenol, 80 °C, neat; c) DIPEA (2.5 eq), 
CH3CN, rt; d) Et3N, Boc2O, EtOAc, rt. 
Next, the allyl moiety was installed in the 3-position using conventional alkylation methodology for 
which the results are shown in Table 2. 
Table 2 Optimization of allylation reaction conditions  
 
Solvent Base Temp (°C) Yield (%) 
THF LiHMDS -78 to 25 < 10 
THF NaHMDS -78 to 0 < 30 
THF/DME (50/50) NaHMDS -78 to 0 40 
THF KHMDS -78 to 0 52 
THF/DME (50/50) KHMDS -78 to 0 63 
 
Of the solvents tested, the best results were obtained using a 50/50 mixture of THF and DME, in 
which KHMDS proved superior over LiHMDS. As expected, the allylation was stereoselective by 
virtue of the product 2.17 appearing as a single spot on tlc, and with no doubling of any peaks in the 
1H NMR spectrum once isolated. The relative stereochemistry was not known with any certainty but 
was likely to be anti- to the Ph group on both stereoelectronic and steric grounds as indicated by the 
product structure in Table 2. Although noteworthy, this was inconsequential, as the stereocentre 
would be destroyed in the ylide generation step. The desired aldehyde partner 2.10 in the 
condensation was generated in three steps from ethane 1,2-diol by monoprotection and oxidation 
procedures. In order to generate the ylid for the cycloaddition, 2.17 had to be Boc-deprotected with 
TFA prior to condensation with the aldehyde. This proved problematic due to in-situ dimerization to 
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2.19, as mentioned before for compound 2.15 and yields of the desired deprotected morpholinone 
2.18 could not be raised above 18 % (Scheme 68).  
 
Scheme 68 Reagents and conditions: a) TFA (1.2 eq), anisole (1.2 eq), DCM, 0 °C to rt. 
 
Following the reaction by tlc indicated the transient formation of the product spot which was quickly 
consumed to give another slightly less polar spot just above it, presumably corresponding to the 
dimer. Chromatographic isolation and subsequent 1H NMR and IR spectral analysis confirmed that 
the minor product was the desired de-protected morpholinone 2.18, the data correlating closely to 
that reported in the literature for the same compound.121 Scheme 69 shows the mechanism of the 
dimerization, which is catalysed by TFA. 
 
Scheme 69 Mechanism of dimerization of 2.18 leading to 2.19 
Several protocols for Boc removal were tested which did not involve acidic conditions, but all failed 
to deliver the desired deprotected morpholinone, resulting either in degradation of the substrate, or 
no reaction. Other research groups who experienced the same stumbling block, simply replaced the 
Boc for a Bn or Cbz group, thus avoiding the use of TFA. However, deprotection in those cases 
requires hydrogenolysis which would likely result in concomitant reduction of the allyl. Nevertheless, 
a Cbz derivative was prepared and allylated hoping for a chemoselective deprotection. 
Unfortunately, and probably unsurprisingly, the allyl moiety was reduced at a faster rate than CbZ 
removal. The disappearance of the diagnostic allylic protons in the 5.80 and 5.20 ppm region of the 
1H NMR spectrum was confirmation of this. 
Another option was to access the morpholinone 2.18 via an addition reaction of an allylic 
nucleophile onto an oxazinone.122,123 However, these types of reactions give variable results and are 
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often low-yielding due to the chemoselectivity issue between the imine and the lactone.122,124  
Although reasonable improvement for obtaining 2.18 via this route has been made in recent 
years,121 before embarking on such a synthetic endeavour, other possible hindrances that could be 
expected further in the synthesis had to be evaluated:  
 Aldehydes other than formaldehyde have only been reported in azomethine ylide 
generation with morpholinones without substituents at C-3, in which only moderate 
selectivity for the E-iminium was achieved.114 Having an allyl group in place at C-3 would 
likely lead to a distribution of imine E/Z-isomers, since the steric differentiation between 
phenyl and allyl is small. This would translate to a reduction in the diastereoselectivity of the 
reaction with respect to the configuration at C-5 of the pyrrolidine product. 
 Monoactivated diapolarophiles were reported to react very poorly in the cycloaddition 
involving substritution at C-3 and in some instances not at all;116,125 a bis-sulfonyl derivative 
would likely be problematic in terms of SO2Ph excision at the end of the process. 
Furthermore, although a boost in reactivity would be achieved by a doubly activated 
dipolarophile, the generated product would be a densely substituted proline derivative, the 
formation of which may be hampered by the high level of steric crowding.  
 The usual hydrogenolysis procedure for dismantling of the template using Pearlman’s 
catalyst would not be viable in this case due to the presence of the allyl group, thus other 
methods would need to be sought. 
In light of these potential difficulties, it was deemed prudent to consider a different approach.  
Disconnection to an acyclic precursor 
The level of complexity in the target pyrrolidine 2.1 made its asymmetric synthesis via direct 
methods a challenge. A disconnection was therefore made to the acyclic precursor 2.20, revealing 
the necessity for the construct of an ATA bearing a bulky, functionalized substituent from which the 
C ring would be generated (Scheme 70). 
 
Scheme 70 Disconnection of pyrrolidine 2.1 to an acyclic quaternary amino acid derivative 
From the outset, the aim was to achieve a chiral non-racemic synthesis via some form of 
diastereoselective process. Of the available methods for ATA construction, alkylation of an N-
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containing enolate was one option, specifically via the Schöllkopf method using a chiral template. 
Although proven to be efficacious in many instances, this type of approach is not without 
drawbacks; low atom efficiency is one, but more pertinent was the often-encountered frustration 
with template degradation when congested quaternary systems are involved. Furthermore, 
installation of the requisite groups would likely call for a highly reactive enolate species, feared to be 
difficult to attain using template-based approaches. These factors prompted the vision of 
formulating and developing a new methodology for ATA construction from which lepadiformine 
could be accessed, as well as providing a general and widely applicable quaternization protocol. In 
the event, the methodology chosen centred on the use of malonate via an auxiliary-directed 
process.  The amino functionality of the ATA was envisaged as arising from a carboxylic acid 
precursor using the well-established Curtius methodology, as reviewed in Chapter 1. The creation of 
a successful protocol for producing all-carbon quaternary compounds in an asymmetric fashion is a 
challenging task in itself and to achieve this, we hoped to exploit the high reactivity of the C-2 in 
malonates, coupled with the possible induction of facial selectivities by cyclic chiral auxiliaries, which 
had the advantage of being recyclable. The challenges, however, in such an approach were not trivial 
and our expectations regarding these are projected in the next Chapter. The general strategy is 
depicted in Scheme 71. 
Scheme 71 Proposed sequence of all-C quaternary generation and transposition to ATAs. 
The following sections will cover three related endeavours: 1) diastereoselective alkylation of 
auxiliary-malonate systems to furnish all-carbon quaternary centres; 2) transposition of the 
quaternary malonates to ATAs; 3) application of the methodology to an attempted synthesis of 
lepadiformine. 
2.2 Malonates as Substrates for Asymmetric Synthesis 
Malonate derivatives are versatile substrates in organic synthesis owing to the high reactivity at C-2 
and the ease of further manipulations at the carboxyl function. For the creation of chiral, non-
racemic malonates essentially three strategies can be adopted for prochiral discrimination as: 1) 
desymmetrization of the ester groups using a chiral catalyst; 2) facial enantioselectivity on a 
prochiral malonate (enolate) face using a chiral catalyst; 3) diastereoselective alkylation using 




2.2.1 Enzymatic Desymmetrisation 
Desymmetrisation, as the name implies, is the loss of one or more symmetry elements in a molecule, 
which in context involves transformation of one of the enantiotopic arms of a prochiral substrate 
into a chiral, non-racemic product. Relevant to this thesis is the case of enzymatic desymmetrization 
of malonates using an esterase enzyme, in which selective hydrolysis of one of the two enantiotopic 
ester groups occurs on a racemic substrate, Fig. 9.  
 
 
Figure 9 Esterase desymmetrisation of malonates. 
 
Many examples of enzymatic desymmetrization can be found in the literature, but these are usually 
target-specific due to the way the molecule docks into the active site of the enzyme. Recently,  
porcine liver esterase (PLE) has gained popularity for the enantioselective hydrolysis of a range  of 
dialkylated methyl malonates to afford chiral, non-racemic half esters that can be subjected to a 
Curtius rearrangement to generate ’-quaternary amino acid derivatives ultimately.101 Yields of 
the half-esters are high, and reported stereoelectivities range from 42 to > 98 % ee, in which the 
enantioselectivity depends on the relative steric demand of the two groups at the emerging chiral 
centre, Scheme 72. 
 
Scheme 72 Generation of ATAs from racemic malonates desymmetrized by PLE 
Although a relatively wide scope of -groups has been demonstrated, the substrate-specific nature 
of the process is limiting. Furthermore, the stereospecificity of PLE hydrolysis also means that one 
cannot access the opposite enantiomer of these adducts via this route unless enzyme antipodes are 
available, which is more often not the case. Enzymatic reactions require specific conditions such as 
aqueous or polar medium and the use of phosphate buffers to maintain a constant pH of 7 -8.  
2.2.2 Catalytic Enantioselective Methods 
An alternative to enzymatic desymmetrization is to transform a prochiral substrate using a chiral 
catalyst in an enantioselective reaction. In context, this has been achieved using catalytic 
enantioselective fluorination of a range of C-2 substituted t-butyl methyl malonates with a -box-
type catalyst 2.21, which affords the products in high yield and selectivity. The esters can then be 
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chemoselectively differentiated via LiAl(OtBu)3H reduction of only the methyl ester. These aren’t 
candidates for ATA production pertinent to this thesis, however, but serve as an illustration of the 
use of malonate esters to generate quaternary carbons asymmetrically and of the subsequent 
chemodifferentiation achievement. Scheme 73 illustrates.  
 
Scheme 73 Reagents and conditions: a) (PhSO2)2N-F (1.2 eq), Zn(OAc)2, 10 mol%, (R,R)-DBFOX-Ph, 11 mol%, 
MS 4 Å, CH2Cl2, reflux; b) LiAl(OtBu)3H (5 eq), THF, -78 °C to rt.  
Similarly, catalytic asymmetric alkylation reactions onto α-benzyl-substituted malonic diesters have 
also been reported employing phase transfer conditions.126 A chinchona-derived catalyst 2.22 was 
shown to facilitate the enantioselective alkylation of α-benzyl tert-butyl methyl malonate with a 
range of electrophiles, affording quaternary malonates in yields of 52 to 92 % and ees of 84 to 94 % 
(Scheme 74).  
 
Scheme 74 Reagents and conditions: a) 2.22 (10 mol %), toluene, 50 % KOH, -20 °C, 48 – 96h. 
Extension to the ATAs was demonstrated for the allylated derivative, in which either of the ester 
groups could be chemoselectively hydrolysed depending on conditions applied, and the resultant 
acid subsequently committed to a Curtius rearrangement step. Hydrolysis of the remaining ester 
furnished either enantiomer of α-allylphenylalanine as shown in Scheme 75.  
71 
 
Scheme 75 Reagents and conditions: a) TFA, CH2Cl2, rt; b) LiOH, MeOH, H2O, reflux; c) DPPA, Et3N, toluene, 
reflux then NaHCO3, THF, H2O, reflux. 
2.2.3 Diastereoselective Methods 
In the abovementioned examples, the chiral catalyst distinguishes between the two faces of a 
prochiral malonate based on size differences. In the following example of a catalytic 
diastereoslective process, a binaphthyl type quaternary ammonium salt 2.23 catalyzes α-alkylation 
of 2-methybenzyl tert-butyl malonates under phase-transfer conditions.127 A range of benzyl ester 
moieties were tested, methylbenzyl giving the best selectivities, where the (R)-isomer gave slightly 
better selectivities compared to the (S)-isomer, likely as a result of the match/mismatch between 
the substrate and catalyst. In total, six derivatives were generated in yields of 72 – 99 % and des of 
75 – 91 %, Scheme 76. 
Scheme 76 Reagents and conditions: a) 2.23 (5 mol%), RBr (5 eq), 50% KOH (5eq), toluene, -40 °C; b) 50% 
KOH, MeOH, rt. 
The authors report that unactivated alkyl halides gave very low yields and were thus not included in 
the account. This, however, is standard for quaternization via SN2 alkylation. Alkylations to the 
quaternary malonates were only carried out on methyl-substituted variants, another limitation of 
the methodology. A chemoselective hydrolysis of the benzyl ester was achieved on the allyl and 
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benzyl derivatives using 50 % KOH. Different benzyl esters were screened in order to achieve the 
correct balance between chemoselective deprotection with retention of the t-butyl ester and 
stereoselectivity.  
Prior to the present work only one example of asymmetric generation of a quaternary malonate via 
a diastereoselective auxiliary-directed process could be found in the literature. Fukumoto et.al128 in 
1989 reported on the functionalization of one of the termini of -methyl malonic acid with 8-phenyl 
menthol as auxiliary to generate a chiral malonic half ester. Subjecting the half-ester to 2 equivalents 
of LDA produced a dianion, which was alkylated with a range of electrophiles to arrive at the 
quaternized products in good yields. Selectivities varied from 4:1 to 16:1, increasing for bulkier alky 
halides as expected, alkylating onto the face opposite the phenyl group with the auxiliary in the 
conformation depicted in Scheme 77. 
Scheme 77 Reagents and conditions: a) DCC, DMAP; b) LDA (2 eq), THF, -78 °C; c) RX 
Unexpectedly, when malonates substituted with various groups were methylated, the same 
diastereoselectivity was observed, indicating methylation took place from the opposite face to the 
alkylations with other groups as is depicted in Scheme 78.  
 
Scheme 78 Reagents and conditions: a) LDA (2 eq), THF, -78 °C; b) MeI 
The authors offered an explanation for facial selectivity reversal by postulating transition state 
models A and B shown in Scheme 79, which differ in the enolate configuration. Thus, with methyl as 
the -group a Z-enolate is preferred, while with an -group larger than methyl (depicted as R) an E-
enolate is preferred in order to minimize steric strain with the auxiliary. The net result is opposite 





Scheme 79 Transition state models for explaining the retention of diastereoselectivity  
Conversion of the alkylated product to a quaternary amino acid was achieved via the Curtius 
rearrangement with subsequent hydrogenolysis of the carbamate, followed by hydrolysis of the 
phenylmenthyl ester with KOH, Scheme 80 (final yields were not given). 
 
Scheme 80 Reagents and conditions: a) DPPA, Et3N, PhCH2OH; b) Pd-C, cyclohexene; c) i) KOH 18-Crown-6, ii) 
HCl-EtOH.  
Given the relatively narrow scope and modest levels of selectivity in the abovementioned accounts, 
it was evident that there was ample incentive for developing an auxiliary-controlled asymmetric 
methodology for the synthesis of quaternized malonates. 
2.3 Choosing the Right Auxiliary 
In Chapter One the three criteria for a successful auxiliary were discussed as: 1) ease of preparation 
and attachment, 2) induction of a high degree of facial selectivity, 3) non-destructive removal 
without racemization of products. One of the most prevalent cyclic auxiliary types is the 
oxazolidinone class of chiral auxiliary, developed and introduced into the chemistry literature by the 
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Evans group in 1981.129 The auxiliary was easily prepared from (S)-valinol in which its first application 
by Evans was in the diastereoselective -alkylation of an acid as depicted in Scheme 81.130  
Scheme 81 Diastereoselective alkylation of an N-acyloxazolidinone 
The mechanistic principles in this classic piece of chemistry have become textbook material. Thus, 
acylation of the lithium anion of the auxiliary with the appropriate acid chloride furnishes an N-acyl-
oxazolidinone substrate in high yield. Its selective enolization using n-BuLi kinetically gives rise to a 
chelated Z-enolate, and subsequent alkylation proceeds with high diastereoselectivity via anti-
addition to the bulky isopropyl group on the chelated auxiliary. The auxiliary could then be easily 
removed by hydroperoxide ion, reductively or by transesterification, and then recovered, adding to 
the utility of this methodology by satisfying all three criteria for high methodology efficiency. Owing 
to the wide scope and high efficacy of Evans’ and Evans-type auxiliaries, this approach is still 
practised today and the literature abounds with examples of successful asymmetric α-
functionalization for the synthesis of chiral building blocks, medicinally valuable compounds and in 
natural product syntheses. Over the years, structurally related auxiliaries of the Evans’ type have 
emerged and been fine-tuned for specific synthetic challenges, some examples of which are shown 





Figure 10 Structural variants based on the Evans’ auxiliary motif. 
2.4 The Enolate Geometry Problem of α,α-Disubstituted Enolates 
Despite the broad utility of the Evans’ auxiliary, transposition to quaternary centres via disubstituted 
enolates is not easily accomplished due to the difficulty in controlling enolate geometry in such 
systems as illustrated in Figure 11. 
 
Figure 11 The disubstituted enolate geometry problem of N-acyloxazolidinones 
Of the few examples that do exist, the scope is often limited. In 2003, Kobayashi reported on a regio- 
and diastereoselective alkylation of α,β-unsaturated imides to generate quaternary centres, and 
applied it to a total synthesis of madindoline A and (+)-ethosuximide (Scheme 82).131 The geometry 
of the double bond in the substrate dictated the geometry of the enolate; thus, -proton abstraction 
with NaHMDS gave the E-enolate which reacted with electrophiles at the α-position. Only 
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quaternary centres bearing an -methyl group were generated in the report and only three of the 
eight electrophiles (R1X) tested gave satisfactory results.   
Scheme 82 Reagents and conditions: a) SOCl2, n-BuLi, THF (96 %); b) NaHMDS, -78 °C; c) H2, PtO2, EtOH. 
Similarly, a strategy reported by Myers and co-workers in 2008132 reported the use of 
pseudoephedrine as a chiral auxiliary to generate enantiomerically pure α-methylbutyramides 2.24a 
and 2.24b, differing only in α-stereogenicity. The control of enolate geometry was realized through a 
stereospecific enolization with 2 equivalents of LDA, delivering Z-enolate 2.25a and E-enolate 2.25b 
respectively based on the stereogenicity at the -carbonyl centre in the substrate as depicted in 





Scheme 83 Myers’ use of pseudeoephedrine as an auxiliary to effect stereospecific enolization. 
 
Alkylation occurred onto the face opposite the pendant benzylic alkoxide to generate alkyl, allyl, and 
benzyl quaternised products in high yields with average to good stereoselectivity. Hydrolysis to the 
acid or reductive cleavage of the pseudoephedrine auxiliary to the primary alcohol completed the 
sequence.  
In the approach by Gleason, the chirality of the starting bicyclic thioglycolate lactam 2.26, which was 
shown not to be dependent on the size of R and R1, but rather on the order of their introduction, 




Scheme 84 Reagents and conditions: i) LDA, LiCl, THF, 0 °C; ii) R-X; b) LDA, LiCl, THF, 0 °C, R1X; c) i)Li, NH3, THF, 
-78 °c; ii) R
2
X; d) 6M H2SO4, dioxane, reflux; e) LiH2NBH3, THF, -78 to -66 °C. 
Stereospecific reductive enolization took place and the subsequent reaction with various 
electrophiles on the face opposite the alkyl-SLi tether afforded the quaternized derivatives with 
excellent drs, the only drawback being the destructive removal of the auxiliary. This intriguing 
approach of effectively controlling the disubstituted enolate geometry differs from conventional 
methods. 
More recently in 2012, the Marek group disclosed a method for generating a stereodefined 
disubstituted chiral enolate from an acyclic ynamide coupled to an oxazolidinone auxiliary (Scheme 
85).134 The process entailed a highly diastereoselective copper-catalysed carbometalation-oxidation 
sequence, furnishing quaternary aldol products in good yields. Only aryl aldehydes and methyl 
cuprates were reactive, however.   
 







2.5 Key Concepts and Objectives for Research Conducted 
The key question in developing a malonate-based diastereoselective protocol for all-C quaternization 
was that of enolate geometry control. It was perceived that this might be accomplished by the 
presence of the additional (malonate) carbonyl promoting coordination to the metal cation and in so 
doing locking the enolate into a chelated Z-conformation. Should this be the case, however, it would 
allow free rotation around the imide C-N bond, which provided a cause of concern regarding facial 
selectivity on the enolate, (Options A (i) and A (ii) in Fig. 12). Conversely, if chelation were to occur to 
place the metal cation into the auxiliary hole, the imide bond conformation would be locked (s-cisC-
N), whilst enolate geometry would be variable, (Options B (i) and B (ii)). The counter-ion being a 
determining factor for chelation would obviously demand a thorough investigation of available bases 
for enolization. Ultimately, either scenario A (i) or A (ii) would lead to high levels of facial selectivity 
so long as propensity for ONE of the two possible imide bond conformations occurred.  
 
Figure 12 Possible scenarios arising from enolization of an auxiliary-malonate system 
2.6 Generation of all-carbon quaternary malonates 
2.6.1 Malonate- Oxazolidinone system 
The broad utility and efficacy of the Evans’ auxiliary made it the obvious starting point for exploring 
malonate quaternization reactions. The oxazolidinone derived from (R)-phenylglycinol was chosen as 
80 
 
the chiral auxiliary over the (S)-valinol-derived variant primarily because UV activity allowed for 
easier reaction profiling.  
The first issue addressed was the question of the stability and reactivity of any -alkylated malonate 
oxazolidinone, in which allyl was chosen as the -substituent. To this end diethyl malonate was 
readily alkylated using sodium hydride and allyl bromide in refluxing THF to give the mono α-
allylated diester in a yield of 92 % after chromatography. This product was then mono-hydrolysed 
with ethanolic KOH (1.05 eq) and the half acid-ester isolated using acid-base extraction. Diagnostic 
peaks in the 1H NMR spectrum of the product were that of the carboxylic OH, which appeared at 
8.13 ppm as a broad singlet, as well as the allylic protons resonating at 5.79, 5.13 and 2.68 ppm. The 
multiplet at 3.51 ppm was assigned to H-2 of the malonate. Evans’ auxiliary was synthesized by 
treating (R)-phenylglycinol with Et3N and triphosgene (0.5 eq) in DCM at 0 °C. The optical rotation 
was measured, which correlated with the literature value. [α]𝐷
20




54° (CHCl3, c = 1.0)].   
The mono-acid was converted to an acid chloride using oxalyl chloride and catalytic pyridine in DCM. 
Once thoroughly dried, a THF solution of the acid chloride was introduced into a solution of the 
lithium anion of the auxiliary (generated form the reaction of Evan’s auxiliary A, with n-BuLi in THF at 
-78 °C). The yields for the coupling reaction were variable, as malonate acid chlorides are susceptible 
to decarboxylation.  Some by-product formation was also evident, since both the desired allylated 
oxazolidinone-malonate 2.27, and the ketene elimination product 2.28 were isolated from the 
reaction in a ratio of about 3:1 and a combined yield of 78 %. These two products were easily 
discernible on tlc, and the identity of 2.28 was confirmed by virtue of its 1H NMR spectrum in which 
a clear absence of ethoxy signals (triplet at 1.2 ppm and multiplet at 4.2 ppm region) supported the 
notion of elimination. The proton count of 13 (for 2.28) and the fact that no α-Hs were visible in the 
2 ppm region of the spectrum eliminated the Krapcho decarboxylation product B as the identity of 
product 2.28. However, its formation could not be excluded, as several other minor spots were seen 
on the tlc but were not isolated; the ketene arising from auxiliary expulsion being another possible 







Scheme 86 Reagents and conditions: a) i) NaH (1.2 eq), THF, 0 °C to rt, 30 min; ii) AllylBr, reflux, 8h (92 %); b) 
KOH (1.05 eq), EtOH, rt, 24h; (95 %); c) pyridine (5 mol %), COCl2, DCM, reflux, 2h; d) Et3N (1.2 eq), triphosgene 
(0.5 eq), DCM, 0 °C; e) n-BuLi (1.1 eq), THF, -78 °C to rt.  
Quaternization under various conditions was then attempted but to no avail (Scheme 87). 
 
Scheme 87 Attempted quaternization with lithium and sodium bases 
As the reaction warmed from -78 °C to around 0 °C, tlc indicated the slow formation of a slightly less 
polar spot on tlc, presumed to be the methylated product. However, the oxazolidinone auxiliary was 
also observed, building in intensity on the plate over time. Chromatographic isolation revealed a less 
than 10 % yield of the methylated product, 50 % auxiliary recovery, with only 25 % recovery of the 
starting material.  A plausible mechanism for auxiliary production is via elimination of the enolate to 
afford a ketene derivative of the malonate as shown in Scheme 88. Partial alkylation of the auxiliary 
(blue arrow in mechanism) also took place, as a small amount of alkylated auxiliary was isolated (less 
than 10 %). The ketene was not isolated but the presence of a non-polar spot high up on the tlc plate 
was a good indication of its formation.  
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Scheme 88 Mechanism of auxiliary expulsion  
Hence, a more chemically robust auxiliary malonate system was required that could withstand the 
reaction conditions. Upon literature inspection, it was decided to study the analogous ephedrine-
derived imidazolidinone auxiliary designed by Helmchen136 to see if elimination was suppressed. The 
two auxiliaries are depicted in Fig 13. 
 
Figure 13 Evans’ oxazolidinone and Helmchen’s imidazolidinone auxiliaries. 
2.6.2 Malonate-Imidazolidinone system 
The corresponding imidazolidinone was easily prepared on a multigram scale via Close’s137 fusion 
reaction of urea and ephedrine in a yield of 52 %. This was in agreement to the reported yields for its 
production, the low values being attributed to the competing formation of the oxazolidinone. The 
first step in the proposed mechanism is the breakdown of urea into cyanic acid (shown as the more 
stable tautomer isocyanic acid) and ammonia driven by the high temperature of the reaction. The 
nitrogen of the ephedrine (shown as the 1S, 2R enantiomer in Scheme 89) then reacts with the acid 
to form the ureido intermediate. At this point, cyclization can occur via either the N or the O of the 
urea, leading to imidazolidinone or oxazolidinone respectively. The origin of the stereoselectivity as 
retention of configuration in the ring closure is unclear. Such a diastereoselectivity precludes a single 
SN2 inversion, so the mechanism appears to either be a stereocontrolled SN1 (blue arrows in 
mechanism shown in Scheme 89), or two SN2 inversions (red arrows), the latter presumably 
involving first the N-Me nitrogen to form an aziridinium intermediate followed by a second 
substitution (rearrangement) to form the less-strained five-membered ring. Scheme 89 summarises 
these ideas. The absolute configuration of the auxiliary used here links to the one needed for (-)-




Scheme 89 Fusion reaction and mechanistic thoughts on the preparation of imidazolidinone 2.29 
The opposite antipode of the auxiliary could similarly be prepared by the use of the other 
enantiomer of ephedrine.  
Following the fusion reaction the residue could be recrystallized with DCM/ EtOAc or ethanol. The 
accumulated mother liquors over a number of runs could then be purified by column 
chromatography. The signals obtained in the 1H NMR spectrum of (-)-2.29 were identical for those 
reported in the literature,138 and the optical rotation measured for the auxiliary matched the 
reported value. [α]𝐷
20
 = -43° (MeOH, c = 1.0), [lit.
138 [α]𝐷
20
 = -41° (MeOH, c = 0.9)]. Auxiliary 2.29 is 
also available commercially. 
An efficient way of coupling the unsubstitued malonate half acid with the auxiliary had to be found, 
and several methods were investigated. Acid chloride methodology was investigated first by 
refluxing the half acid with either thionyl chloride or oxalyl chloride, removing excess reagent and 
then refluxing the residual acid chloride with the imidazolidinone auxiliary in acetonitrile,139 rather 
than via its lithium anion (extra step). Reasonably high yields (~70 %) could be obtained but only 
when a large excess of acid was used in order to account for decarboxylation. In addition, the 
volatility of the unalkylated malonoyl chloride made isolation from the reaction mixture difficult, 
also obviating higher equivalents of acid to be committed. Mechanistically, reaction probably 
proceeds via acylation of the imidazolidinone urea carbonyl oxygen followed by O to N transposition, 
as the corresponding oxazolidinone can’t be acylated this way.  
84 
 
 The mixed anhydride method using pivaloyl chloride gave lower yields (~60 %) as well as producing 
a number of side-products and was therefore also not the protocol of choice.   
It was thus decided to investigate the peptide-like coupling of auxiliary (+)-2.29 with ethyl malonate 
half- acid 2.30 with DCC. This was not appropriate for coupling the oxazolidinone because of poor 
nucleophilicity but it was felt as described above that the superior nucleophilicity of the 
imidazolidinone might be sufficient to promote the reaction. Indeed that turned out to be the case.  
A typical procedure involved the gradual introduction of a solution of DCC (1.2 eq) in DCM into a 
stirring mixture of the half acid-ester of malonate, the auxiliary and a catalytic amount of HOBt in 
DCM at 0 °C. After complete addition the mixture was allowed to warm up to rt (Scheme 90). 
Pleasingly, the desired imidazolidinone derivative was obtained in 89 % yield after chromatography. 
Proof of successful coupling was provided by 1H NMR spectroscopy in which signals diagnostic for 
the auxiliary and the ester functionality of the malonate were present. Signals arising from the 
auxiliary included the multiplets in the aromatic region (correctly integrating for 5 protons) followed 
by a doublet at 5.32 ppm assigned to the benzylic hydrogen on the ring; an N-Me singlet at 2.81 
ppm, and an upfield doublet integrating for 3 protons at 0.80 ppm for the methyl at C-4 of the 
auxiliary. Similarly, the ethoxy multiplets appeared with the normal chemical shifts. The only 
drawback with the procedure, as is often the case with DCC-promoted coupling reactions was that 
the dicyclohexyl urea by-product was very close in polarity to the product, hampering isolation, 
although most of it was removed by several precipitations from cold ethyl acetate. This was by no 
means ideal, especially when multi-gram reaction scales were needed.   
Scheme 90 DCC and BtCl coupling techniques 
An alternative approach using N-acylbenzotriazoles as activated carboxylic acid analogues was 
examined next. The protocol was based on the work done by Katritzky140 who demonstrated the 
utility of N-acylbenzotriazoles as air- and water-stable alternatives to acid chlorides. In his reports 




Scheme 91 Katritzky’s activation of carboxylic acids using Bt. 
A protocol that avoids the use of acid chlorides was devised by Hunter and Msutu141 who showed 
that N-acylbenzotriazoles could be obtained from the reaction of carbamate salts, 
triphenylphosphine PPh3 and 1-chlorobenzotriazole (BtCl). The BtCl reagent was in turn easily 
prepared in multi-gram scales by oxidation of BtH with bleach. Successful extension of the 
methodology to carboxylic acids meant that it could be applied to our system. The procedure 
entailed the initial reaction of BtCl and PPh3 in ACN for 10 minutes at – 10 °C to generate the 
chlorophosphonium salt. Subsequent addition of the carboxylic acid with continued stirring, 
furnished the Bt-derivative after 1 hour. Auxiliary (+)-2.29 was then introduced and the mixture 
refluxed for 8 hours. The protocol provided a good yield of 80 %, but isolation and purification was 
again problematic owing to the arduous removal of BtH and triphenylphosphine oxide. Nevertheless, 
either option offered an alternative method superior to the acid chloride methodology. Ultimately 
going forward the DCC method was preferred as it required no reagent synthesis and gave slightly 
better yields.  
2.6.3 Optimization of alkylation reaction conditions  
Before attempting quternization, reaction conditions for the alkylation of 2.31 to form a tertiary 
centre needed to be developed, with the reasonable expectation that they could be successfully 
implemented in the second alkylation. A range of kinetic bases were tested, with 1-bromobutane as 
the electrophile. Although not the most reactive, if successful, it would be a good indication that the 
reaction would work with the more reactive electrophiles like methyl and allyl halides. Furthermore, 
butyl presented a model system relevant to early steps in lepadiformine construction.  The results of 
the study are shown in Table 3. The enolate was generated by the slow addition of the appropriate 
base at -78 °C in THF. After stirring for an hour, 1-bromobutane was syringed in and the reaction 
allowed to warm up to rt. The reaction was aided by the addition of a catalytic amount of TBAI for 
the in-situ halogen exchange between Br and I to generate a more reactive electrophile. After 12 










Table 3 Optimization of Reaction Conditions for the Alkylation of 2.31 
 
Entry Base Reaction Conversion (%) 
1 LDA < 10a,b 
2 LiHMDS < 10a,b 
3 NaHMDS 50a 
4 KHMDS 98c 
a
 Estimated by TLC after 72 hrs.
 b
Addition of LiCl and HMPA also tested.
 c 
After column chromatography 
 
In contrast to the reported literature on alkylations of acylated imidazolidinone systems,138,142,143 no 
reaction took place when lithium bases were tested under a number of conditions. Similarly, the 
reaction stalled at roughly 50 % conversion when NaHMDS was used, but gratifyingly, the enolate 
generated with KHMDS provided a 100 % conversion of substrate (tlc) in a 98 % yield of desired 
product after chromatography. The butyl derivative 2.32a was clearly visible on the tlc as two spots 
of equal intensity for the two diastereomers. The 1H NMR spectrum indeed revealed a 50:50 ratio of 
diastereomers, as determined by the relative integrations of various duplicated diagnostic signals. 
Most notably, two discernible doublets for the auxiliary benzylic hydrogen were visible at 5.37 and 
5.29 ppm, and an even more obvious duplication was evident in terms of two -methine malonate 
multiplets appearing at 4.80 and 4.62 ppm for individual diastereomers. Two methyl triplets of the 
ethoxy group were also seen (at 1.25 and 1.19 ppm) as well as two highfield doublets for the 
auxiliary methyl group.  
2.6.4 Quaternization reaction 
Having arrived at optimal alkylation conditions for the mono-alkylation, it was anticipated that 
success would follow in the crucial quaternization step using these conditions and allyl bromide as 
the electrophile. Thus, 2.32a was enolized at -78 °C with 1.2 equivalents of KHMDS, and allyl 
bromide was added after an hour, followed by warming to rt, Scheme 92. The reaction progressed 





Scheme 92 Reagents and conditions: a) i) KHMDS, THF -78 °C, ii) C4H6Br rt; b) i) KHMDS, THF -78 °C, ii) allylBr, 
rt. 
The 1H NMR spectrum of product 2.33a is shown in Fig 14, with diagnostic signals being the allylic 
protons resonating at 5.35 and 4.22 ppm, integrating for 1 and 2 hydrogens respectively.  Further 
upfield, the signals at 2.92 and 2.73 ppm were assigned to each diastereotopic proton of the allyl 
group. The absence of a signal in the region expected for the malonate -methine hydrogen (H-2) 
was also a strong indication that alkylation had taken place. Pleasingly, though, there was no visible 
doubling of any of the resonances in the 1H NMR spectrum, suggesting a high level of 
diastereoselectivity for the quaternization, which was later corroborated by HPLC analysis to be 
98:2.  
 
Figure 14 Assigned 1H NMR spectrum of 2.33a 
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The reactivity dependence on counter-ion is noteworthy. An obvious possibility is that chelation of 
the lithium (and to a lesser extent sodium) occurs into the auxiliary hole. This takes it away from the 
site of alkylation where it is needed to assist with departure of the leaving group. This can’t be the 
only reason otherwise Evans’ oxazolidinones wouldn’t alkylate, so enolate stability with Li or Na 
counter-ions must also play a role. By comparison, potassium is too large for the auxiliary hole and 
the enolate is more ionic anyway and hence more reactive. Aggregation probably also plays a role in 
that lithium enolates are known to aggregate more than potassium ones, which have more open 
accessible structures. Addition of LiCl and HMPA, which are known to dissociate enolates, didn’t 
switch on reactivity in the lithium enolate case. However, It is well-known that the 
diastereoselectivity in Evans’ oxazolidinone alkylation to afford chiral tertiary carbons at the 
alkylation site depends on: i) control of enolate geometry; and ii) a preferred (chelated) 
conformation of the enolate. In the present case, the potassium result suggested that the first 
criterion might be satisfied by virtue of the counter-ion placement in the malonate hole to afford a 
Z-enolate.  
2.6.5 Reaction Scope 
To investigate the scope of the methodology, a choice had to be made as to which route towards the 
targets would be adopted. Scheme 93 shows the two possible sequences in which option A involved 
two sequential alkylations on a common precursor (malonate-imidazolidinone) in order to furnish 
the quaternized target, while option B proceeded via an -substituted malonate as starting point.  
 
Scheme 93 Possible routes towards quaternized targets  
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Several derivatives were prepared via both routes for comparison and each option had its own 
advantages and drawbacks. Table 4 compares the two methodologies in terms of efficiency in which 
the green colouration depicts an advantage, while orange shading a drawback. 
Table 4 Comparison of routes A and B for the generation of α-substituted auxiliary-malonate 
derivatives 
Process/route ROUTE A ROUTE B 
DCC Coupling 
 Consistent high yields.  
 Predictable isolation after 
coupling. 
 DCC reaction can be done 
once on a large scale. 
 Yields were lower for all alkylated 
derivatives tested.  
 Isolation more difficult as 
products closer to urea side-
product; not possible in some 
cases. 
 DCC reaction to be done for each 
individual derivative. 
Alkylation 
 First alkylation conditions 
require the use of expensive 
KHMDS and a precious SM 
(auxiliary-malonate). 
 Difficulties in installing bulky 
electrophiles as R. 
 First alkylation uses cheap 
reagents of NaH and diethyl 
malonate.  
 Bulky electrophiles can be 
incorporated as R. 
 
After weighing up the advantages and drawbacks of each, it was decided that route A was the better 
option. Thus, 2.31 was prepared on a multi-gram scale , then enolized at -78 °C using 1.2 eq of 
KHMDS and after the electrophile was syringed in the reaction was allowed to warm to rt overnight. 
All of the alkylated products 2.32 a to e were visible on tlc slightly above the starting material as two 
distinct spots for the two diastereomers. The first alkylation to furnish mono-substituted auxiliary-
malonate derivatives proceeded in high yields but without selectivity (See Table 5). This was 







Table 5 Reaction Scope of the Mono-alkylation of 2.31 
 
Compound R Yield (%) drb 
2.32a Bu 98a 51:49 
2.32b Et 94a 51:49 
2.32c Allyl 92 52:48 
2.32d (CH2)3OBn 87
a 52:48 
2.32e Me 90 50:50 
  aWarmed to 65 °C;  b determined by NMR  
The diastereomers of some of the compounds were separable by column chromatography whilst 
others were analysed as diastereomeric mixtures. 1H NMR spectra of diastereomeric mixtures 
displayed distinct signal duplication, which were most evident for hydrogens pertaining to the 
auxiliary, as well as for H-2, which had shifted downfield compared to the unalkylated analogue to 
4.83 and 4.79 ppm. All derivatives showed expected signals associated with the auxiliary-malonate 
backbone as well as those corresponding to the alkyl chain in question.  
The installation of unactivated electrophiles and longer alkyl chains was successful, but required 
heat in order to achieve high yields. The fact that the reactions could be refluxed in THF clearly 
indicated a greater stability of the malonate-imidazolidinone enolates compared to their 
oxazolidinone counterparts. This could be understood by considering the electron-releasing 
resonance effect (outweighing its inductive effect) of the N-Me nitrogen in 2.29, which reduces the 
stability of the imidazolidinone anion as a leaving group. By comparison, in the oxazolidinone case, 
the more electronegative oxygen helps to stabilise the anion leaving group by a strong inductive 




Figure 15 Electronic effects on stability of imidazolidinones vs oxazolidinones 
With a range of mono-substituted auxiliary malonates successfully generated, the scope of the 
crucial quaternization reaction was examined by employing the optimal reaction conditions and 
various SN2-reactive electrophiles. The results are shown in Table 6.  
Table 6 Scope of Quaternization of Monoalkylated Auxiliary malonates 2.32a to 2.33e 
 
Entry Compound R R1 Yield (%)a d.r b 
1 2.33a Bu Allyl 85 98:2 
2 2.33b Et Bn 89 96:4 
3 2.33c Allyl Me 92 95:5 
4 2.33d (CH2)3OBn Allyl 93 98:2 
5 2.33e Me Allyl 93 60:40 
aAfter chromatography; bmeasured by HPLC 
The reaction proceeded smoothly to furnish quaternized products 2.33a to 2.33e in excellent yields 
and selectivities (apart from entry 5). Unsurprisingly, due to the increased steric crowding and 
decreased reactivity of the enolate, only SN2 reactive electrophiles were effective. Evidence for the 
successful installation of the second alkyl group was provided by 1H and 13C NMR spectroscopy. The 
hydrogen at C-2 was no longer present in any of the spectra, and all contained signals arising from 
the auxiliary, the ethoxy signals and all the resonances associated with the two substituents on the 
malonate. For compound 2.33b, an additional five hydrogens were present in the aromatic region, 
and the benzylic singlet appeared at 3.37 ppm. The methyl singlet of 2.33c appeared at 1.45 ppm. 
The new allylic multiplets for 2.33d were visible at 5.50 and 4.90 ppm. With the exception of 
compound 2.33e, no doubling of signals was evident. In the 13C NMR spectra, C-2 resonated in the 55 
ppm region for all analogues. 
The diastereoselectivity in the quaternized products 2.33a to 2.33e was measured by chiral HPLC 
which gave a good separation of the 2 diastereomers. Immediately evident from the results in Table 
6 is that with R as Me, there was essentially no diastereoselectivity for the allylation (entry 5), 
whereas all other combinations where R was a two-carbon unit or larger and R1 was any chain length 
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including methyl, drs of 95:5 and above were achieved, with virtually complete diastereoselectivity 
observed for bulkier R groups. Yields were good to excellent for all derivatives. A single crystal X-Ray 
structure was determined for compound 2.33b. Importantly, the diastereoselectivity translated to 
placing the R1 group syn to the bulky groups on the auxiliary when the molecule was drawn in the all-




Figure 16 X-ray structure of 2.33b 
2.6.6 Transition state postulation 
Information on the origin of the diastereoselectivity can be gleaned from the X-ray structures where 
the auxiliary is seen to adopt an s-transC-N conformation, as shown in Figure 16 for 2.33b. If one 
extends this to the transition state and couples it to an electrophile trajectory that is expected to be 
anti- to the bulky phenyl and methyl groups on the auxiliary, one reaches the conclusion that the 
reaction proceeds via a Z-enolate from the si-face. This type of enolate configuration could only be 
possible by potassium chelation into the six-membered malonate hole, which in turn would leave 
the auxiliary unchelated. However, there is a converse option that could still account for the 
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observed diastereoselectivity and this would involve an E-enolate and the auxiliary in an s-cisC-N 
conformation, probably with potassium chelated. The two transition state options, X and Y, are 
illustrated in Figure 17.  
 
Figure 17 Proposed transition state of quaternization. 
A key piece of information in the appraisal of the relative merits of the two transition state 
intermediates X and Y was that with R as Me, no diastereoselectivity was observed but with R as two 
carbons in size or more a very high diastereoselectivity was observed.  This crucial empirical 
observation was not consistent with the intermediacy of Y, since the R group consistently would 
point away from any point of steric non-bonded interaction with the auxiliary. Conversely, the 
intermediacy of X would allow explanation of the diastereoselectivity by virtue of R = Me allowing 
rotation of the unchelated auxiliary, so that the 40:60 mixture would be as a result of both s-cis and 
s-trans conformers reacting with opposite facial selectivity. Moving to a bulkier R group would then 
restrict auxiliary C-N rotational movement, locking it into the sterically least demanding s-trans 
conformation (R/CO preferred).   
Furthermore, as indicated previously, the fact that only the potassium cation was effective in the 
reaction also suggests the counter-ion being close to the site of electrophile attack in the form of a 
Z-enolate, since lithium (and to a lesser extent sodium) would be expected to go into the auxiliary 
hole. The potassium chelation model, with the cation in the malonate hole (via X), offers an effective 
solution to the problem of controlling geometry at the terminus of a disubstituted enolate, except 
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with one of the groups as an ester. Details of this work can be found in our publication in 2015 in the 
Journal of Organic Chemistry.144 
2.7 Transposition of quaternary all-Cs to ATAs 
With the successful realization of a stereoselective methodology for construction of all-C quaternary 
centres, extension to ATAs required a quaternary carboxylic acid as the substrate for the Curtius 
transposition. Chemoselective auxiliary detachment was targeted for this purpose,  and of the 
methods developed by Evans130 for the oxazolidinone cleavage and successfully applied by workers 
to the imidazolidione variant,47,138,143 only the first one involving saponification with LiOOH was 
directly applicable in our case, as shown in Scheme 94.   
 
                               Scheme 94 Known methods for imidazolidinone cleavage 
In the all-C quaternization study published in JOC,144 successful chemoselective auxiliary removal was 
achieved using ten equivalents of lithium ethanethiolate in THF at 40 °C to afford the quaternized 
ester / thioester. The thioester could then be selectively reduced to the aldehyde using a Fukuyama 
reduction with Et3SiH / Pd-C. Hence, with this backdrop, in the present context it appeared that 
studies initially needed to focus on selective auxiliary removal either via hydrolysis to an ester/acid 
or to form the ester/thioester product, which would then need to be further selectively hydrolysed. 
Reductive options were ruled out in view of the need for subsequent re-oxidation. Studies on 
hydrolytic removal are described next.  
2.7.1 Hydrolysis studies on the imide bond 
The malonate-imidazolidinone bond was initially targeted for selective hydrolysis based on the 
premise that the lithium ion of LiOOH would chelate into the imidazolidinone hole, promoting attack 
by the hydroperoxide anion at the exocyclic carbonyl. This was presumably the basis of the 
deprotection with the ethanethiolate. In his comparative studies on HOO- and OH- reactivity, Wiberg 
reported that hydroperoxide ion does not react with ethyl acetate, in contrast to its rapid reaction 
with activated esters such as phenyl benzoate, in which reactivity far exceeds that of hydroxide.145 
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This difference can be rationalized by the more nucleophilic (softer) and less basic nature of the 
HOO- ion based on the hyperconjugative -effect. Later, Evans showed a remarkable 
chemoselectivity of LiOOH for carboximide hydrolysis in the presence of unactivated esters (benzyl 
and methyl), albeit in the context of selective oxazolidinone auxiliary cleavage.146 Although to the 
best our knowledge no examples existed for chemoselective imidazolidinone cleavage in the 
presence of esters, it was surmised that similar selectivity effects might manifest as in the 
unactivated ester-oxazolidinone cases based on the imidazolidinone carbonyl being the softer site. 
Scheme 95 shows the strategy formulated for obtaining ATAs and amino acid ester derivatives 
specifically via a chemoselective hydrolysis of the malonate-imidazolidinone bond. 
 
Scheme 95 Proposed sequence to ATAs entailing a chemoselective hydrolysis with LiOOH 
To this end, imidazolidinone cleavage with LiOOH was studied using LiOOH generated by the 
addition of LiOH (1.6 eq) to a solution of H2O2 (4 eq) in a THF/ H2O mixture (3/1) at 0 °C, followed by 
subsequent addition of the substrate and warming to rt (Table 7, entry 1). Here, no reaction was 
observed after 24 hours according to tlc, prompting a broader study of temperature, equivalents and 
solvent. The results are shown in Table 7. Under mild conditions and low LiOOH equivalents, no 
auxiliary cleavage was observed (entries 1 and 2). When equivalents were increased or harsher 
conditions applied, auxiliary cleavage occurred selectively but in competition with cleavage of both 
groups to afford the di-acid 2.35, although still at low conversion (entries 4 to 9). The addition of 2 
equivalents of LiCl has been reported to aid the imide bond cleavage but unfortunately this did not 
have any marked effect on conversion either (entries 4, 5 and 9). Surmising that the congested and 
relatively hydrophobic environment might be retarding the hydrolysis, the unalkylated auxiliary 
malonate 2.31 was then committed to a few of the same hydrolysis conditions (a in the Table), and 
although yields and selectivities were better in these cases, the reaction was still not completely 




















1 Bu allyl THF/H2O (3/1) 1.6 4 rt 24h 0 0 
2 Bu allyl THF/H20 (3/1) 1.6 4 50 48h 0 0 
3 Bu allyl THF/H20 (3/1) 1.6 4 100
a
 24h 18 10 
4 Bu allyl THF /H2O (4/1) 1.6 4 50
b
 24h 10 0 
5 Bu allyl THF /H2O (4/1) 1.6 4 100
a,b
 24h 15 0 
6 Bu allyl THF /H2O (4/1) 3 4 100
a
 24h 12 8 
7 Bu allyl THF/ H2O (4/1) 5 10 50 48h 20 22 
8 Bu allyl THF/ H2O (4/1) 5 10 50
b
 24h 26 20 
9 Bu allyl THF/ H2O (4/1) 1.6 4 150
b,c
 30 min 13 10 
10 Bu allyl THF/DMF/H2O (3/3/1) 1.6 4 50 24h 21 0 
11 Bu allyl THF/DMF/H2O (3/3/1) 1.6 4 100
a
 24h 32 17 
12 H H THF/ H2O (4/1) 1.6 4 50 24h 42 11 
13 H H THF/ H2O (4/1) 1.6 4 100
a
 24h 48 23 
a Reaction carried out in a sealed tube b 2 equivalents of LiCl added  cMW assisted  
For identification purposes, the products from entry 3 were extractively isolated from the reaction 
mixture, then chromatographed on a short column and their identity confirmed by 1H NMR 
spectroscopy. For subsequent reactions, however, only the mono-acid 2.34 was isolated from the 
column (after extractive work-up) due to the difficulty in recovering the highly polar di-acid from the 
column. The yield of the di-acid was therefore determined by the weight difference between the 
acid product mixture and the isolated mono-acid, being reasonably confident of its identity by 
comparison of the tlc standard obtained previously.  
Evidently, apart from hydrophobicity aspects, the electron-releasing nature of the N-Me moiety on 
the auxiliary was reducing the lability of the imide bond and hampering its hydrolysis. Given the 
lower-than-expected reactivity of the imide bond, it was decided to target the ethyl ester, in the 
hope that conditions for its chemoselective hydrolysis could be found. 
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2.7.2 Hydrolysis studies on the ethyl ester 
Although less likely to succeed by base mediated hydrolysis, chemoselective cleavage of the ethyl 
ester was nonetheless attempted in the hope that the less sterically congested environment around 
the ethyl ester (compared to the malonate-auxiliary region) would lead to preferential reaction at 
that site. In contrast to the reactivity of the HOO- ion, shown to be largely unaffected by steric 
effects,146 the reactivity of the much larger solvated HO- ion does follow expected steric-governed 
trends, and is harder too, which we hoped would be responsive to the ester over the imide. A range 
of bases were tested under different conditions, starting with the weakly basic LiOH through to KOH, 
and the results are summarized in Table 8.  
Table 8 Results of Base Hydrolysis of 2.33c 
 







1 LiOH (1.1) EtOH rt 48h 0 0 0 
2 LiOH (1.1) EtOH reflux 24h 0 0 0 
3 LiOH (1.1) EtOH/H20 (5/1) reflux 24h 0 0 0 
4 NaOH (1.1) EtOH/H20 (5/1) rt 24h 16 0 0 
5 NaOH (1.5) EtOH/H20 (5/1) rt 24h  13 0 6 
6 NaOH (1.5) EtOH/H20 (5/1) 50 °C 24h 24 9 17 
7 KOH (1.1) EtOH/H20 (5/1) 0 °C  48h 0 0 0 
8 KOH (1.1) EtOH/H20 (5/1) rt 48h 11 0 34 
 
Employing LiOH resulted in no cleavage (entries 1, 2 and 3) and although NaOH displayed some 
selectivity for the ester, yields for the conversion were low (entries 4, 5 and 6). Reactions with KOH 
were not chemoselective at all and also gave low yields (entries 7 and 8). In these cases, all products 
obtained from reactions were extractively isolated, chromatographed and identified by 1H NMR 
spectroscopy.  
The low reactivity of the ester bond was again ascribed to the highly congested and hydrophobic 
environment. Acid hydrolysis was tested briefly, but wasn’t pursued further due to the evidence of 
several side-reactions as well as low conversions. Ultimately, it was concluded that selective 
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hydrolysis for this particular system was not possible. Re-design of the system was necessary in 
which the chemoselectivity between the ester and imide was inherent by virtue of an ester cleavage 
specificity. Of the possible ester candidates, those involving hydrogenolysis such as benzyl esters 
were not considered as that would preclude the use of unsaturated groups derived from the 
alkylation. The PMB and t-Bu esters were identified as possible candidates as their deprotection is 
achieved with TFA (no auxiliary cleavage was evident in the preliminary acid hydrolysis reactions.) 
and follows a different mechanism to hydrolysis. The PMB variant was chosen over the t-Bu due to 
concerns that the bulky t-Bu substituent might negatively impact alkylation reactions of the 
malonate. The TFA-mediated deprotection mechanism of a PMB ester is shown in Scheme 96. 
Scheme 96 Mechanism of PMB ester cleavage by TFA.  
Unlike acid or base hydrolysis, which requires approach of the OH- at the congested carbonyl carbon, 
the fragmentation of a PMB ester is driven by protonation of the ester carbonyl group followed by 
heterolytic cleavage to afford a resonance-stabilised carbocation. Although the imidazolidinone was 
deemed to be more Lewis basic it was expected that no further cleavage could ensue. These 
mechanistic considerations bore fruit in practice. As with the Boc deprotection with TFA, anisole was 
added as a carbocation scavenger.  
2.7.3 PMB ester studies 
In order to probe the chemoselectivity of PMB deprotection in a malonate-imidazolidinone system, 
allyl- methyl-PMB malonate was chosen as a model system. Its synthesis is outlined in Schemes 97 
and 98 using a double DCC condensation strategy. 
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Scheme 97 Reagents and conditions: a) DCC, DCM, rt, 2h; b) DCC, BtOH 2.29, DCM, rt, 12h 
 
The starting point of the sequence was in this case malonic acid, a cheap and readily available 
reagent. A known procedure was followed for the mono-esterification of malonic acid,147 adjusted 
here using DCC and PMBOH with an excess of malonic acid (1.4 eq) to supress diesterification 
(Scheme 97). Pleasingly, the mono-PMB malonic acid could be isolated extractively and its 1H NMR 
spectrum revealed no further need for purification. A second DCC coupling of auxiliary (-)-2.29 with 
mono-PMB malonic acid 2.37 was performed employing the same conditions as in the ethyl ester 
series, furnishing the auxiliary malonate substrate 2.38 in a yield of 85 % from the mono-acid after 
chromatography. Owing to the reversal in the order of cleavage (ester vs. auxiliary), in the PMB 
series the opposite antipode of the auxiliary was employed so as to maintain the correct 
stereochemistry required for (-)-lepadiformine since the ATA would be generated on the opposite 
terminus of the malonate.  
Formation of the auxiliary-PMB malonate was confirmed by 1H NMR analysis, which showed all the 
diagnostic signals for the auxiliary: the downfield doublet at 5.28 ppm corresponding to the benzylic 
auxiliary hydrogen; the singlet integrating for 3 hydrogens at 2.78 ppm arising from the N-methyl 
and the distinctive doublet at 0.76 ppm accounting for three hydrogens assigned to the methyl 
group of the auxiliary. In addition, 2 new multiplets integrating for 4 hydrogens were now visible in 
the aromatic region; the downfield singlet at 3.78 ppm was assigned to the methoxy group, while 
the singlet at 5.09 ppm was assigned to the benzylic hydrogens on the PMB. Although 
diastereotopic, presumably they were too far away from the chiral imidazolidinone to resolve. 
Similarly, the diastereotopic malonate methylene hydrogens appeared as a singlet at 3.99 ppm. The 
13C NMR spectrum had all the expected resonances, most notably 3 carbonyl resonances (at 167.6, 
164.9 and 155.6 ppm). 
Alkylation of the auxiliary-PMB malonate system was achieved analogously to the ethyl ester series, 
using KHMDS to form the anion at -78 °C followed by addition of allyl bromide and warming to rt 




Scheme 98 Reagents and conditions: a) i) KHMDS (1.2 eq), THF, -78 °C; ii) allylBr (1.5 eq), warm to rt, 12h; b) 
KHMDS (1.2 eq), THF, -78 °C ii) MeI (2 eq) warm to rt, 24h. 
 
The monoallylated derivative 2.39b was isolated in a yield of 97 % after column chromatography and 
as a 50/50 ratio of diastereomers as expected, Figure 17 shows the assigned 1H NMR spectrum of 
2.39b. In the 1H NMR spectrum, distinct signal duplication was seen for the hydrogens present on 
the auxiliary (H-4’, H-5’, H-6’ and N-Me), as well as for the diastereotopic PMB methylene hydrogens 
(H-6), which appeared as two sets of AB doublets (5.15 and 5.05 ppm); the PMB methoxy singlets 
were also duplicated (3.83 and 3.82 ppm). In addition, the H-2 singlet of 2.38 which had resonated at 
3.99 ppm, now shifted downfield and appeared as two dd sets (only one discernible at 4.85 ppm) 
corresponding to 1H in total by integration.  
 
Figure 17 Assigned 1H NMR spectrum of 2.39b 
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The reactivity of the system towards quaternization was unchanged when compared to the ethyl 
ester series and proceeded smoothly with methyl iodide as the alkylating agent to furnish the 
quaternized derivative 2.40b in a yield of 90 % after purification (Scheme 98). While the signals for 
the PMB methoxy, the NMe, H-4’, H-6, H-5 and H-6’ were all clearly duplicated in the 1H NMR 
spectrum (shown in Figure 17) of the mono-allylated derivative, no discernible duplication for these 
signals was observed for the quaternized product. The new methyl singlet resonated at 1.47 ppm, 
and the notable absence of H-2 was a definite indicator of the second group installation. The 
assigned 1H NMR spectrum of 2.40b is shown in Figure 18. HPLC analysis indicated a dr ratio of 98:2, 
see Figure 19.  
 
Figure 18 Assigned 1H NMR spectrum of 3.40b 
 
Figure 19 HPLC trace for compound 3.40b 
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2.7.4 Chemoselective PMB ester cleavage 
A reported procedure for PMB ester removal with TFA148 was applied to 2.40b involving anisole (1.1 
eq) as carbocation scavenger at rt (Scheme 99). The reaction was followed by tlc, which required 
neutralization of the TFA in the tlc aliquot with aqueous NaHCO3 for easy visualization, noting 
complete consumption of starting material after 3 hours.  
 
Scheme 99 TFA catalysed PMB ester cleavage 
 
Following the removal of solvent and excess TFA, the product was isolated by acid-base extraction, 
which produced acid 2.41b of sufficient purity for characterization. No auxiliary cleavage was 
observed under these conditions and the yield of the acid was virtually quantitative (98 %). The IR 
absorption spectrum showed a distinctive broad OH absorbance at 3431 cm-1. The aromatic region 
of the 1H NMR spectrum integrated for only 5 hydrogens for the auxiliary phenyl; in addition, the 
benzylic AB doublets of the PMB group were absent as well as the methoxy singlet, all of which 
confirmed the loss of the PMB. A new, very broad singlet appeared at 5.45 ppm, corresponding to 
the carboxylic acid hydroxyl. This is surprisingly highfield for this type of signal and probably reflects 
intermolecular hydrogen bonding in CDCl3. All other peaks were essentially unchanged when 
compared to the PMB ester precursor.  
2.7.5 Curtius Rearrangement Optimization 
With a dependable methodology for generating non-racemic quaternary malonate half-esters, the 
stage was set for transformation to the ATAs via Curtius rearrangement. Following the literature on 
this well-established reaction, a one-pot procedure was investigated, involving conversion to the 
acyl azide with diphenyl phosphoryl azide (DPPA) followed by insitu thermal Curtius rearrangement 
and trapping out of the isocyanate with t-BuOH to furnish the Boc-protected amine. The mechanism 
of the reaction is shown in Scheme 100. Deprotonation of the acid by Et3N generates a carboxylate  
which substitutes the phosphoryl azide with expulsion of N3
-. The azide ion then carries out a SNAc 
reaction onto the carbonyl of the phosphorylated acid which results in the formation of the acyl 
azide and diphenylphosphate ion. The concerted rearrangement from the acyl azide to the 
isocyanate is heat driven, releasing N2 gas in the process. Finally, nucleophilic addition to the 
isocyanate with t-butyl alcohol gives the N-Boc carbamate. Ureas can similarly be prepared by 




Scheme 100 The Curtius rearrangement mechanism with alcohol interception of the isocyanate  
 
A typical procedure entailed the addition of Et3N to a solution of 2.41b in toluene, followed by DPPA 
and refluxing for several hours until complete consumption of the acid was observed. t-BuOH was 
then added and the reflux continued (Scheme 101). 
 
Scheme 101 Reagents and conditions: a) Et3N (2.5 eq), DPPA (1.2 eq), toluene, reflux; b) t-BuOH (5 eq), reflux 
 
Several attempts under various conditions were made in this direction but the carbamate product 
2.45 could not be detected, the isocyanate 2.43b being the only product isolated in yields of 40 – 50 
%. As expected, the 1H NMR spectrum of 2.43 looked very similar to that of 2.41b, apart from the 
disappearance of the broad carboxylic OH peak at 5.45 ppm. The absence of a t-Bu singlet in the 1 -2 
ppm region, excluded formation of the Boc- protected derivative. The carbonyl peak in the 13C NMR 
spectrum of 2.43b also displayed the expected shift from 171.1 ppm (acid) to 125.3 ppm 
(isocyanate). Confirmation of rearrangement was provided by the IR spectrum in which a medium, 
sharp absorption band at 2253 cm-1 for the N=C=O stretch was taken as indicative of isocyanate 
formation (azides typically give rise to absorptions closer to 2140 cm-1). In an attempt to improve 
yields and scrutinise the reaction, the intermediate acyl azide was allowed to form first at room 
temperature in which the formation of a product spot with an increased rf on the tlc, indicated acyl 
azide formation from the acid; once all of the acid had been consumed, reflux conditions were 
applied. As the reaction progressed, consumption of the acyl azide spot was seen, reciprocated by 
steady formation of isocyanate 2.43b as judged by tlc. Addition of t-BuOH to this reaction mixture, 
once again resulted in no carbamte formation and the yield of the isocyanate did not improve (43 % 
after column chromatography). 2.43b was a stable crystalline solid, easily withstanding aqueous 
work-up and column chromatography, which indicated a low reactivity, mirroring the setbacks 
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experienced with hydrolysis/ auxiliary cleavage. Again, this was not surprising, as Curtius 
rearrangements in sterically crowded environments of quaternary systems are often problematic, 
sometimes requiring the use of stronger nucleophiles to intercept the isocyanate. To examine 
whether such an approach might bear fruit, a 1M solution of lithium tert-butoxide was prepared by 
treating dry t-BuOH with n-BuLi at 0 °C. Addition of 1.1 equivalent of t-BuOLi to a solution of 
isocyanate 2.43b in THF did not result in carbamate formation but rather led to a few side reactions.  
Another way to increase reactivity in these systems is with Lewis acid activation, in which titanium 
tetra-t-butoxide (Ti(Ot-Bu)4) has been reported as an efficient catalyst for the reaction of hindered 
isocyanates and alcohols. This method was tested, whereby the isocyanate 2.43b was refluxed with 
1.5 equivalents of t-BuOH and Ti(Ot-Bu)4 (0.1 eq). However, no change in the starting material was 
seen after 24 hours. Over the following 24 hours, another 3 equivalents of t-BuOH were added in 
half-equivalent increments, but still no significant amount of isocyanate conversion was observed 
(Scheme 102). Several runs with increased equivalents of the Lewis acid were also performed but 
conversion to 2.45 could not be accomplished.  
 
Scheme 102 Reagents and conditions: a) t-BuOLi, THF, 0 °C to rt; b) t-BuOH (1.5 to 4.5 eq), Ti(Ot-Bu)4 (0.1 to 
0.5 eq), toluene, reflux. 
 
The protocol developed by Lebel and co-workers in 2005,149 whereby a combination of 
tetrabutylammonium bromide (Bu4NBr) and Zn(OTf)2 was used to catalyse the carbamate formation, 
was also considered on paper, but despite the method having the advantage of being a mild one-pot 
procedure (starting from the acid), the mediocre yields reported for quaternary malonates (60-75 %) 
were deemed unsatisfactory and thus the protocol was not tested. Instead a step-wise sequence 
involving hydrolysis of the isocyanate to the corresponding amine under various hydrolysis 
conditions was adopted, from which a standard Boc protection could presumably be performed. The 








Table 9 Optimization of Isocyanate to Amine Hydrolysis Conditions 
 
Entry Solvent Temperature  Yield 2.44b (%) 
1 H2O  Rt to reflux 0 
2 H2O/ THF Rt to reflux 0 
3 H2O/ Toluene Rt to reflux 0 
4 H2O/ ACN Rt to reflux 0  
5 ACN/ aq. NaOH Rt to 40 °C 10 and decomp. 
6 ACN/ 1 M HCl Rt 20 
7 ACN/ 5 M HCl 60 °C 90 
 
Generally, isocyanates are known to decompose in aqueous systems via the carbamic acid 
intermediate, which gives rise to the free amine following a spontaneous decarboxylation (Scheme 
103).  
 
Scheme 103 Decomposition of isocyanates upon reaction with water. 
 
Surprisingly, refluxing 2.43b in water returned no free amine even when water-miscible solvents 
were added to achieve homogeneity (entries 1 to 4). This gave definitive proof of the extreme 
hydrophobic environment around the grouping. Base hydrolysis was also tested but resulted mostly 
in unwanted side-reactions (entry 5). Fortunately, heating 2.43b in a mixture of acetonitrile and 5M 
aqueous HCl gave a clean conversion to the amine 2.44b which could be extractively isolated in a 
yield of 90 %. Evidently, such harsh conditions were required in order to overcome the steric 
congestion and hydrophobicity around the isocyanate. Importantly, the imide bond remained intact. 
Evidence for the formation of the amine was given by 1H NMR spectroscopy, with the appearance of 
an exchangeable broad singlet at 2.25 ppm arising from the NH2. The diagnostic NH2 stretch at 3392 
cm-1 corroborated the assignment. All auxiliary, allyl and methyl signals in the 1H and 13C NMR 
spectra were essentially unchanged compared to the isocyanate precursor.  
Next, the consistently low yields for the rearrangement were addressed. Suspecting that the 
presence of several by-products from acyl azide formation as well as some unreacted DPPA may 
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have resulted in side-reactions at the high temperatures needed for the rearrangement, it was 
deemed prudent to carry out a stepwise procedure and isolate the acyl azide prior to the thermal 
rearrangement.  There was some concern over whether the acyl azide could withstand column 
chromatography, however, but the high stability of the isocyanate led us to believe that the acyl 
azide might behave similarly. The results of the study are shown in Table 10. 
 
Table 10 Optimization of Reaction Conditions for Acyl Azide Formation 
 
Entry Solvent Eq Et3N Eq DPPA 
Isolated Yield 2.42 
(%) 
1 Toluene 1.2 1.2 42 
2 Toluene 1.8 1.2 48 
3 THF 1.8 1.2 50 
4 CH3CN 1.2 1.2 66 
5 CH3CN 1.2 1.5 50 
6 CH3CN 2.0 1.2 91 
All reactions done at rt. 
At first, yields of 2.42 (from column chromatography) were low but eventually optimal conditions 
were established; CH3CN was the best solvent and highest yields were obtained with 2 equivalents of 
Et3N. Because treatment of the acid with Et3N converts it to the triethylammonium salt, direct tlc 
analysis was not possible to determine if all of the acid had been converted to the acyl azide due to 
the presence of excess Et3N and the diphenylphosphate ion by-product, all of which appeared close 
to the tlc baseline. Thus, an acidic mini-work up with ethyl acetate was performed on aliquots of the 
reaction mixture in order to visualize the acid and follow the reaction. For isolation purposes, no 
work up was carried out and the acyl azide was purified directly by flash chromatography in a yield 
of 91 %. Thermal rearrangement of the purified acyl azide in refluxing ACN resulted in complete 
conversion to the isocyanate 2.43b (evidenced by tlc). At that point, hydrolysis to the amine was 
performed without isolation of the isocyanate using the optimized conditions established earlier. 
Acid-base extraction was a favourable way to isolate the amine, which was achieved in an overall 
yield of 88 % from the acid 2.41b, vindicating the purification step (Scheme 104).  
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Scheme 104 Modified Curtius rearrangement/ hydrolysis protocol 
2.7.6 Reaction scope of the PMB malonate-auxiliary system 
Encouraged by this result, a further six quaternized analogues were synthesized according to the 
sequential alkylation procedure, and the results are shown in Table 11. The nature of the R group 
introduced was determined by the choice of the α,α-disubstituted amino acid target ultimately 
(after auxiliary removal), in which the emphasis was on the production of quaternized naturally 
occurring ones. Here, one of the R groups had to be either the amino acid side chain itself (entries 1 
and 2), or be able to generate the side chain in question by virtue of manipulation post 
rearrangement (entries 3 and 4). Where applicable, the target amino acid for respective derivatives 
is included in the Table for clarity. Compound 2.40f, entry 6 was designed as a precursor for the 
lepadiformine sequence. The alkyl halides for compounds 2.40c and d required synthesis, which will 
be covered in the section relevant to their application. 
Excellent yields and selectivities (determined by HPLC) were obtained for all 6 derivatives following 
column chromatography. All 1H NMR spectra of the quaternized products contained the familiar 
auxiliary resonances, as well as the characteristic AB doublets of the diastereotopic benzylic 
hydrogens on the PMB (5.15 and 5.05 ppm regions, with a J value of 13 Hz) and the signals 











Table 11 Scope of sequential di-alkylation of PMB malonate-auxiliary 2.38 
 









 Target  
1 2.40a Bn Me 95 98:2 Methyl-phenylalanine 
2 2.40b Allyl Me 94 98:2 Allyl-alanine 
3 2.40c (CH2)4N3 Allyl 90 98:2 Allyl-lysine 
4 2.40d (CH2)3OBn Bn 94 97:3 Benzyl-Proline 
5 2.40e Et Allyl 92 94:6 N/A 
6 2.40f (CH2)3OBn Allyl 96 98:2 Lepadiformine precursor 
7 2.40g Bn Allyl 94 96:4 Allyl-phenylalanine 
a Over two steps; b determined by HPLC  
Applying the TFA-catalysed PMB deprotection conditions to analogues 2.40a to f reproduced high 
yields in every case (Table 12). The 1H NMR spectra of all the acids showed the expected loss of 
signals associated with the PMB group, and featured a broad singlet in the region between 5 and 6 
ppm for the carboxyl hydrogen.  
Table 12 PMB Deprotection Results for Derivatives 2.40a to g 
 
Entry Compound R R
1
 Yield (%) 
1 2.41a Bn Me 95 
2 2.41b Allyl Me 94 
3 2.41c (CH2)4N3 Allyl 86 
4 2.41d (CH2)3OBn Bn 91 
5 2.41e Et Allyl 95 




Next, the modified Curtius rearrangement/ hydrolysis protocol was applied to acids 2.41a to f via a 
purified acyl azide as described previously, which gratifyingly furnished ATAs 2.44a to f in high yields 
following extractive work-up procedures (Table 13). Yields for the three-step sequence were 
consistently high overall, with approximate yields (in order) of 85 % 
Table 13 Results of the Modified Curtius Procedure to Generate ATAs 2.44a to f 
 





1 2.44a Bn Me 79 
2 2.44b Allyl Me 88 
3 2.44c (CH2)4N3 Allyl 86 
4 2.44d (CH2)3OBn Bn 87 
5 2.44e Et Allyl 86 
6 2.44f (CH2)3OBn Allyl 90 
aFinal yield over two steps from the acid; bExtractive isolation 
The 1H NMR spectra of the amine products showed a characteristic NH2 broad singlet peak in the 
2.20 ppm region, which was corroborated by the presence of broad absorbance stretches in the 
3400 cm-1region in the IR spectra. Similarly, the distinctive isocyanate absorption stretch at 2253 cm-
1 had disappeared. There was no discernible duplication of signals in the spectrum, suggesting that 
the rearrangement and hydrolysis had proceeded without epimerization of the products. This 
preliminary assumption was satisfactory at that point as ees would be assessed by chiral HPLC on the 
final products after removal of the auxiliary. Although this modified Curtius route to amines from 
carboxylic acids was a three-step sequence, the need for only one flash column and the high yields 
obtained compensated for the additional operations.   
2.8 Generation of α,α-disubstituted amino acids  
2.8.1 Quaternary alanines  
The successful diastereoselctive assembly of a targeted range of ATAs provided entry into 
enantioselective production of α,α-disubstituted amino acid esters via a transesterification auxiliary 
cleavage reaction. The known transesterification using 1.1 equivalent of 1M MeONa in MeOH at 0 °C 
was applied to compounds 2.44a and b bearing methyl as the R1 group (2.40g was not elaborated 
further). Since no reaction progress was evident at this temperature, the reaction was allowed to 
warm up to rt. Reaction times varied form half an hour to 3 hours, and following aqueous work-up 
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and a flash column generated α,α-disubstituted amino acid esters 2.46a and 2.46b in good yield, as 
well as recovered auxiliary (80 – 89 % yield). The results are summarized in Table 14.  
Table 14 Methanolysis of ATAs 2.44a and b to Generate Quaternary Alanines 
 
Entry Compound R R
1
 Isolated Yield (%) ee
a
 (%) 
1 2.46a Bn Me 79 94 
2 2.46b Allyl Me 76 96
b
 
aDetermined by chiral HPLC; bee of the NH-Bz derivative 2.47 
(S)-α-Allyl-alanine methyl ester and (S)-α-methyl-phenylalanine methyl ester were obtained in 79 
and 76 % yield respectively. The absolute configuration was assigned as S based on previously 
observed selectivities in the quaternization. (S)-α-Allyl-alanine methyl ester 2.46b was benzoylated 
for the purposes of HPLC detection by reaction with pyridine and BzCl in DCM (Fig. 20). Both 
quaternary alanines were fully characterized, and their data correlated with reported values, 
confirming the assignment of absolute stereochemistry as (S). For 2.47: [α]𝐷
20= +9.80°, (CHCl3, c = 1), 
[lit.150[α]𝐷
20
 = +9.74° (CHCl3, c = 1.0)]. For 2.46a: [α]𝐷
20= -8.9°, (CHCl3, c = 0.67), [lit.
151 [α]𝐷
20= -14.1° 
(CHCl3, c = 1.6)]  
 
Figure 20 Quaternary alanines 
2.8.2 α,α-Disubstituted lysine 
The lysine side-chain comprises a 4-carbon unit with a primary amine terminus. As a precursor to the 
side chain, a four-carbon unit terminating with an azide was chosen as the substituent on the 
malonate, the amine expected to be accessible via reduction of the azide. This was preferred to 
other N-protected moieties such as a phthalimide (this would require strong nucleophilic conditions 
for deprotection).The requisite electrophile, 1-azido-4-bromobutane, was generated from the 




Scheme 107 Reagents and conditions: a) NaN3 (3 eq), DMF, 50 °C 
Yields for the conversion were low within the 20 % range but did at least correlate with those 
quoted in the literature of 22 %.152 The yield was improved to 30 % by increasing the number of 
equivalents of NaN3 from 1.5 to 3 and using freshly distilled 1,4-dibromobutane, although raising the 
number of equivalents of NaN3 above 3, as well as increasing the temperature did not result in 
higher yields. Separation of the unreacted 1,4-dibromobutane from the product was problematic, 
primarily because of the similarity in rf and difficulty in visualization of the spots on tlc, and it was 
imperative that 2.48 not be contaminated with 1,4-dibromobutane as this would lead to unwanted 
side-products in the alkylation step and a loss of valuable material. However, careful 
chromatography using a low polarity MeOH/ DCM (2/98) solvent system and employing CAN spray 
for visualization made product isolation possible.   
With the desired four-carbon tether featuring an azide terminus in hand, sequential dialkylation, 
deprotection and Curtius rearrangement/ hydrolysis was performed as discussed in the previous 
sections, furnishing the ATA methyl ester 2.46c. (Scheme 108 shows the complete sequence from 
the auxiliary malonate to the α-allyl lysine derivative as an N-benzoate). 
Scheme 108  Regents and conditions: a) i) KHMDS (1.2 eq), THF, -78 °C; ii) 2.48 (1.5 eq), warm to rt, 12h; b) 
KHMDS (1.2 eq), THF, -78 °C ii) AllylBr (2 eq) warm to rt, 24h; c) TFA (6 eq), anisole (1.1 eq), DCM, rt, 3 h; d) i) 
Et3N (2 eq), DPPA (1.2 eq), ACN, rt; ii) ACN reflux 4h, then 5M HCl, 70 °C; e) NaOMe (1.1 eq), MeOH, rt, 2h; f) 
BzCl (1.1 eq), pyr (1.2 eq), DCM, rt; g) P(Ph)3 (2 eq), THF/H2O (6:1), rt, 9h, then Boc2O (2 eq) rt, 15 min.  
 
The amine of ATA 2.46c was protected with a benzoyl group using benzoyl chloride and pyridine in 
DCM to give the Bz protected amino acid methyl ester 2.49 in a yield of 88 % after chromatography. 
The Bz group was again chosen due to its ability to impart UV activity to the molecule for analytical 
purposes (HPLC). No broad singlet at 2.79 ppm in the product corresponding to the NH2 was visible 
in the 
1H NMR spectrum, the NH giving rise to a new amide downfield singlet at 7.15 ppm. 
Resonances in the aromatic region both in the 1H and 13C NMR spectra were a definitive indicator of 
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the presence of the benzoyl group. Reduction of the azide to the amine needed to be performed 
next and a number of methods exist for this transformation. In analogous work done by colleagues 
in the research group, quaternary azides were cleanly reduced to ATAs using a Zn/NH4Cl protocol. 
Naturally, this was attempted first but did not give clean conversions, persistently forming several 
side-products.  The Staudinger reaction with in situ Boc-protection of the resultant amine was then 
considered as an attractive alternative. In the Staudinger reaction, the PPh3 reacts with the azide to 
form a phosphazide, which upon loss of N2 gas generates an iminophosphorane. Aqueous work up 
furnishes the amine and phosphine oxide. When a mixture of THF and water are used as solvent, the 
amine is generated without work-up and Boc anhydride can be added for In situ protection. Reaction 
of 2.49 with two equivalents of PPh3 in THF/H2O (6:1) at rt for 9 hours pleasingly revealed a very 
polar product on the tlc plate, and once the azide had been fully consumed, 2 equivalents of Boc2O 
were added, which resulted in full conversion to a much less polar spot within 15 minutes. Following 
chromatography the diprotected α-allyl-lysine methyl ester 2.50 was isolated in a yield of 76 % after 
chromatography. The t-Bu singlet of the Boc integrating for 9 hydrogens was visible at 1.33 ppm and 
the broad singlet at 4.49 ppm was assigned to the Boc-protected NH. In addition, a new carbonyl 
resonance arising from the Boc C=O appeared at 156.1 ppm in the 13C NMR spectrum. The er of the 
final product was determined by chiral HPLC as 98:2.  
2.8.3 α,α-Disubstituted proline 
The tether chosen as a precursor for quaternary proline was a three-carbon chain unit with a 
protected hydroxyl terminus. A benzyl group was selected for this purpose but of course this would 
be incompatible with any unsaturated R group at the quaternary centre. Obtaining proline via this 
substituent would entail a ring closing reaction between the amino group of the amino acid. The 
requisite alkyl halide was synthesised in simple, high yielding steps as shown in Scheme 105. 
Monoprotection of the hydroxyl group was carried out using sodium hydride and benzyl bromide. In 
order to achieve high yields, an excess (2 equivalents) of 1,3- propane diol was used together with  
an inverse addition of NaH, i.e. the NaH was added in small portions to the solution of the diol in THF 
at 0 °C over a period of 30 minutes in order to minimize dianion formation. After another 30 minutes 
at rt, benzyl bromide was syringed into the reaction, which was refluxed overnight. Isolation by 
chromatography furnished 2.51 in a yield of 81 %. 1H NMR spectral data was the same as that 





Scheme 105 Reagents and conditions: a) NaH (0.5 eq), THF 0 °C, then BnBr (0.5 eq), reflux; b) PPh3(1.3 eq), 
imidazole (1.3 eq), I2( 1.3 eq), toluene, rt, 12h.  
An Appel reaction was then employed for converting the remaining hydroxyl group into its iodide. 
This well-known reaction is a mild and convenient way of generating an alkyl halide from the 
corresponding alcohol and is carried out using an excess of PPh3 and CX4 (where X = Cl or Br). A 
variation for obtaining the iodide involves the addition of iodine and imidazole in place of the carbon 
tetrahalide. Thus, a solution of 2.51 in toluene was cooled to 0 °C and imidazole (1.3 eq), PPh3 (1.3 
eq) and I2 (1.3 eq) were added successively. The equivalents of PPh3 had to be kept to a minimum as 
it had a very similar rf to the product, but anything below 1.3 equivalents gave lower yields. 
Complete conversion to the iodide 2.52 took place within 8 hours as evidenced by tlc, which was 
obtained following a work up with sodium thiosulfate by flash chromatography in a 96 % yield.  
The resultant iodide was susceptible to hydrolysis by moisture and would slowly degrade, even when 
stored at -20 °C. It was therefore better to stockpile the mono-protected alcohol 2.51 and prepare 
the iodide freshly as needed. This tether was also used for the sequence pursued in the 
lepadiformine work, which will be discussed later.   
The iodide 2.52 was used in the alkylation of auxiliary malonate and the ensuing synthetic steps 
(already covered in depth) outlined in Scheme 106, furnished the amino acid methyl ester 2.46d. 
Further elaboration to the α-benzyl proline derivative involved four additional operations. The first 
step was the Boc protection of the amine where it was discovered that a good yield (80 %) could 
only be achieved if base (Et3N) was excluded from the reaction. The 
1H NMR spectrum of the product 
2.53 clearly revealed the new carbamate hydrogen singlet at 5.30 ppm. A t-Bu singlet integrating for 




Scheme 106 Reagents and conditions: a) i) KHMDS (1.2 eq), THF, -78 °C; ii) 2.52 (1.5 eq), warm to reflux, 12h; 
b) KHMDS (1.2 eq), THF, -78 °C ii) BnBr (2 eq) warm to rt, 24h; c) TFA (6 eq), anisole (1.1 eq), DCM, rt, 3 h; d) i) 
Et3N (2 eq), DPPA (1.2 eq), ACN, rt; ii) ACN reflux 4h, then 5M HCl, 70 °C; e) NaOMe (1.1 eq), MeOH, rt, 2h; f) 
Boc2O (1.5 eq), t-BuOH, rt, 24h; g) H2, Pd/C (10 mol%), MeOH, rt, 2h; h) pyridine (2 eq), MsCl (2 eq), DMAP (0.5 
eq), DCM, rt, 12h; i) TFA (1.5 eq), DCM, 0 °C, 2h; then Et3N (3 eq), THF, rt, 1h. 
 
The benzyl protecting group on the hydroxyl was removed under standard hydrogenolysis conditions 
using 10 mol % Pd/C in MeOH under a hydrogen atmosphere.  The reaction was complete within 2 
hours furnishing the alcohol 2.54 in a yield of 98 % after column chromatography. Debenzylation 
was corroborated by loss of five hydrogens in the aromatic region of the 1H NMR spectrum, as well 
as the appearance of a new broad singlet at 1.59 ppm for the OH. To cyclize to the proline derivative, 
the two-step sequence of hydroxyl group mesylation followed by intramolecular nucleophilic 
substitution was chosen over the one-pot Mitsunobu procedure, primarily because literature yields 
for a similar system utilizing the Mitsunobu protocol were reported as only moderate (60 %).154 
Mesylation of the hydroxyl group proceeded smoothly in DCM using 2 equivalents of pyridine, 0.5 
equivalents of DMAP and 2 equivalents of mesyl chloride. The product and the SM had very similar 
rfs on the tlc plate and also had the same appearance after spray visualization. Several low polarity 
tlc runs were required to achieve their separation and thus follow the reaction which was complete 
within 5 hours. Chromatographic isolation gave the mesylated product 2.55 in a yield of 92 %. In the 
1H NMR spectrum of the product, a new singlet at 3.70 ppm integrating for 3 protons was assigned 
to the mesyl methyl group. Most other signals were unchanged when compared to the alcohol, 
except for the multiplet of the methylene alpha to the OMs which had now shifted downfield from 
3.81 ppm to 4.13 ppm. The broad singlet for the hydroxyl at 1.59 ppm was also absent.   
The Boc removal and cyclization steps were carried out sequentially, without isolation of the 
deprotected amine. Deprotection was carried out in DCM at 0 °C using 1.5 equivalents of TFA. When 
all of the starting material had been consumed (ca. 2hours), the solvent and excess TFA were 
removed under vacuum, and the residue re-dissolved in THF. Addition of 3 equivalents of Et3N and 
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stirring at rt for a further hour resulted in cyclization, which furnished the desired (R)-α-benzyl 
proline methyl ester 2.56 following a conventional isolation in a 75 % yield for the two steps. The 
mesyl and t-Bu singlets were now absent from the 1H NMR spectrum and the broad singlet of the 
amino hydrogen had shifted upfield from 5.31 ppm in the Boc-protected analogue to 2.06 ppm. 
Chiral HPLC revealed an ee of 96 % for the final product. 
2.9 Application of the quaternization methodology to the construction of (-)-
Lepadiformine  
2.9.1 Towards (-)-Lepadiformine A via Malic Acid-based Tethers 
From the outset of planning the synthesis of the target it was clear that the choice of R groups on 
the malonate -position was a crucial design aspect. Incorporating an allyl group was necessary for 
the construction of the A ring via ring-closing metathesis, and this fitted nicely with it being the R1 
group in the form of a reactive SN2 electrophile (allyl iodide) in the alkylation. Conversely, the second 
group needed to be functionalized at its terminus so as to provide an opportunity for 
heterocyclisation to form the C-ring. While lepadiformine C lacks a chiral centre in the C ring, making 
for a simple achiral tether, lepadiformines A and B both contain a C-ring chiral centre at C-5 bearing 
a hydroxymethyl group, which meant that a more complex tether needed to be considered. Figure 
21 shows the substituents on the ATA needed for lepadiformine A. 
 
Figure 21 The ATA of lepadiformine A translated to an acyclic derivative 
The Curtius methodology just described in section 2.7 was developed after initial attempts to make 
inroads on the targeted synthesis. The strategy of lepadiformine construction remained the same 
throughout, and initially it was assumed in the first-generation synthesis that chemoselective 
auxiliary removal would be possible to provide a carboxyl group (as an ester / acid) for the Curtius 
rearrangement. In this next section two synthesis approaches are thus described: (i) the first one 
attempted based on generation of the carboxyl function via auxiliary removal, and (ii) a second-
generation approach that made uses of the successful methodology for Curtius rearrangement 
involving a PMB ester.  




 Scheme 109 Retrosynthesis of lepadiformine A  
The disconnection shown in Scheme 109 assumes C-ring construction early in the synthesis in 
keeping with the earlier work from the group described in section 2.1. Hence, disconnection of the A 
and B rings from the target generated key chiral synthon A as a disubstituted pyrrolidine, which by 
way of a C-ring cyclisation strategy and a Curtius transposition could be disconnected back to the key 
α’-disubstituted malonate D derived by selective hydrolysis of the auxiliary in E. In turn, for 
synthesis of mono-substituted malonate F, a ketal-protected iodide G needed to be synthesised, 
which could be derived from (R)-Malic acid. At this stage we were aware that the alternative of 
leaving the C-ring construction till late in the synthesis had the advantage that epoxidation of the 
required terminal alkene had been shown to be diastereoselective (the epoxide would then be 
opened in a 5-exo-tet fashion to afford the target), which would make for a shorter synthesis overall. 
However, at this stage it was decided to stay with the route published in 2002 centred on building up 
from the C-ring. 
Synthesis of iodide G was relatively straightforward starting with malic acid. Although in the context 
of the naturally occurring isomer of lepadiformine, the tether required the use of (R)-malic acid, the 
substantially cheaper and more abundant (S)-malic acid was chosen for investigating the sequence 
with the intent of switching to the (R) isomer later on or by using Mitsunobu chemistry. Being a 
readily available chiral pool reagent with numerous examples of application in synthesis, a literature 




Scheme 110 Reagents and conditions: a) H+, MeOH; b) BH3SMe2, 5 mol % NaBH4; c) (CH3O)2C(CH3)2, p-TsOH, 
C3H6O; d) LiAlH4 (1 eq), THF, -20 °C; e) Et3N (1.2 eq), MsCl (1.2 eq), DMAP (10 mol %), DCM, 0 °C; f) NaX, 
acetone reflux. 
The synthesis began with the Fischer esterification of malic acid, achieved by bubbling dry HCl gas 
through a solution of (S)-malic acid in methanol for fifteen minutes and allowing the reaction to stir 
overnight (Scheme 110). This procedure was chosen as it was perceived to be the most suitable for 
large-scale preparation of dimethyl malate. Purification by vacuum distillation after removal of 
solvent, conveniently delivered the product in a yield of 88 %. Owing to the slow decomposition of 
dimethyl malate, the next step was performed immediately. In order to obtain the desired 1,2-
acetonide, the method developed by Saito et al155 was followed as it allowed for a chemoselective 
reduction that minimized formation of the triol, which would have resulted in mixed acetonide (1,2 
vs 2,4 hydroxyl groups) formation subsequently. The procedure entailed the use of BH3SMe2 and 
catalytic sodium borohydride in THF at rt and the origin of the chemoselectivity due to chelation 
involving a borinate formed by exchange is shown. The common view of the reaction mechanistically 
is that it goes via an initial exchange of the proton of the hydroxyl group with BH3SMe2, realising H2 
gas in the process. This is followed by chelation of the resultant borinate borane to the closer of the 
two ester carbonyls, directing the reduction at that position, whilst the other ester is left unchanged. 
It was imperative that the reaction be closely monitored, though, as over-reduction to the triol took 
place if not immediately quenched by the addition of ethanol after consumption of starting material. 
The resultant triethyl borate (B(OEt)3) side product was removed by repeatedly azeotroping with 
toluene, and the pure diol was obtained by column chromatography of the residue in a yield of 72 %. 
The 1H NMR spectroscopic data of the product agreed with that in the literature.155 The ketalization 
step was performed according to a known procedure using catalytic p-toluenesulfonic acid (p-TsOH) 
and dimethoxypropane in acetone, and the reaction was complete within an hour, after which the p-
TsOH was neutralised by the addition of triethylamine. The resultant salt was removed by filtration 
through a silica pad, followed by a thorough washing with ether. Vacuum distillation proved the 
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most efficient way to purify large quantities of the acetonide in reproducible yields of around 90 %. 
Similarly, the 1H NMR spectral data was identical to that published in the literature.155 Reduction of 
the ester was carried out using 1 equivalent of LiAlH4 in THF at -20 °C and was complete within 2 
hours (Scheme 110). Quenching with the slow addition of THF/H20 (50/50) until all precipitated 
lithium salts were white was followed by the filtration of the mixture through Celite. The product 
was purified by distillation in a yield of 95 %, and once again the 1H NMR spectrum matched that of 
the reported data.155 The primary alcohol of 2.57 was then transformed to its iodide using a two-
step mesylation/SN2 substitution protocol. The mesylation was carried out using Et3N and MsCl in 
DCM, giving the mesylate in a yield of 98 % following flash chromatography. Conversion to the alkyl 
halide was achieved virtually quantitatively by heating the mesylate product with three equivalents 
of NaI (or NaBr) in acetone. With the production of the requisite electrophile concluded, its 
implementation in the alkylation of auxiliary-malonate system 2.31 was probed. Initially, the iodo- 
derivative 2.59 was chosen owing to its superior reactivity compared to its bromo- counterpart. 
Application of optimal alkylation conditions developed for the auxiliary malonate system furnished 
the desired α-substituted auxiliary-malonate in only a 23 % yield (Table 15). Furthermore, the iodide 
electrophile was unstable in solution and underwent considerable decomposition during the course 
of the reaction and could not be recovered after work-up. Various alkylations were carried out 
varying the base and the leaving group as shown in Table 15 but no improvement in yield could be 
achieved. However, the bromo- derivative 2.60 displayed very little decomposition compared to the 
iodo- counterpart, and unreacted electrophile was recovered virtually quantitatively based on the 












Table 15 Alkylation of auxiliary-ethyl malonate with acetonide-containing electrophiles 
 
Entry Base (eq)  X E+ equivalents Isolated Yield 2.61 (%) 
1 KHMDS (1.1) THF I 1.5 20b 
2 KHMDS (1.1) THF I 2.5 23b 
3 NaH THF I 1.5 0b 
4 KHMDS (1.1) THF Bra 2.0 27c 
a10 mol % TBAI added;  bno E+ recovered c unreacted E+ recovered after reaction 
An alternative route for accessing the alkylated auxiliary malonate system was thus investigated, 
involving the alkylation of diethyl malonate first, followed by mono-hydrolysis and auxiliary coupling 
(referred to as route B, as set out in Scheme 93, vide supra). The alkylation step was carried as 
before by inverse addition of NaH to diethyl malonate, followed by introduction of 2.60 (chosen over 
the iodo-derivative owing to its greater stability) and warming to reflux, furnishing the product in a 
yield of 76 % after chromatography (Scheme 111). Mono-hydrolysis to the half acid-ester was 
performed as before using KOH in EtOH, furnishing the desired alkylated mono-acid 2.62 in a yield of 
77 %. However, several attempts to couple the alkylated mono-acid to the auxiliary using the range 
of methodologies available, all gave disappointingly low yields and several side-products. Coupling 
reactions using the Bt and DCC activation methods would stall at roughly 30 % conversion, even at 
elevated temperatures. Solvent and additive variation (DMAP and BtOH for DCC) did not improve 
results. Mixed anhydride activation with pivalic anhydride resulted in a complex tlc profile due to the 
decomposition of the acid. This was attributed to acetonide hydrolysis since the reaction medium 




Scheme 111 Reagents and conditions: a) i) NaH (1.2 eq), THF, 0 °C; b) 2.60 (1.5 eq), reflux; b) KOH (1.2 eq), 
EtOH, rt. 
Owing to the unstable nature of 2.59 and 2.60, which was thought to be due to the acid lability of 
the acetonide, an analogous tether was sought bearing O-protecting groups that were less labile. 
Upon investigation of the literature, it was decided to replace the acetonide with PMB and TBDPS 
ether groups, since these could be selectively manipulated later on in the sequence. Scheme 112 
shows its synthesis according to a known protocol.156  
 
Scheme 112 Reagents and conditions: a) CH(OMe)3 (10 eq), p-TsOH (5 mol %), MeOH, reflux; b) BH3∙SMe2 (4 
eq), B(OMe)3 (2 eq), THF, 0 °C to rt.; c) PMP acetal (2 eq), CSA  (5 mol %), DCM, rt; d) imidazole (1.1 eq), 
TBDPSCl (1.1 eq), CH3CN, rt. e) DIBAL-H (4  eq), toluene, -78 °C; f) PPh3 (1.3 eq), imidazole (1.2 eq), I2 (1.3 eq). 
Thus, starting with (S)-malic acid again, reduction using BH3SMe2 in the presence of B(OMe)3 was 
performed, allowing full reduction to the triol 2.63. The PMP acetal needed for the protection of the 
diol was generated from anisaldehyde and trimethyl orthoformate in dry MeOH, using a catalytic 
amount of p-toluenesulfonic acid (p-TsOH). Acetal formation of anisaldehyde was first attempted 
using p-TsOH under Dean-Stark conditions, but this gave low yields and a number of side-products. 
Next the triol 2.63, PMP acetal and a catalytic amount of camphorsulfonic acid (CSA) were reacted at 
rt in DCM to furnish the PMP acetal 2.64 in a yield of 77 % after column chromatography. The 
reaction was followed by tlc which showed the expected marked increase in rf as well as UV activity 
for the newly formed product. The formation of the less stable five-membered 1,2-acetal was 
minimal and the two regioisomeric products were separated by chromatography. 1H NMR 
spectroscopy confirmed the identity of the product, with diagnostic signals evident in the aromatic 
region, as well as the downfield singlet at 5.50 ppm for the PMP hydrogen. The diastereotopic 
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hydrogens at C-4 each gave rise to a doublet of doublets at 4.29 ppm and a multiplet at 4.01 ppm. 
Next, TBDPS protection of the primary hydroxyl was achieved using TBDPSCl and imidazole in CH3CN, 
to furnish compound 2.65 in an isolated yield of 86 %. Disappearance of the hydroxyl resonance 
from 2.02 ppm and a new t-Bu singlet at 1.11 ppm as well as extra resonances in the aromatic region 
indicated the successful installation of the TBDPS group. Finally, alcohol 2.66 was generated in a 
yield of 95 % following column chromatography by the regioselective reduction of 2.65 using 4 
equivalents of DIBAL in toluene at – 78 °C. The sequence of PMP formation followed by 
regioselective reduction is an effective way of installing a bulky protecting group such as PMB onto a 
relatively sterically hindered hydroxyl group, avoiding unnecessary protecting group manipulations. 
The aluminium of the bulky reducing agent coordinates to the more accessible oxygen, which results 
in an oxocarbenium ion involving the C-2 and not the C-1 oxygen. Finally, reduction of it results in a 
C-2 PMB-protected product, with the protecting group on the sterically more hindered oxygen 
(Scheme 113).  
 
Scheme 113 Mechanism of the regioselective reduction of the PMP acetal 
The 1H NMR spectrum of the alcohol contained two distinctive AB doublets for the diastereotopic 
benzylic hydrogens; the new broad OH signal appeared at 2.09 ppm. The regio-outcome of the 
reaction was not scrutinized, however, relying on the close correlation of NMR spectral data to that 
in the literature,157 where the regioselectivity of the reaction had been confirmed by virtue of COSY 
experiments on the acetate derivative of 2.66. To convert the alcohol to the iodide, a one-pot Appel 
reaction was performed using PPh3, imidazole and iodine in toluene, furnishing the desired iodide 
2.67 in an isolated yield of 92 %. At this point it was decided to follow route ‘B’ for generation of the 
alkylated auxiliary-malonate. To this end, diethyl malonate was alkylated with 2.67 according to the 
general procedure using NaH in an excellent yield of 98 % (Scheme 114); however, monohydrolysis 
with KOH under several varied conditions was sluggish possibly due to the presence of hydrophobic 




Scheme 114 Reagents and conditions: a) i) NaH, (1.2 eq), THF, 0 °C; ii) 2.67 (1.2 eq), reflux; b) EtOH/ H20 
(80/20), KOH (1.2 to 3.0 eq), rt to 50 °C.  
One way to circumvent this problem was by variation of the ester groups for easier cleavage. Allyl 
ethyl malonate was chosen to replace diethyl malonate as the alkylation substrate, in the hope of 
cleaving the allylic ester using a palladium catalyst. To this end, diethyl malonate was mono-
hydrolysed using 1.2 equivalent of KOH in EtOH as before and the allyl/ethyl ester 2.69 was 
generated via DCC coupling of allyl alcohol and ethyl malonic half-acid in a yield of 75 % after 
chromatography (Scheme 115). The 1H NMR spectrum of the product revealed the allyl double bond 
signals at 5.91 ppm for the C-H and 5.21 ppm for the terminal CH2, while the methylene hydrogens 
of the allyloxy group resonated at 4.65 ppm. The ethyl ester methyl triplet and methylene quartet 
were also evident and the malonic methylene multiplet appeared at 2.39 ppm. Alkylation of 2.69 
was successfully carried out using NaH in refluxing THF furnishing 2.70 in a yield of 93 % following 
column chromatography. Although the product was a 50/50 mixture of diastereomers due to the 
two stereogenic centres present, the doubling of signals in the 1H NMR spectrum was noticeable 
only for the ester methyl triplet and the allylic C-H, with the remaining signals essentially 
overlapping. All the allylic ester and ethyl ester peaks were present as for the unalkylated version, 
their chemical shifts essentially unchanged. The absence of the malonic methylene at 2.39 ppm 
confirmed that alkylation had been successful, the malonic methine triplet now appearing at 3.36 
ppm. All signals expected for the tether were accounted for.  
 
Scheme 115 Reagents and conditions: a) EtOH/ H20 (80/20), KOH (1.2 eq), rt; b) allylOH (3.0) eq, DCC (1.2 eq), 
DCM rt. c) i) NaH (1.2 eq), THF, 0 °C; ii) 2.67 (1.2 eq), reflux; d) EtOH, KOH (2.5 eq), reflux. 
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Applying reported conditions for allylic cleavage using Pd(PPh3)4 and morpholine resulted in no 
reaction whatsoever. Surmising that the allylic ester would be more susceptible to hydrolysis than 
the ethyl ester group due to allylalkoxide being a better leaving group, compound 2.70 was 
subjected to hydrolysis using KOH in ethanol. The reaction was monitored by tlc, and only one acid 
product could be seen. As 1.5 equivalents of KOH could not achieve complete conversion, another 
equivalent was added after 24 h and this was sufficient to drive the reaction further. Half-acid 2.71 
was isolated in a yield of 73 %, with the remaining 27 % of starting material also recovered. There 
was no evidence of ethyl ester hydrolysis. The 1H NMR spectrum of 2.71 resembled that of 2.70, but 
was devoid of allylic signals and instead contained a very broad singlet for the carboxylic OH at 8.90 
ppm. Several of the methodologies used in developing the malonate alkylation methodology were 
used in attempting to couple the mono-acid 2.71 to the auxiliary (+)-2.29 (acid chloride, DCC and Bt 
activation), in which the Bt protocol gave the best results, furnishing auxiliary malonate 2.72 in a 
yield of 66 % yield for the coupled product as a 50/50 mixture of diastereomers that were separable 
by column chromatography (Scheme 116). Key signals in the 1H NMR spectrum were those 
pertaining to the auxiliary - namely a doublet at 5.34 ppm for the benzylic hydrogen and a double 
quartet at 3.91 ppm for the hydrogen α to the methyl as well as a singlet at 2.79 ppm for the N-
methyl and a doublet for the methyl at 0.78 ppm (for one of the diastereomers). The remaining 
resonances largely resembled the 1H NMR spectrum of the acid 2.71, with the expected 
disappearance of the carboxylic OH resonance at 8.90 ppm. The 13C NMR spectrum displayed an 
additional carbonyl resonance at 155.2 ppm as well as additional aromatic singlets for the phenyl 
group of the auxiliary. The quaternization of derivative 2.72 was accomplished with 1.2 equivalents 
of KHMDS and 1.5 equivalents of allyl bromide to give the quaternary derivative 2.73 in an excellent 
yield of 98 % following chromatographic purification. 
 
Scheme 116 Reagents and conditions: a) i) BtCl (1.2 eq), PPh3 (1.3 eq), CH3CN 0 °C; ii) (+)-2.29 (1.2 eq), reflux; 
b) i) KHMDS (1.2eq), THF, -78 °C; ii) allylBr, (1.5 eq), rt.  
The ratio of diastereomers was determined to be 32:1 from the 1H NMR spectrum, which now also 
displayed the distinctive allylic peaks: a multiplet at 5.42 ppm for the CH, a multiplet at 4.92 ppm for 
124 
 
the terminal CH2 and the diastereotopic CH2 multiplets were detected at 2.81 and 2.69 ppm. 
Similarly, the 13C NMR spectrum contained the diagnostic allylic resonances at 133.3 ppm and 118.1 
ppm. The assigned 1H NMR spectrum of the quaternary auxiliary-malonate product 2.73 is shown in 
Fig. 22 in which the relative stereochemistry was assigned based on the outcome of the 
quaternization model study. 
 
Figure 22 Assigned 1H NMR spectrum of quaternary auxiliary-malonate 2.73 
 
Next came the selective removal of the auxiliary so as to be able to carry out the Curtius 
transposition step. Subjecting 2.73 to an attempted selective hydrolysis of the auxiliary based on the 
idea that metal ions like lithium would selectively chelate into the auxiliary hole consumed an 
enormous amount of effort but was to no avail.  
These hydrolysis studies were ongoing with development of the end-game of the quaternization 
methodology, in which once it became clear that the best approach for the Curtius rearrangement 
involved using PMB esters, it also emerged that this tether would be incompatible, or at the very 
least necessitate a re-protection step (OPMB ether susceptible to TFA). Given the earlier success in 
the monohydrolysis reaction with the allyl ester, going forward with diallyl malonate was another 
option. However, given the relatively lengthy synthesis of the tether, a decision was made to move 
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onto a simpler variant. Nonetheless, its successful implementation in the quaternization step 
showed that even bulky, functionalized side chains could be incorporated via this methodology.  
2.9.2 Towards (-)-Lepadiformine C 
It was at this stage that lepadiformine C, which lacks the chiral centre in the C ring looked to be a 
more realistic target. Here one could use a less complex electrophile, I(CH2)3OBn (2.52) and a full 
plan towards a lepadiformine C synthesis using this tether as well as implementing the revised 
Curtius methodology based on the PMB ester emerged as depicted in Scheme 117. 
 
 
Scheme 117 Synthetic plan for lepadiformine C 
 
Applying the quaternization methodology on the alkylated malonate derivative A, followed by PMB 
cleavage would set up the requisite acid B for the Curtius transposition. Reductive removal of the 
auxiliary on the resultant ATA would give rise to the amino alcohol C, from which the diallyl alcohol 
126 
 
D could be accessed following oxidation and Grignard addition. A ring-closing metathesis reaction 
would furnish the A ring, at which point closure of the C ring could be pursued to the aza-spirocycle 
(route shown in red), or alternatively, further elaboration to cyclohexene F could be undertaken 
(route shown in blue). Because of the modest level of selectivity (2:1) achieved in the hydrogenation 
of the aza-spiro analogue in Richards’ approach, it was decided to leave the C ring closure for later, 
in the hope that there would be a stereoselective reduction from the underneath face of 
cyclohexene F based on the notion that the tether would have the larger A-value compared to the N-
Boc. Alternatively, deprotection to the amine via an assisted hydrogenation (the question of catalyst 
interference was a possibility though) or amine reprotection with a smaller protecting group 
provided further options. Use of a chiral catalyst with a diastereoselective bias was yet another 
possibility. Though not a trivial problem, the feeling was that a solution could probably be found. 
Hence, aza-decalin G was envisaged to arise from cyclohexene F, via a stereoselective 
hydrogenation, B-ring closure and side-chain introduction. Finally, C-ring closure would furnish 
lepadiformine C.  
Results pertaining to this approach towards lepadiformine C will be covered in the next section, 
commencing with elaboration from auxiliary-tethered ATA 2.44f, the synthesis of which has been 
addressed in section 2.7. 
Protecting the amino group of 2.44f before decoupling of the auxiliary was decided on, primarily 
because of the ease of handling of products as well as avoiding possible side-reactions.  
 
Scheme 118 Reagents and conditions: a) Et3N (1.2 eq), Boc2O (1.2 eq), THF, rt.  
 
To this end, a standard Boc protection protocol was performed on 2.44f using Et3N (1.2 eq) and 
Boc2O in THF (Scheme 118).  Tlc analysis showed an expected change in the Rf, from the starting 
amine streak-like spot at rf 0.3 to 0.7 for the product. However the 1H NMR spectrum revealed the 
absence of t-Bu hydrogens in the 1.20-1.50 ppm region giving a clear indication that the product of 
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the reaction was not the Boc-protected amine. Upon closer inspection of the 1H NMR spectrum, the 
identity of the isolated product was concluded to be the isocyanate 2.43f, arising via expulsion of the 
t-butoxide anion as shown in Scheme 118 due to steric hindrance between the Boc group and the 
auxiliary around the crowded auxiliary centre. The linear isocyanate is far less energetically 
demanding, and BuO- expulsion is entropically favoured. Tlc comparison with the intermediate 
isocyanate product from the Curtius rearrangement did indeed indicate that these were the same 
compound, and this was corroborated by 1H and 13C NMR spectra which were identical in 
appearance for the two compounds. The diagnostic N=C=O stretch at 2253 in the IR spectrum of the 
product further supported the assignment.  Rather than investing time in optimizing conditions for 
Boc-protection at that stage, removing the auxiliary first was deemed as a possible solution, with the 
aim of decongesting the molecule enough for subsequent Boc-protection to be successful. Hence, 
2.44f was subjected to reductive cleavage conditions using three equivalents of LiBH4 and here the 
choice of solvent was important for good yields; in THF the reaction was sluggish and did not go to 
completion, whilst reduction in Et2O proceeded much faster, giving the amino alcohol 2.74 in an 
isolated yield of 76 % (Scheme ). The auxiliary was also recovered in a yield of 80 %.    
 
Scheme 119 Reagents and conditions: a) LiBH4 (3 eq), Et2O, -20 ° to 0 °C. 
 
All of the signals characteristic of the auxiliary were absent from the 1H and 13C NMR spectra of 2.74, 
and the appearance of a new singlet at a shift of 3.98 ppm integrating for 2 hydrogens 
corresponding to the methylene α to the hydroxyl as well as a broad hydroxyl singlet at 2.00 ppm 
supported the product assignment. The IR spectrum also revealed the characteristic sharp stretch at 
3693 cm-1 for the hydroxyl, as well as a broad stretch at 3444 cm-1 for the primary amine.  
Subjecting 2.74 to standard Boc-protection conditions with Et3N (1.1 equivalents) and Boc anhydride 
(1.1 equivalents) now furnished the desired Boc-protected amino alcohol 2.75 in a yield of 88 % in 
which the 1H NMR spectrum unmistakably displayed the t-Bu singlet at a shift of 1.42 ppm. Similarly, 
the 13C NMR spectrum showed a tall peak at a shift of 28.5 ppm corresponding to the t-butyl methyl 
groups, as well as an expected carbonyl shift at 156.5 ppm. Next, oxidation to the aldehyde 2.76 was 
performed using Dess-Martin periodinane as the oxidising reagent, which proceeded smoothly to 




Scheme 120 Reagents and conditions: a) Et3N (1.1 eq), Boc2O (1.1 eq), DCM, rt; b) DMP (1.1 eq), CH2Cl2, 0 °C, 
1h, then aq. NaHCO3; c) AllylMgCl (1.2 eq), THF, - 78 to -20 °C, 2 h.  
 
The presence of the aldehyde was verified by 1H NMR spectroscopy which showed the distinctive 
aldehyde singlet at 9.45 ppm, as well as the absence of both the hydroxyl signal at 2.00 ppm, and the 
α-hydroxy methylene signal. A shift at 200.6 ppm in the 13C NMR spectrum for the newly formed 
carbonyl could also be seen, that was not present in the spectrum of 2.75. Although stable to flash 
chromatography, the aldehyde was committed to the Grignard addition step quickly to avoid 
decomposition. A Grignard addition using allylMgCl (bought commercially) was carried out at -78 °C 
but the reaction required warming to -20 °C for a clean, high yielding conversion, ultimately 
furnishing the diallyl adduct 2.77 in  a yield of 95 % after column chromatography.  
The first obvious indication from the 1H NMR spectrum that the addition had taken place was the 
absence of the aldehyde signal in the region of 9.50 ppm. More importantly, two distinct sets of 
signals were visible for both allyl groups. The new hydroxyl resonance appeared at 4.56 ppm, 
corroborated by the broad absorbance stretch at 3415 cm-1 in the IR absorption spectrum. The 
multiplet at 3.59 ppm was assigned to the α-hydroxyl hydrogen.  2D NMR analysis in the form of 
COSY was carried out in order to unambiguously assign individual allylic signals. The addition was 
stereoselective with a dr of 4:1 as determined by 1H NMR spectroscopy; the origin of the 
stereoselectivity can be rationalized by considering one of two possible Felkin-Anh transition states 
for addition to carbonyls (Fig. 23). The first one, depicted as transition state A, involves chelation 
control; here, chelation of Mg to the carbonyl of the Boc is not likely as it would entail a 7-
membered ring intermediate, although involving the N of the NBoc group isn’t out of the question 
and addition from the least hindered trajectory in this transition state would result in diastereomer 
2.77a. The other possibility is depicted as conformation B, in which the nitrogen aligns itself 
perpendicular to the C=O, to allow for orbital overlap between the π* of the C=O and * of the C-N, 
lowering the energy of the LUMO. Nucleophile attack from the least hindered pathway on this 
conformation would lead to the opposite diastereomer 2.77b. Grignard reactions tend to involve 
chelation control, hence it is postulated that the major product in this case was a result of addition 
via transition state A, the chelation control model. The relative stereochemistry between the 
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quaternary centre (known to be R) and the -centre of 2.77 was not determined (eg by X-Ray of a 
suitable derivative), however, as this chiral centre would be removed at a later stage in the 
synthesis.  
 
Figure 23 Proposed transition states to predict the stereoselectivity in the Grignard addition 
 
Having successfully installed the second allyl group, the stage was set for a ring-closing metathesis 
reaction using Grubb’s first-generation catalyst. This ruthenium-based alkylidene complex has high 
functional group tolerance for alcohols, amides, aldehydes and carboxylic acids. When applied to 
2.77 with a catalyst loading of 5 mol %, cyclization was effected smoothly in refluxing DCM (Scheme 
121). The reaction changed colour from purple to black and the was complete within three hours as 
evidenced by tlc. Metathesis reactions are reportedly often plagued by contamination by Ruthenium 
side-products and a number of purification methods have been reported for their removal. In this 
case, careful column chromatography was enough to ensure pure cyclohexene product 2.78 in a 
yield of 86 %, which was further purified by recrystallization to give colourless needle-like crystals. 
The two diastereomers were separable by chromatography in this case. The 1H NMR spectrum (pure 
diastereomer) displayed the expected changes in the olefinic region, containing only two multiplets 
at 5.35 and 5.75 ppm arising from H-3 and H-4. The hydroxyl and NH signals were unchanged, as well 
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as the benzyl ether peaks.  Similarly, the 13C NMR spectrum was devoid of allylic resonances, the 
olefinic signals now present at 127.0 and 122.6 ppm. 
 
Scheme 121 Reagents and conditions: a) RhCl2(PCy3)2=CHPh, CH2Cl2, 40 °C; b) Pd/C, H2, EtOH, rt. 
 
Next, the benzyl protecting group was removed using hydrolytic conditions, with concomitant 
reduction of the olefinic bond in the ring, achieved by using 10 % Pd/C under a hydrogen 
atmosphere. Tlc showed the expected decrease in the Rf of the newly formed product, and the 
reaction was complete within six hours to afford the cyclohexanol product 2.79 in a yield of 92 % 
following column chromatography. Both debenzylation and reduction were corroborated by the 1H 
and 13C NMR spectra, which were free of signals in the aromatic and olefinic regions, as well as the 
signal for a benzylic methylene. Two unambiguous broad singlets were visible for the two hydroxyls, 
at 2.26 ppm for the primary and 4.90 ppm for the secondary. The protection of the primary hydroxyl 
had to be carried out and a TBDPS group was chosen for this purpose. This group seemed 
appropriate for the remaining reactions. Apart from requiring a protecting group other than benzyl 
(the Grignard addition further on in the sequence would involve the same three carbon benzyl 
ether), a bulky substituent on the pendant chain would hopefully induce higher selectivities in the 
reduction step further in the sequence, as mentioned in the synthetic plan outline.  
The regioselecivity of the protection was not expected to be a problem as it was anticipated to take 
place first at the primary hydroxyl. However, attempting the protection under standard conditions 
using imidazole and TBDPSCl was proving to be sluggish, with less than 50 % conversion evident after 
24 hours at rt, as determined by tlc analysis. Hence, it was decided to resort to using a stronger base, 
but to keep the temperature low. Dissolving 2.79 in THF and treating it with NaH (1.1 eq) and 
TBDPSCl (1.1) at 0 °C gave the expected tlc profile of an increase in Rf (Scheme 122).  Tlc analysis also 
indicated that there was still a considerable amount of starting material present and that the 
reaction wasn’t progressing, thus it was allowed to warm up to 10 °C, which resulted in further 
consumption of the starting material and formation of one major product spot higher up on the tlc 
plate. However, the isolated product, obtained in 61 % yield after chromatography, revealed only 
one t-Bu signal (at 1.06 ppm) in the 1H NMR spectrum, which based on the chemical shift appeared 
likely to be that of a TBDPS group. This was confirmed by the presence of appropriate resonances in 
the aromatic region of the spectrum as well as the absence of the primary hydroxyl resonance. Thus, 
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it was concluded that the TBDPS had indeed been installed, but that the Boc group was no longer 
present. In conjunction with the tlc profile, together with the absence of a primary amino resonance 
in the 1H NMR spectrum led to the conclusion that the oxazolidinone 2.80 had been generated by 
nucleophilic attack of the alkoxide of the secondary alcohol onto the carbonyl of the carbamate 
(Scheme 122). The product observed was likely the cis isomer, which would have arisen from the 
cyclization of the predicted major diastereomer from the Grignard reaction (4:1). The yield of 61 % 
of the oxazolidinone supported this view. The tlc profile of the reaction also supported this, as there 
were three other minor spots present, the most polar one of which corresponded to the starting 
material and was therefore likely to be the remaining trans-isomer which did not cyclize, and a 
second, slightly higher spot was likely from the TBDPS-protected trans isomer.  
All of the resonances in the 1H and 13C NMR spectra correlated with the proposed structure.   
 
Scheme 122 Reagents and conditions: a) NaH (1.1 eq), TBDPSCl (1.1 eq), THF, 0 °C to 10 °C.   
 
Although this setback was not insurmountable and a set of conditions where the cyclization does not 
take place could possibly be found, the easiest approach was to oxidise the secondary alcohol 
earlier. Thus the sequence was altered to oxidize prior to hydrogenation / hydrogenolysis, which was 
achieved using standard Swern conditions on 2.78 to deliver the cyclohexenone 2.81 in a yield of 90 
% after chromatographic purification (Scheme 123). Oxidation using the TPAP/ NMO protocol was 
also tested, but gave lower yields. The signals for the secondary hydroxyl and the associated α-
hydroxyl hydrogen were no longer present in the 1H NMR spectrum and the diastereotopic 
hydrogens at C-5 had shifted downfield from a region of 2.20 – 2.40 ppm in the substrate, to 2.90 – 
3.08 ppm in the product being now a- to a carbonyl group. The 13C NMR spectrum displayed the 
anticipated ketone resonance at 207.5 ppm. Removal of the benzyl group and reduction of the 
olefinic bond was carried out as before using palladium on carbon under a hydrogen atmosphere, 
furnishing the product 2.82 in a yield of 97 % after column chromatography. Again, the 
disappearance of aromatic signals in both 1H and 13C NMR spectra, as well as the absence of the 
olefinic signals were confirmation that the benzyl group was removed and that the double bond had 
been reduced. TBDPS protection was again carried out using NaH and TBDPSCl in THF and the 
reaction was complete after 6 hours to give the desired product 2.83 in an isolated yield of 89 %. The 
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1H NMR spectrum now clearly displayed two signals integrating for 9 protons each at 1.04 ppm and 
1.41 ppm, confirming the presence of two t-Bu groups, one from the Boc and the other from the 
TBDPS. The other obvious indicator was the appearance of signals in the aromatic region integrating 
correctly for ten hydrogens. Similarly, the 13C NMR spectrum showed new aromatic peaks as well 
two distinct t-Bu carbons and methyl signals.  
 
Scheme 123 Reagents and conditions: a) i) COCl2 (1.2 eq), DMSO (2.4 eq), DCM, -78 °C; ii) Et3N (4 eq), 0 °C; b) 
Pd/C (10 mol %), H2, EtOH, rt; c) NaH (1.2 eq), TBDPSCl, (1.2 eq), THF, rt.  
 
With the O-protected ketone in hand, Grignard addition of the 3-carbon tether bearing the benzyl 
ether terminus was investigated. The Grignard reagent was generated by addition of Br(CH2)3OBn to 
freshly activated Mg turnings in THF and stirring for 10 to 20 minutes. At first, conversion to the 
Grignard was low even with the addition of a crystal of iodine. After a few attempts it was 
discovered that the THF solution of the alkyl bromide had to be very concentrated in order to 
achieve full conversion. Once the Grignard reagent was fully formed and cooled, a solution of the 
cyclohexanone 2.83 in THF was introduced at 0 °C but the reaction required warming to rt for good 
conversion, ultimately furnishing the Grignard adduct 2.84 in a yield of 79 % after chromatographic 
purification (Scheme 124).  
Scheme 124 Reagents and conditions: a) BnO(CH2)3MgBr (2 eq), THF, 0 °C; b) CuSO4 (5 eq), p-xylene, reflux. 
The 1H NMR spectrum confirmed the identity of the product 2.84, as all the signals expected for the 
tether were present, as well as a broad singlet at 5.42 ppm coming from the hydroxyl. This was true 
for the 13C NMR spectrum too, in which the carbonyl resonance at 207.5 ppm had also disappeared, 
and all twenty six resonances could be accounted for. A single carbonyl stretch at 1708 cm-1 was 
present in the IR absorbance spectrum for the carbamate, as well as a diagnostic broad absorbance 
stretch at 3408 cm-1 assigned to the hydroxyl. The parent ion was found to be 660.4076 [M+H]+ 
correlating to the correct molecular formula of C40H58NO5Si. 
1H NMR and 13C spectra indicated the 
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presence of two diastereomers in a ratio of 14:1, the major presumably arising from equatorial 
attack by the bulky Grignard reagent on a cyclohexanone chair conformation with one of the 
substituents equatorial (this was postulated as being the NBoc group earlier but this might be 
incorrect). The two possible chair conformations are labelled as transition state A, where the NBoc is 
equitorail (TS A), and transition state B with the alkyl chain in equatorial position (TS B), Scheme 125. 
In any event this was of no consequence because of the intention to dehydrate subsequently, with 
loss of that particular stereogenic centre.  
 
Scheme 125 Proposed transition states of the Grignard addition and predicted major diastereomer 
arising from TS A.  
Thereafter, the dehydration step needed to be carried out and the protocol of using dry CuSO4 in 
refluxing xylene was employed. Richards’ accounts pertaining to the analogous racemic synthesis 
(Scheme 61) screened several dehydration methodologies and concluded that the CuSO4/ xylene 
system gave the highest yields and cleanest conversions. In this case, however, successful 
dehydration with the CuSO4 was only accomplished after numerous attempts under various 
conditions, in a modest yield of 22 % after chromatography. Conversions were not clean either, with 
several by-products forming during the reaction, as evidenced by tlc. The dehydration was also 
performed on the deprotected amine derivative; however, this did not have a positive effect on the 
outcome either. The product 2.85 was not characterized fully so although its formation could not be 
categorically proven, indication of successful conversion mainly came from the 1H NMR spectrum, 
which no longer contained the broad hydroxyl signal at 5.49 ppm and featured a new doublet of 
doublets at 5.00 ppm for either an exo or endo cyclic alkene. Unfortunately, the trials exhausted all 
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of the available material and the sequence could not be continued at that point. Although the 
synthesis broke down at that stage, the fact that some product was obtained from the dehydration 
step was a sign that conditions for the dehydration could possibly be optimized to increase yields. 
Alternatively, other dehydration methods could be applied, such as using phosphorous oxychloride. 
The marked difference in the results of the dehydration in this system to that of the aza-spirocycle, 
implied that the more rigid bicyclic system was better-suited substrate for the dehydration. Any 
future work would therefore entail earlier closure of the C ring (i.e. route shown in red in Scheme 
117) for comparison.   
2.10 Conclusions and Future work 
2.10.1 Conclusion 
A novel methodology for the stereoselective construction of quaternary carbons was accomplished 
via high-yielding sequential alkylations on auxiliary-malonate systems 2.31a to d, in which the 
second alkylation proceeded with high diastereoselectivity (>95:5) to deliver quaternary malonates 
2.33a to d. With the aid of a crystal structure for derivative 2.33b, it was concluded that the reaction 
proceeds via a Z-enolate with the K+ cation chelated into the malonate hole, and the imide bond in a 
s-transC-N conformation. Adaptation of the sequence to incorporate a PMB malonate ester, allowed 
for chemoselective ester cleavage under acidic conditions, furnishing quaternary carboxylic acids 
2.41 a to f which were successfully transformed to a range of ATAs 2.44a to f via a modified Curtius 
procedure. Subsequent methanolysis reactions delivered various α,α-disubstituted amino acid 
methyl esters in high yields (75 – 82 %) and ees (>95 %), with concomitant recovery of the auxiliary. 
As a demonstration of utility, enantioenriched α-allyl-alanine, α-methyl-phenylalanine, α-allyl-lysine 
and α-benzyl-proline derivatives were generated via this protocol.  
The methodology was applied to the enantioselective construction of the requisite ATA contained 
within the lepadiformines in the form of amino alcohol 2.74, which was further proliferated towards 
cyclohexane derivative 2.84 in seven steps, at which point a problematic dehydration step 
terminated the sequence prematurely.  
2.10.2 Future Work 
Extension of this methodology to generate additional α-substituted natural amino acids is currently 
underway with quaternary leucine, tryptophan, methionine and serine in different stages of 
completion, all following the same trend with regards to selectivity thusfar; findings will be 
published in due course. With regards to the synthetic sequence towards (-)-lepadiformine C, two 
options could be investigated in order to accomplish a successful total synthesis: 
 Earlier closure of the C-ring and construction of the B-ring last using the Richards protocol. 
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 Removal of the hydroxyl group of compound 2.84 following the Grignard step using radical 
deoxygenation methodology (Barton-McCombie).158 In order to generate the required trans 
A/B azadecalin ring junction stereochemistry one would presumably need to carry out the 
deoxygenation on a fused A/B azadecalin. Radicals equilibrate, and conversion to the 
favoured trans [6.6] azadecalin stereochemistry would be favoured and independent of the 
diastereoselectivity in the Grignard step. However, one would need to deoxygenate at a 
quaternary centre (tertiary radical) in which formation of an appropriate precursor from the 




Scheme 126 Possible route for completion of lepadiformine C synthesis from 2.84. 
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Chapter 3: Experimental Section 
3.1 General Methods 
 
All reactions were carried out in oven-dried glassware, and performed under a nitrogen atmosphere 
unless otherwise stated. Reagents were obtained from commercial sources (Sigma–Aldrich, Fluka, 
Merck, Kimix) and used as obtained unless stated. The following reaction solvents were distilled 
under nitrogen, from the drying agents indicated: THF (Na wire, benzophenone), DCM (P2O5), Et2O 
(CaH2), CH3CN (CaH2), toluene (CaH2). 
Reaction temperatures were achieved with heat/silicone oil (for > 25 ⁰C), ice/NH4Cl salt (for 0 ⁰C), 
and acetone/liquid nitrogen (< -20 ⁰C). Aqueous solutions were prepared using deionized water.  
All reactions were monitored by tlc using aluminium-backed Merck silica-gel 60 F254 plates, and 
column chromatography was carried out using Kieselgel 60 silica-gel (Merck). Active compounds 
were observed under UV-lamp (ultraviolet), while non-UV active compounds were sprayed with a 
2.5 % solution of p-anisaldehyde in a mixture of sulphuric acid and ethanol (1:10 v/v), iodine vapour, 
or ceric ammonium sulphate solution and then heated for visualization.  
Nuclear Magnetic Resonance (NMR) spectra were recorded on a Bruker 400 MHz spectrometer (1H 
at 399.95 MHz and 13C at 100.6 MHz), or a Varian Mercury 300 MHz spectrometer (1H at 300.08 MHz 
and 13C at 75.46 MHz). Chemical shifts (δ) and J-coupling values were reported in units of ppm and 
Hz respectively. Chemical shifts for 1H and 13C were recorded relative to residual chloroform, 7.26 
and 77.16 ppm respectively. High resolution mass spectra (HRMS) were recorded on Waters Synapt 
G2 in electrospray positive mode. Elemental analyses were performed using a Fisons EA 1108 CHNS 
elemental analyzer. Infra-Red (IR) spectroscopy was performed on a Perkin-Elmer Paragon 1000 FT-
IR Spectrometer on NaCl plates, with vibrations measured in units of cm-1. Optical rotations were 
obtained using a Perkin Elmer 343 polarimeter at 20 °C and are reported as: [α]𝐷
20 (c g/ml, solvent). 
Determination of melting points was done using a Reichert-Jung Thermovar hot stage microscope 
(HSM) and are uncorrected. The enantiomeric excess (ee) of products was determined by HPLC on 








LiAlH4 (2.51 g, 6.62 mmol, 2 eq) was placed in THF (200 ml) and cooled to 0
 °C in an ice bath. (S)-
Phenylglycine (5.0 g, 3.31 mmol) was added in 10 increments over 30 minutes. The mixture was 
stirred at 0 °C for an hour, following which it was refluxed overnight. After this time, it was cooled to 
0 °C and quenched by a slow addition of water (5.0 ml), followed by NaOH (2.5 mL, 2M, 5.0 mmol). 
Stirring was continued for 20 min at room temperature, until all the LiAlH4 was consumed and the 
white lithium salts remained. Filtering through Celite, washing with DCM (150 ml) and drying with 
MgSO4 gave a bright-yellow solution which when concentrated to yield a dark-orange solid. This 
material was recrystallized to yield the product as an off-white powder (3.86 g, 2.81 mmol, 85 %).  
M.p. (DCM/EtOAc) = 73-76 °C, lit = 74 – 76 °C;159 1H NMR (400 MHz, CDCl3) δ 7.34 (m, 5H, aromatic), 
5.62 (s, 1H, OH), 4.11 (m, 1H, CH), 3.59 (dd, 1H, CH2a), 3.56 (dd, 1H, CH2b), 2.28 (broad s, 2H, NH2). 
The data obtained corresponds to the published data for this compound. 
(S)-5-Phenylmorpholin-2-one (2.15)120 
 
(S)-Phenylglycinol 2.14 (1.500 g, 10.933 mmol) and Hünig’s base (4.712 ml, 27.332 mmol, 2.5 eq) in 
acetonitrile (30 ml) were placed in a dropping funnel and added to a stirring solution of phenyl 2-
bromoacetate (3.531 g, 16.400 mmol, 1.5 eq) in acetonitrile (10 ml) over 30 minutes. After overnight 
stirring, the reaction mixture was concentrated and the residue subjected to flash chromatography 
using EtOAc/ Hexanes (50/50) which included filtration through a plug (1 cm) of anhydrous sodium 
carbonate placed on top of the silica gel. Morpholinone 2.15 was isolated (1.368 g, 7.761 mmol, 70 






tert-Butyl (S)-2-oxo-5-phenylmorpholine-4-carboxylate (2.16)120 
 
Morpholinone, 2.15 (1.00 g, 5.640 mmol) and triethylamine (0.745 ml, 5.640 mmol, 1 eq) were 
stirred in ethyl acetate (40 ml), and  di-tert-butyl dicarbonate (1.426 g, 6.204 mmol, 1.1. eq) was 
added . The reaction solution was then stirred at room temperature for 6 hours, following which it 
was diluted with diethyl ether (40 ml), washed with HCl (1M, 50 ml), then saturated aqueous sodium 
carbonate (50 ml). The organic layer was dried over anhydrous MgSO4, filtered and concentrated to 
a yellowish oil. Recrystallization gave 2.16 as a white crystalline solid (1.218 g, 4.394 mmol, 78 %). 
M.p. (diethyl ether/ hexanes) = 86 – 89 °C, lit.120 87 – 88 °C; 1H NMR (400 MHz, CDCl3) δ 7.34 (m, 5H, 
aromatic), 5.18 – 5.14 (m, 1H, H-5), 4.70 – 4.48 (m, 3H, H-6 + H-3a), 4.19 (d, J = 11.9 Hz, H-3b) 1.33 (s, 
9H, t-Bu).The data obtained corresponds to the published data for this compound. 
tert-Butyl (3S,5S)-3-allyl-2-oxo-5-phenylmorpholine-4-carboxylate (2.17) 
 
A solution of 2.16 (2.671 g, 9.630 mmol) in THF/DME (50/50, 100 ml) was cooled to -78 °C, followed 
by the dropwise addition of KHMDS (0.5 M, 19.3 ml, 9.63 mmol, 1 eq) and further stirring at -78 °C 
for one hour. Alyll bromide (1.24 ml, 14.45 mmol, 1.5 eq) was then syringed in slowly and the 
reaction left at -78 °C for 3 hours after which it was quenched by the addition of saturated 
ammonium chloride (15 ml) and diluted with diethyl ether (30 ml). The organic phase was then 
successively washed with HCl (1M, 20 ml), saturated aqueous sodium bicarbonate (20 ml) and brine 
(30 ml), then dried over MgSO4, filtered and concentrated in vacuo to give the crude allylated 
product 2.17. Purification by chromatography yielded 2.17 as a colourless crystalline solid (1.926 g, 
6.067 mmol, 63 %).  
1H NMR (400 MHz, CDCl3) δ 7.66 – 6.57 (m, 5H, aromatic), 5.92 – 5.99 (m, 1H, CH2=CH), 5.28 – 5.20 
(m, 2H, CH=CH2), 5.13 – 4.95 (m, 2H, H-5 + H-6a), 4.85 (dd, J = 11.8, 3.1 Hz, 1H, H-3), 4.51 – 4.36 (m, 
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1H, H-6b), 2.92 – 2.62 (m, 2H, CHCH2), 1.38 (s, 9H, t-Bu); 
13C NMR (101 MHz, CDCl3) δ 168.8 (C=O 
lactam), 153.7 (C=O Boc), 132.4 (CH=CH2), 129.1 (Ar), 128.0 (Ar), 125.6 (Ar), 119.7 (CH=CH2), 81.6 
(C(CH3)3), 69.9 (C-6), 56.9 (C-3), 54.9 (C-5), 38.5 (CH2CH=CH2), 28.2 (C(CH3)3). 
(3S,5S)-3-allyl-5-phenylmorpholin-2-one (2.18)120 
 
The allylated Boc-morpholinone 2.17 (0.300 g, 0.945 mmol) was dissolved in DCM (50 ml) and cooled 
to 0 °C. To this stirring solution was added anisole (0.130 ml, 1.134 mmol, 1.2 eq) and TFA (0.092 ml, 
1.134 mmol, 1.2 eq) and the mixture allowed to warm up to rt over the course of an hour. Following 
the addition of saturated NaCO3 at 0 °C, the organic layer was immediately isolated and the aqueous 
phase extracted with DCM (3 x 20 ml). Pooled organic fractions were dried over anhydrous MgSO4, 
filtered and concentrated, and the residue was subjected to flash chromatography using 
EtOAc/hexanes (30/70) to yield the title allylated morpholinone 2.18 (0.037 g, 0.170 mmol, 18 %) as 
a yellow oil. 1H NMR spectral data IR data corresponded closely to that published in literature.121  
1H NMR (400 MHz, CDCl3) δ 7.41 – 7.35 (m, 5H, aromatic), 5.91 – 5.80 (m, 1H, H-2’), 5.22 – 5.11 (m, 
1H, H-3’a), 5.18 – 5.17 (m, 1H, H-3b), 4.41 – 4.37 (m, 3H, H-5 and H-6), 3.95 – 3.90 (m, 1H, H-3), 3.60 
(broad s, 1H, NH), 2.67 – 2.60 (m, 2H, H-1’). 
3-(Benzyloxy)propan-1-ol (2.51) 
 
1,3-propanediol (20.0 ml, 0.277 mol, 1.9 eq) was placed in dry THF (300 ml) and cooled to 0 °C. NaH 
(60 % 5.881 g, 0.147 mol, 1 eq) was added in 15 portions over a period of 30 min and the reaction 
was left to stir at room temperature for 30 minutes,  following which benzyl bromide (17.5 ml, 0.147 
mol, 1 eq) was syringed into the mixture. The reaction was left at room temperature for one hour, 
and then refluxed overnight. Once cooled, a mixture of THF and water (50/50, 100 ml) was added 
slowly, the solvent evaporated, water was added (100 ml) and the mixture extracted with Et2O (3 x 
200 ml) and EtOAc (200 ml). The organic extracts were washed with saturated aqueous sodium 
bicarbonate (100 ml) and brine (100 ml), dried over anhydrous MgSO4 and concentrated. Flash 
chromatography using EtOAc/ hexane (15/85) yielded the title compound 2.51 (21.0 g, 0.126 mol, 86 
%) as a clear oil. 1H NMR (400 MHz, CDCl3) δ 7.33 (m, 5H, aromatic), 4.52 (s, 2H, OCH2Ph), 3.72 (m, 




NMR (101 MHz, CDCl3) 138.1 (Arq), 128.3 (Ar), 127.9 (Ar) 127.7 (Ar), 73.0 (OCH2Ph), 69.3 (CH2OBn), 
60.9 (CH2OH), 32.3 (CH2CH2). 
((3-Iodopropoxy)methyl)benzene  (2.52) 
 
The alcohol, 2.51 (2.00 g, 12.03 mmol) was placed in dry toluene (100 ml). Imidazole (1.31 g, 19.25 
mmol, 1.6 eq), triphenylphosphine (5.05 g, 19.25 mmol, 1.6 eq) and iodine (3.97 g, 15.64 mmol, 1.3 
eq) were added successively to the stirring mixture. The reaction was left to stir at room 
temperature for 4 hours and then saturated aqueous sodium thiosulphate solution (100 ml) was 
added and stirring continued for 15 minutes. The aqueous layer was extracted with diethyl ether (3 x 
100 ml) and the combined organic fractions were washed with saturated aqueous sodium 
bicarbonate (100 ml) and brine (80 ml). Once dried over anhydrous MgSO4 and concentrated, the 
residue was subjected to flash chromatography using EtOAc/ hexane (5/95) to afford iodide 2.52 
(3.19 g, 11.55 mmol, 96 %) as a clear liquid.  
1H NMR (400 MHz, CDCl3) δ 7.33 (m, 5H, aromatic), 4.53 (s, 2H, OCH2Ph), 3.55 (t, J = 5.8 Hz, 2H, 
CH2OBn), 3.31 (t, J = 6.8 Hz, 2H, ICH2), 2.12 – 2.07 (m, 2H, CH2CH2); 
13C NMR (101 MHz, CDCl3) 138.4 
(Arq), 128.6 (Ar), 128.7 (Ar) 127.8 (Ar), 73.3 (OCH2Ph), 69.8 (CH2OBn), 33.7 (CH2CH2), 3.4 (CH2I).  
 
Ethyl malonate-auxiliary series 
3-Ethoxy-3-oxopropanoic acid (2.30)144 
 
To a solution of diethyl malonate (20.0 ml, 0.131 mol) in EtOH (150 mL) at 0 °C was added dropwise 
a solution of aq. KOH (2.5 M, 57.70 ml, 0.144 mol, 1.1 eq) and the contents allowed to slowly warm 
up to rt. After 3 hours the EtOH was removed under reduced pressure, the concentrate diluted with 
water (50 mL) and extracted with DCM (3 x 50 ml) to remove unreacted diethyl malonate. The 
aqueous layer was then acidified with conc. HCl to pH = 2 and then re-extracted with DCM (3 × 50 
ml), the organic extracts combined, dried over MgSO4, filtered, and concentrated in vacuo to obtain 
the half-acid  (15.6 g, 0.118 mol, 90 %) as a colourless oil. 
1H NMR (300 MHz, CDCl3) δ 9.58 (broad s, 1H, COOH), 4.38 – 4.10 (m, 2H, CH2CH3), 3.48 – 3.17 (m, 




Synthesis of auxiliary malonate 
Ethyl 3-((4R,5S)-3,4-dimethyl-2-oxo-5-phenylimidazolidin-1-yl)-3-oxopropanoate (2.31) 
 
Malonate half ester 2.30 (5.00 g, 37.85 mmol), (4R, 5S)-1,5-dimethyl-4-phenylimidazolidin-2-one (+)-
2.29 (7.23 g, 37.85 mmol, 1 eq) and HOBt (1.16 g, 7.57 mmol, 20 mol %) were dissolved in DCM and 
stirred at 0 °C. A solution of DCC (9.83 g, 45.42 mmol, 1.2 eq) and in DCM was gradually added to the 
mixture via a pressure-equalizing dropping funnel and once addition was complete, the cooling bath 
was removed. The reaction was complete within 3 hours at room temperature after which time it 
was filtered through Celite, the solvent evaporated and the resultant residue purified by column 
chromatography with ethyl acetate/hexane (20/80) to furnish auxiliary malonate 2.31 (10.25 g, 
33.69 mmol, 89 %) as a colourless solid. Mp 84 °C (EtOAc/ hexane); [α]D20 = –6.2, (c = 1.0, DCM); IR 
νmax (cm
-1) 3008 (C-H aromatic), 2860 (C-H alkanes), 1736 (C=O ester), 1687 (C=O imide); 1H NMR 
(300 MHz, CDCl3) δ 7.35 (m, 3H, aromatic), 7.18 (m, 2H, aromatic), 5.32 (d, J = 8.7 Hz, 1H, CHPh), 4.18 
(q, J = 7.2 Hz, 2H, CH2CH3), 4.02 (s, 1H H-2a), 3.97 (s, 1H, H-2b), 3.93 (dq, J = 8.7, 6.6 Hz, 1H, CHCH3), 
2.81 (s, 3H, NCH3), 1.26 (t, J = 7.2 Hz, 3H, CH2CH3), 0.80 (d, J = 6.6 Hz, 3H, CHCH3); 
13C NMR (75.5 MHz, 
CDCl3) δ 167.7 (C=O), 165.1 (C=O), 155.6 (C=O), 136.1 (Arq), 128.6 (Ar), 128.3 (Ar), 127.2 (Ar), 61.3 (C-
1’), 59.5 (CHPh), 54.2 (CHCH3), 43.5 (C-2), 28.3 (NCH3), 15.1 (C-2’), 14.2 CHCH3); Anal. Calc. for 
C16H20N2O4 (%): C, 63.14; H, 6.61; N, 9.20. Found (%): C, 63.19; H, 6.57; N, 9.24. 
General procedure for mono-alkylation of auxiliary malonate 2.31 to prepare α-substituted auxiliary 
malonates 2.32a – 2.32e 
A solution of 2.31 (1 eq) in tetrahydrofuran was cooled to -78 °C followed by the dropwise addition 
of KHMDS in toluene (0.5 M, 1.2 eq) and stirring at this temperature was continued for a further 30 
minutes after which time the electrophile (1.5 - 3 eq) was added in one portion to the anion 
solution. The reaction was slowly warmed to room temperature and stirred for a further 8 hours. It 
was then quenched with saturated aqueous ammonium chloride solution and extracted with ethyl 
acetate. The combined organic extracts were dried over anhydrous MgSO4 and evaporated to give 





Ethyl 2-((4R,5S)-3,4-dimethyl-2-oxo-5-phenylimidazolidine-1-carbonyl)hexanoate (2.32a) 
 
Title butyl-substituted auxiliary malonate 2.32a was obtained (0.462 g, 1.284 mmol, 98 %) via the 
general alkylating procedure from 2.31 (0.400 g, 1.131 mmol) using KHMDS (3.15 ml, 1.575 mmol) 1-
bromobutane (0.42 ml, 3.932 mmol, 3.0 eq) and TBAI (0.241 g, 0.655 mmol, 0.5 eq). In this case, the 
reaction was refluxed overnight and column chromatography with EtOAc/ hexane (15/85) yielded 
2.32a as a colourless oil in a 51:49 mixture of diastereomers as determined by NMR spectroscopy. 
IR: νmax (cm
-1) 3010 (C-H aromatic), 2861 (C-H aliphatic), 1732 (2x C=O, ester and amide), 1689 (C=O, 
urea); HRMS (ES): calc. 361. 2127; C20H29N2O4 [M + H]
+ requires 361.2125. 
Major diastereomer: 1H NMR (400 MHz, CDCl3) δ 7.29 (m, 3H, aromatic), 7.23 (m, 1H, aromatic), 7.12 
(m, 1H, aromatic), 5.31 (d, J = 8.6 Hz, 1H, CHPh), 4.63 (dd, J = 5.3, 3.4 Hz, 1H, H-2), 4.24-4.08 (m, 2H, 
H-1’), 3.91 (m, 1H, CHCH3), 2.82 (s, 3H, NCH3), 2.00-1.75 (m, 2H, H-1”), 1.35-1.28 (m, 2H, H-3”), 1.25-
1.18 (m, 2H, H-2”), 1.20 (t, J = 7.2 Hz, 3H, H-2’), 0.82 (t, J = 7.2 Hz, 3H, H-4”), 0.80 (d, J = 6.4  Hz, 3H, 
CHCH3); 
13C NMR (100.6 MHz, CDCl3) δ 170.4 (C=O, ester), 168.4 (C=O, amide), 155.7 (C=O, urea), 
136.2 (Ar), 128.4 (Ar), 128.2 (Ar), 127.2 (Ar), 61.1 (C-1’), 59.7 (CHPh), 54.0 (CHCH3), 51.1 (C-2), 29.2 
(C-1”), 28.3 (NCH3), 27.6 (C-3”), 22.6 (C-2”), 15.1 (CHCH3), 14.3 (C-2’) 14.2 (C-4”). 
Minor diastereomer: 1H NMR (400 MHz, CDCl3) δ 7.29 (m, 3H, aromatic), 7.23 (m, 1H, aromatic), 7.12 
(m, 1H, aromatic), 5.36 (d, J = 8.6 Hz, 1H, CHPh), 4.61 (dd, J = 6.4, 1.2 Hz, 1H, H-2), 4.24-4.08 (m, 2H, 
H-1’), 3.91 (m, 1H, CHCH3), 2.81 (s, 3H, NCH3), 2.00-1.75 (m, 2H, H-1”), 1.35-1.28 (m, 2H, H-3”), 1.25-
1.18 (m, 2H, H-2”), 1.26 (t, J = 7.2 Hz, 3H, H-2’), 0.87 (t, J = 7.2 Hz, 3H, H-4”), 0.79 (d, J = 6.4  Hz, 3H, 
CHCH3); 
13C NMR (100.6 MHz, CDCl3) δ 170.5 (C=O, ester), 168.8 (C=O, amide), 155.7 (C=O, urea), 
136.7 (Ar), 128.6 (Ar), 128.3 (Ar), 127.3 (Ar), 61.1 (C-1), 59.8 (CHPh), 54.2 (CHCH3), 51.3 (C-2), 29.3 








Ethyl 2-((4R,5S)-3,4-dimethyl-2-oxo-5-phenylimidazolidine-1-carbonyl)butanoate (2.32b) 
 
Title ethyl-substituted auxiliary malonate 2.32b was obtained (0.388 g, 1.23 mmol, 94 %) via the 
general alkylating procedure from 2.31 (0.400 g, 1.31 mmol) using KHMDS (3.15 ml, 1.58 mmol) and 
iodoethane (0.31 ml, 3.93 mmol, 3.0 eq). In this case, the reaction was refluxed overnight and 
column chromatography with EtOAc/ hexane (25/75) yielded 2.32b as a colourless solid and in a 
51:49 mixture of diastereomers as determined by NMR spectroscopy. Mp 126-129 °C; [α]𝐷
20 = -4.5, (c 
= 1.0, DCM); IR: νmax (cm
-1) 3010 (C-H aromatic), 2886 (C-H aliphatic), 1732 (2x C=O, ester and 
amide), 1689 (C=O, urea); 1H NMR (400 MHz, CDCl3) δ 7.31 (m, 3H, aromatic), 7.21 (m, 2H, aromatic), 
5.31 (d, J = 8.8 Hz, 1H, CHPh), 4.59 (dd, J = 5.6, 2.8 Hz 1H, H-2), 4.25-4.08 (m, 2H, H-1’), 3.91 (dq, J = 
8.8, 6.8 Hz, 1H, CHCH3), 2.82 (s, 3H, NCH3), 2.04-1.86 (m, 2H, H-1”), 1.20 (t, J = 7.2 Hz, 3H, H-2’), 0.97 
(t, J = 8.0 Hz, 3H, H-2”), 0.80 (d, J = 6.8 Hz, 3H, CHCH3); 
13C (100.6 MHz, CDCl3) δ 170.3 (C=O, ester), 
168.1 (C=O, amide), 155.7 (C=O, urea), 136.2 (Arq), 128.5 (Ar), 128.2 (Ar), 127.3 (Ar), 61.0 (C-1’), 59.8 
(C-CHPh), 54.2 (CHCH3), 52.7 (C-2), 28.3 (NCH3), 22.1 (C-1”), 15.2 (CHCH3), 14.2 (C-2’), 12.2 (C-2”); 
Anal. Cal. for C18H24N2O4 (%): C, 65.04; H, 7.28; N, 8.43. Found (%): C, 64.85; H, 7.06; N, 8.36. 
 
Ethyl 2-((4R,5S)-3,4-dimethyl-2-oxo-5-phenylimidazolidine-1-carbonyl)pent-4-enoate (2.32c) 
 
Title allyl-substituted auxiliary malonate 2.32c was obtained (0.415 g, 1.21 mmol, 92 % yield) via the 
general alkylating procedure from 2.31 (0.400 g, 1.31 mmol) using KHMDS (3.15 ml, 1.58 mmol) and 
allyl bromide (mmol, 1.8 eq) at rt. Column chromatography with EtOAc/ hexane (20/80) yielded 
2.32c as a colourless oil in a 52:48 mixture of diastereomers as determined by NMR spectroscopy. IR: 
νmax (cm
-1) 3010 (C-H aromatic), 2959 (C-H aliphatic), 1732 (2x C=O, ester and amide), 1689 (C=O, 
urea); HRMS (ES): Calc. 345.1814; C19H25N2O4, [M + H]
+ requires 345.1813. 
Major diastereomer: 1H NMR (400 MHz, CDCl3) δ 7.30 (m, 3H, aromatic), 7.20 (m, 1H, aromatic), 7.17 
(m, 1H, aromatic), 5.81-5.45 (m, 1H, H-4), 5.35 (d, J = 8.8 Hz, 1H, CHPh), 5.09 (m, 1H, H-5a), 4.97 (m, 
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1H, H-5b), 4.91 (m, 1H, H-2), 4.25-4.11 (m, 2H, H-1’), 3.98 – 3.85 (m, 1H, CHCH3), 2.83 (s, 3H, NCH3), 
2.50-2.21 (m, 2H, H-3), 1.25 (t, J = 7.2 Hz, 3H, H-2’), 0.80 (d, J = 6.4 Hz, 3H, CHCH3); 
13C NMR (100.6 
MHz, CDCl3) δ 171.6 (C=O, ester), 169.7 (C=O, amide), 155.1 (C=O, urea), 136.1 (Ar), 135.0 (C-4), 
128.5 (Ar), 128.2 (Ar), 127.2 (Ar), 117.1 (C-5), 61.3 (C-1’), 58.8 (CHPh), 54.1 (CHCH3), 50.9 (C-2), 32.8 
(C-3), 28.3 (NCH3), 15.2 (CHCH3), 14.3 (C-2’). 
Minor diastereomer: 1H NMR (400 MHz, CDCl3) δ 7.30 (m, 3H, aromatic), 7.20 (m, 1H, aromatic), 7.17 
(m, 1H, aromatic), 5.81-5.45 (m, 1H, H-4), 5.30 (d, J = 8.8 Hz, 1H, CHPh), 5.09 (m, 1H, H5a), 4.80 (dd, J 
= 5.4, 3.6 Hz, 1H, H-5b), 4.91 (m, 1H, H-2), 4.25-4.11 (m, 2H, H-1’), 2.82 (s, 3H, NCH3), 2.50-2.21 (m, 
2H, H-3), 1.21 (t, J = 7.2 Hz, 3H, H-2’), 0.80 (d, J = 6.4 Hz, 3H, CHCH3); 
13C NMR (100.6 MHz, CDCl3) δ 
171.6 (C=O, ester), 170.7 (C=O, amide), 155.1 (C=O, urea), 136.7 (Ar), 135.4 (C-4), 128.6 (Ar), 128.3 
(Ar), 127.3 (Ar), 117.1 (C-5), 61.3 (C-1’), 58.8 (CHPh), 54.2 (CHCH3), 51.1 (C-2), 32.8 (C-3), 28.3 (NCH3), 




      
Title α-substituted auxiliary malonate 2.32d was obtained (0.515 g, 1.140 mmol, 87 %) via the 
general alkylating procedure from 2.31 (0.400 g, 1.312 mmol) using KHMDS (3.15 ml, 1.575 mmol) 
and alkyl halide 2.52 (0.435 g, 1.574 mmol, 1.2 eq) under reflux conditions. Column chromatography 
with EtOAc/ hexane (20/80) yielded 2.32d as a gummy solid in a 52:48 mixture of diastereomers as 
determined by NMR spectroscopy.  
Major diastereomer: HRMS (ES): m/z found 453.2352, C26H33N2O5 [M+H]
+ requires 453.2350; [α]𝐷
20= -
26.2, (DCM, c = 1); IR: vmax (cm
-1) 3053 (C-H aromatic), 2937 (C-H aliphatic), 1732 (C=O ester), 1687 
(C=O imide); 1H NMR (400 MHz, CDCl3) δ 7.32 – 6.99 (m, 10H, aromatic), 5.28 (d, J = 8.7 Hz, 1H, 
CHPh), 4.74 (dd, J = 8.6, 5.4 Hz, 1H, H-2), 4.47 (s, 2H OCH2Ph), 4.14 – 4.07 (m, 2H, CH2CH3), 3.81 (dt, J 
= 8.7, 3.6 Hz, 1H, CHCH3), 3.49 (t, J = 6.4 Hz, 2H, H-5), 2.78 (s, 3H, NCH3), 2.03 – 1.87 (m, 2H, H-3), 
1.78 – 1.74 (m, 2H, H-4), 1.26 (t, J = 6.6 Hz, 3H, CH2CH3 ), 0.79 (d, J = 6.6 Hz, 3H, CHCH3); 
13C NMR 
(101 MHz, CDCl3) δ 170.3 (C=O), 168.6 (C=O), 155.5 (C=O), 138.5 (C1’), 135.9 (C1’’), 128.5 (C3’), 128.3 
( C3’’), 128.0 (C2’), 127.4 (C2’’), 126.9 (C4’’), 125.9 (C4’), 72.7 (OCH2Ph), 70.1 (C-5), 61.1 (CH2CH3), 




1H NMR (400 MHz, CDCl3) δ 7.32 – 6.99 (m, 10H, aromatic), 5.36 (d, J = 8.7 Hz, 1H, CHPh), 4.83 (t, J = 
7.0 Hz, 1H, H-2), 4.44 (s, 2H, OCH2Ph), 4.14 – 4.07 (m, 2H, CH2CH3), 3.91 (dt, J = 8.7, 3.6, 1H, CHCH3), 
3.44 (t, J = 6.4 Hz, 2H, H-5), 2.81 (s, 3H, NCH3), 2.03 – 1.87 (m, 2H, H-3), 1.74 – 1.64 (m, 2H, H-4), 1.19 
(t, J = 7.1 Hz, 3H, CH2CH3), 0.77 (d, J = 6.6 Hz, 3H, CHCH3). 
 
Ethyl 3-((4R, 5S)-3,4-dimethyl-2-oxo-5-phenylimidazolidin-1-yl)-2-methyl-3-oxopropanoate (2.32e) 
 
Title methyl-substituted auxiliary malonate 2.32e was obtained (0.375 g, 1.118 mmol, 90 %) via the 
general alkylating procedure from 2.31 (0.400 g, 1.312 mmol) using KHMDS (3.15 ml, 1.575 mmol), 
MeI (0.25 ml, 3.936 mmol, 3 eq) at room temperature as an off-white solid and as a mixture of 
diastereomers. Saturated aq. Na2S2O3 was also used in the work-up. Recrystallization from EtOAc/ 
hexane to a constant Mp afforded one single diastereomer. Mp 152-153 °C; [α]𝐷
20
 = -31.9° (DCM, c = 
1.0); IR: νmax 3010 (C-H aromatic), 2863 (C-H aliphatic), 1732 (2 × C=O, ester and imide), 1689 (C=O, 
urea); 1H NMR (300 MHz, CDCl3) δ 7.31 (m, 3H, aromatic), 7.22 (m, 2H, aromatic), 5.30 (d, J = 8.7 Hz, 
1H, CHPh), 4.65 (q, J = 7.5 Hz, 1H, H-2), 4.14 (m, 2H, H-1’), 3.90 (dq, J = 8.7, 6.6 Hz, 1H, CHCH3), 2.81 
(s, 3H, NCH3), 1.39 (d, J = 7.5 Hz, 3H, H-1”), 1.21 (t, J = 7.6 Hz, 3H, H-2’), 0.8 (d, J = 6.6 Hz, 3H, CHCH3); 
13C NMR (75.5 MHz, CDCl3) δ 171.1 (C=O, ester), 169.0 (C=O, amide), 155.7 (C=O, urea), 136.2 (Arq), 
128.5 (Ar), 128.2 (Ar), 127.3 (Ar), 61.2 (C-1’), 59.8 (CHPh), 54.3 (CHCH3), 45.9 (C-2), 28.4 (NCH3), 15.2 
(CHCH3), 14.2 (C-2’), 13.5 (C-2”); Anal. Cal. for C17H22N2O4 (%): C, 64.13; H, 6.97; N, 8.80. Found (%): C, 
64.02; H, 7.04; N, 8.89. 
General procedure for alkylation of α-substituted auxiliary-malonates 2.32a – 2.32e to prepare α,α-
disubstituted auxiliary-malonates 2.33a – 2.33e 
To a solution of the appropriate derivative of 2.32 (1 eq) in THF at -78 °C was added a solution of 
KHMDS (1.2 eq, 0.5 M) and the reaction contents allowed to stir at this temperature for 30 min. 
Thereafter, the appropriate alkylating agent (1.5 – 3 eq.) was slowly added, the reaction contents 
allowed to slowly warm up to rt and left to stir overnight for 20 hrs. The reaction was quenched with 
sat. aqueous NH4Cl, extracted with EtOAc, the organic extracts dried over MgSO4, filtered under 
vacuum and the organic solvent removed in vacuo. The crude residue was chromatographed using 
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EtOAc / hexane mixtures to afford the derivative 2.33, which was analysed by chiral HPLC and NMR 




The title disubstituted auxiliary malonate 2.33a was prepared (0.189 g, 0.472 mmol, 85 %) via the 
general alkylating procedure from 2.32a (0.200 g, 0.555 mmol), KHMDS (1.44 ml, 0.721 mmol, 1.3 
eq, 0.5 M) and allyl iodide (0.15 ml, 1.66 mmol, 3.0 eq). Chromatography with EtOAc/ hexane (20/ 
80) afforded 2.33a as a colourless solid in 98:2 ratio of diastereomers. Mp = 88-90 °C (EtOAc/ 
hexane); [α]𝐷
20  = -30.2, (DCM, c = 0.8); IR: νmax 3009 (C-H aromatic), 2989 (C-H aliphatic), 1738 (2 x 
C=O, ester and amide), 1674 (C=O, urea); 1H NMR (400 MHz, CDCl3) δ 7.30 (m, 3H, aromatic), 7.20 
(m, 2H, aromatic), 5.41 (m, 1H, H-4), 5.31 (d, J = 8.4 Hz, 1H, CHPh), 4.97 (m, 1H, H-5a), 4.89 (m, 1H, 
H-5b), 4.17 (m, 2H, H-1’), 3.91 (dq, J = 8.4, 6.4 Hz, 1H, CHCH3), 2.92 (m, 1H, H-3a), 2.79 (s, 3H, NCH3), 
2.73 (m, 1H, H-3b), 1.93 (m, 2H, H-3'), 1.35-1.19 (m, 3H, H-5’ + H-4’a), 1.26 (t, J = 7.2 Hz, 3H, H-2’), 
1.02 (m, 1H, H-4’b), 0.86 (t, J = 7.2 Hz, 3H, H-6’), 0.79 (d, J = 6.4 Hz, 3H, CHCH3); 
13C NMR (100.6 MHz, 
CDCl3) δ 171.6 (C=O, ester), 170.0 (C=O, amide), 155.3 (C=O, urea), 136.7 (Ar), 133.4 (C-4), 128.5 (Ar), 
128.2 (Ar), 127.3 (Ar), 118.0 (C-5), 60.6 (C-1’), 60.5 (CHPh), 58.4 (C-2), 54.4 (CHCH3), 38.1 (C-3), 32.8 
(C-3’), 28.3 (NCH3), 26.3 (C-4’), 23.1 (C-5’), 15.1 (CHCH3), 14.4 (C-2’), 14.1 (C-6’); Anal. Calc. 




The title disubstituted auxiliary malonate 2.33b was prepared (0.219 g, 0.536 mmol, 89 %) via the 
general alkylating procedure from 2.32b (0.200 g, 0.602 mmol), KHMDS (1.57 ml, 0.783 mmol, 1.3 
eq, 0.5 M) and benzyl bromide (0.21 ml, 1.806 mmol, 3.0 eq). Chromatography with EtOAc/ hexane 
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(25/ 75) afforded 2.33b as a colourless solid in a 96:4 mixture of diastereomers. Mp = 107-110 °C 
(EtOAc/ hexane); [α]𝐷
20  = -42.0 (DCM, c = 0.8); IR: νmax 3008 (C-H aromatic), 2863 (C-H aliphatic), 
1739 (2 x C=O, ester and amide), 1635 (C=O, urea); 1H NMR (400 MHz, CDCl3) δ 7.37 (m, 3H, 
aromatic), 7.25 (m, 2H, aromatic), 7.07 (m, 1H, aromatic), 6.98 – 6.84 (m, 4H, aromatic), 5.37 (d, J = 
7.2 Hz, 1H, CHPh), 4.04 (q, J = 9.6 Hz, 2H, H-6), 3.95 (dq, J = 8.5, 6.6 Hz, 1H, CHCH3), 3.37 (s, 2H, H-5), 
2.81 (s, 3H, NCH3), 1.91 (m, 2H, H-3), 1.12 (t, J = 9.6 Hz, 3H, H-7), 0.87 (t, J = 7.5 Hz, 3H, H-4), 0.86 (d, 
J = 7.5 Hz, 3H, CHCH3); 
13C NMR (100.6 MHz, CDCl3) δ 171.5 (C=O, ester), 169.9 (C=O, amide), 155.6 
(C=O, urea), 137.12 (C-1’), 136.7 (C-1”), 130.7 (C-2”), 128.6 (C-3’), 128.2 (C-4’), 128.0 (C-2’), 127.8 (C-
3”), 126.41 (C-4”), 61.0 (C-6), 60.5 (CHPh), 55.4 (C-2), 54.7 (CHCH3), 39.5 (C-5), 28.36 (NCH3), 26.65 
(C-3), 15.1 (CHCH3), 14.1 (C-7), 9.1 (C-4); Anal. Calc. C25H30N2O4 (%): C, 71.07; H, 7.16; N, 6.63. Found 




The title disubstituted auxiliary-malonate 2.33c was obtained (0.191 g, 0.535 mmol, 92 %) via the 
general alkylating procedure from 2.32c (0.200 g, 0.581 mmol) with MeI (0.109 ml, 1.743 mmol, 3 
eq) as a colourless oil in a 95:5 mixture of diastereomers. [α]𝐷
20  = -33.3 (DCM, c = 1.0); IR: νmax 3010 
(C-H aromatic), 2991 (C-H aliphatic), 1735 (2 x C=O, ester and amide), 1675 (C=O, urea); 1H NMR (400 
MHz, CDCl3) δ 7.31 (m, 3H, aromatic), 7.17 (m, 2H, aromatic), 5.73 (m, 1H, H-4), 5.29 (d, J = 8.4 Hz, 
1H, CHPh), 5.04 (m, 1H, H-5a),  5.01 (m, 1H, H-5b), 4.19 (m, 2H, H-1’), 3.90 (dq, J = 8.4, 6.4 Hz, 1H, 
CHCH3), 2.79 (s, 3H, NCH3), 2.70 (m, 2H, H-3), 1.45 (s, 3H, H-3’), 1.27 (t, J = 7.2 Hz, 3H, H-2’), 0.79 (d, J 
= 6.4 Hz, 3H, CHCH3); 
13C NMR (100.6 MHz, CDCl3) δ 173.1 (C=O, ester), 170.2 (C=O, amide), 155.9 
(C=O, urea), 136.7 (Ar), 133.8 (C-4), 128.6 (Ar), 128.2 (Ar), 127.0 (Ar), 118.2 (C-5), 60.8 (C-1’), 60.5 
(CHPh), 54.5 (C-2), 54.5 (CHCH3), 40.5 (C-3), 28.3 (NCH3), 21.4 (C-3’), 15.1 (CHCH3), 14.3 (C-2’); HRMS 
(ES): m/z calc. 359.1971; C20H27N2O4, [M + H]
+ requires 358.1971. 






        
The title disubstituted auxiliary-malonate 2.33d was obtained (0.201 g, 0.41 mmol, 93 %) via the 
general alkylating procedure from 2.32d (0.200 g, 0.442 mmol) with allyl bromide (0.057 ml, 0.663 
mmol, 1.5 eq) as a gummy solid in a 98:2 mixture of diastereomers. HRMS (ES): m/z found 493.2667, 
C29H37N2O5 [M+H]
+ requires 493.2658; [α]𝐷
20= -36.9, (DCM, c = 1); IR: vmax (cm
-1) 3034 (C-H alkenes), 
2978 (C-H aromatic), 2862 (C-H alkanes), 1736 (C=O ester), 1674 (C=O imide); 1H NMR (400 MHz, 
CDCl3) δ 7.37 – 7.23 (m, 8H, aromatic), 7.19 (m, 2H, aromatic),  5.50 – 5.36 (m, 1H, CH=CH2), 5.28 (d, 
J = 8.5 Hz, 1H, CHPh), 4.98 (m, 1H, CH=CH2a), 4.89 (m, 1H, CH=CH2b), 4.47 (m, 2H, OCH2Ph), 4.27 – 
4.18 (m, 2H, CH2CH3 ), 3.86 – 3.66 (dq, J = 8.5, 6.6 Hz, 1H, CHCH3), 3.49 – 3.40 (m, 2H, H-3’), 2.93 (m, 
1H, CH2=CHCH2a), 2.75 (s, 3H, NCH3), 2.74 (m, 1H, CH=CH2CH2b), 2.10 – 2.05 (m, 2H, H-1’), 1.69 – 1.58 
(m, 1H, H-2’), 1.46 – 1.33 (m, 1H, H-2’), 1.26 (t, J = 7.2 Hz, 3H, CH2CH3), 0.77 (d, J = 6.6 Hz, 3H, 
CHCH3); 
13C NMR (101 MHz, CDCl3) δ 171.5 (C=O), 169.7 (C=O), 155.3 (C=O), 138.8 (C-1’’), 136.7 
(C1’’’), 133.3 (CH2=CH), 128.5 (C-3’’), 128.4 (C-3’’’), 128.2 (C-2’’), 127.7 (C-2’’’), 127.6 (C-4’’’), 127.3 
(C-4’’), 118.2 (CH=CH2), 72.9 (OCH2Ph), 70.5 (C-3’), 64.9 (q C), 60.6 (OCH2CH3), 58.2 (CHPh), 54.3 
(CHCH3), 38.2 (CH2CH=CH2), 29.7 (C-1’), 28.2 (NCH3), 24.6, (C-2’), 15.1 (CHCH3), 14.3 (CH2CH3). 
PMB Ester-malonate-auxiliary series 
3-((4-Methoxybenzyl)oxy)-3-oxopropanoic acid (2.37)147 
 
To a cooled solution of malonic acid (15.00 g, 0.144 mol, 1 eq) and p-methoxybenzyl alcohol (19.9 
ml, 0.144 mol, 1 eq) in DCM (350 ml) was added a solution of DCC (29.71 g, 0.144 mol, 1 eq) in DCM 
(150 ml) via a dropping funnel over a period of 30 min, whilst stirring vigorously. The cooling bath 
was then removed and the reaction left to stir for 1 hour at room temperature after which time the 
solid urea precipitate was removed by filtration through a pad of Celite, and the filtrate evaporated. 
The residue was taken up in ethyl acetate (250 ml) and the organic layer extracted with saturated 
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aqueous sodium bicarbonate solution (2 x 200 ml). The combined aqueous extracts were washed 
once with ethyl acetate (100 ml), acidified to pH 3 with 3M HCl and then extracted with ethyl 
acetate (1 x 300 and 2 x 150 ml). The organic extracts were dried over anhydrous MgSO4, filtered 
and evaporated to yield title product 2.37 (27.77 g, 0.124 mol, 86 %) as a light yellow liquid. This 
product was pure enough as judged by 1H NMR spectroscopy to proceed to the next step. 
 1H NMR (400 MHz, CDCl3) δ 8.41 (broad s, 1H, COOH), 7.31 - 7.29 (m, 2H, aromatic), 6.81 – 6.77 (m, 
2H, aromatic), 5.15 (s, 2H, CH2Ph), 3.81 (s, 3H, OCH3), 3.45 (s, 2H, CH2). 
4-Methoxybenzyl 3-((4S,5R)-3,4-dimethyl-2-oxo-5-phenylimidazolidin-1-yl)-3-oxopropanoate 
(2.38) 
         
Mono-p-methoxybenzyl malonate 2.37 (1.00 g, 4.46 mmol, 1 eq) and (-)-2.29 (0.85 g, 4.47 mmol, 1 
eq) were dissolved in dichloromethane (100 ml) and stirred at 0 °C. A solution of DCC (1.09 g, 5.28 
mmol, 1.2 eq) and HOBt (0.12 g, 20 mol %) in dichloromethane (60 ml) was gradually added to the 
mixture via a pressure-equalizing dropping funnel. Once addition was complete, the cooling bath 
was removed. The reaction was followed by tlc, which indicated completion within 3 hours at room 
temperature after which time it was filtered through Celite, the solvent evaporated and the 
resultant residue purified by column chromatography with ethyl acetate/hexane (30/70). The 
product 2.38 was obtained as a thick, clear gum (1.50 g, 3.78 mmol, 85 %). HRMS (ES): m/z found 
397.1725, C22H25N2O5 [M+H]
+ requires 397.1719; [α]𝐷
20= -30.3, (DCM, c = 1); IR: vmax (cm
-1) 3067 (C-H 
aromatic), 2961 (C-H aliphatic), 1732 (C=O ester), 1687 (C=O imide); 1H NMR (400 MHz, CDCl3) δ 7.31 
– 7.19 (m, 5H, aromatic), 7.17 – 7.08 (m, 2H, aromatic), 6.86 (d, J = 8.7 Hz, 2H, aromatic), 5.28 (d, J = 
8.7 Hz, 1H, CHPh), 5.09 (s, 2H, OCH2), 3.99 (m 2H, CH2), 3.87 (dq, J = 8.7, 6.6 Hz, 1H, CHCH3), 3.78 (s, 
3H, PhOCH3), 2.78 (s, 3H, NCH3), 0.76 (d, J = 6.6 Hz, 3H, CHCH3); 
13C NMR (101 MHz, CDCl3) δ 167.6 
(C=O), 164.9 (C=O), 159.8 (C-4), 155.6 (C=O), 136.1 (C-1’), 130.2 (C-2), 128.6 (C-3’), 128.2 (C-1), 127.9 
(C-2’), 127.2 (C-4’), 114.1 (C-3), 66.9 (OCH2Ph), 59.5 (CHPh), 55.4 (CHCH3), 54.2 (OCH3), 43.5 




Mono-alkylation of auxiliary malonate 2.38 with alkyl halides to generate α-substituted auxiliary 
malonates 2.39a to 2.39e 
A solution of 2.38 (1 eq) in THF (0.01M) was cooled to -78 °C followed by the dropwise addition of 
KHMDS in toluene (0.5 M, 1.2 eq) and stirring at this temperature was continued for a further 30 
minutes after which time the electrophile (1.5 eq) was added in one portion to the anion solution. 
The reaction was slowly warmed to room temperature and stirred for a further 8 hours. It was then 
quenched with saturated aqueous ammonium chloride solution (ca. ½ reaction vol.) and extracted 
three times with EtOAc (1 x reaction vol. and 2 x ½ reaction vol.). The combined organic extracts 
were dried over anhydrous MgSO4 and evaporated to give the crude product which was 




The title compound 2.39a was obtained (1.05 g, 2.16 mmol, 95 %) as a thick oil using general 
alkylating procedure from 2.38 (0.900 g, 2.27 mmol), KHMDS (0.5 M, 5.45 ml, 2.73 mmol) and benzyl 
bromide (0.41 ml, 3.41 mmol) in a 54:46 ratio of diastereomers as determined by 1H NMR 
spectroscopy. HRMS (ES): m/z found 487.2245, C29H31N2O5 [M+H]
+ requires 487.2233; IR: vmax (cm
-1) 
3027 (C-H aromatic), 2933 (C-H aliphatic), 1724 (C=O ester, amide), 1680 (C=O imide).  
Major diastereomer: 1H NMR (400 MHz, CDCl3) δ 7.42 – 7.15 (m, 11H, aromatic), 7.09 – 6.82 (m, 3H, 
aromatic), 5.51 (d, J = 8.2 Hz, 1H, CHPh), 5.36 (dd, J = 9.4, 5.6 Hz, 1H, H-2), 5.21 (d, J = 12.1 Hz, 1H, 
OCH2aPh), 5.13 (d, J = 12.1, Hz, 1H, OCH2bPh), 3.90 (s, 3H, OCH3), 3.80 – 3.74 (m, 1H, CH3CH), 3.46 – 
3.16 (m, 2H, CH2Ph), 2.83 (s, 3H, NCH3), 0.82 (d, J = 6.4 Hz, 3H, CHCH3); 
13C NMR (101 MHz, CDCl3) δ 
169.7 (C=O), 167.4 (C=O), 159.6 (C-4’), 155.4 (C=O), 138.9 (C-1’’), 136.0 (C-1’’’), 129.9 (C-2’), 129.5 (C-
3’’’), 128.5 (C-3’’), 128.4 (C-1’), 128.3 (C-2’’’), 128.0 (C-2’’), 127.1 (C-4’’’), 126.4 (C-4’’), 114.0 (C-3’), 
66.7 (OCH2Ph), 59.7 (OCH3), 55.4 (CHPh), 53.9 (CHCH3), 52.7 (C-2), 34.5 (CH2Ph), 28.2 (NCH3), 15.0 
(CHCH3).  
Minor diastereomer: 1H NMR (400 MHz, CDCl3) δ 7.42 – 7.15 (m, 11H, aromatic), 7.09 – 6.82 (m, 3H, 
aromatic), 5.50 (d, J = 8.7 Hz, 1H, CHPh), 5.34 (dd, J = 9.4, 5.5 Hz, 1H, H-2), 5.19 (d, J = 11.8, 1H, 
OCH2aPh), 5.12 (d, J = 11.8, 1H, OCH2bPh), 3.93 – 3.86 (m, 4H, OCH3 + CH3CH), 3.46 – 3.16 (m, 2H, 
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CH2Ph), 2.87 (s, 3H, NCH3), 0.83 (d, J = 6.0 Hz, 3H, CH3CH); 
13C NMR (101 MHz, CDCl3) δ 169.5 (C=O), 
167.9 (C=O), 159.7 (C-4’), 155.4 (C=O), 138.6 (C-1”), 136.2 (C-1’’’), 129.9 (C-2’), 129.3 (C-3’’’), 128.7 
(C-3’’), 128.5 (C-1’), 128.4 (C-2’’’), 128.0 (C-2”), 126.9 (C-4’’’), 126.3 (C-4”), 114.0 (C-3’), 66.9 






Title compound 2.39b was obtained (0.961 g, 2.20 mmol, 97 %) as a colourless gum  using general 
alkylating procedure from 2.38 (0.900 g, 2.27 mmol), KHMDS (0.5 M, 5.45 ml, 2.73 mmol) and allyl 
bromide (0.30 ml, 3.41 mmol) in a 51:49 ratio of diastereomers as determined by NMR 
spectroscopy. HRMS (ES): m/z found 437.2042, C25H29N2O5 [M+H]
+ requires 437.2031; IR: vmax (cm
-1) 
3071 (C-H aromatic), 2922 (C-H aliphatic), 1729 (C=O ester), 1679 (C=O imide). 
Major diastereomer; 1H NMR (400 MHz, CDCl3) δ 7.34 – 7.09 (m, 8H, aromatic), 6.88 – 6.82 (m, 2H, 
aromatic), 5.88 – 5.71 (m, 1H, H-4), 5.30 (d, J = 8.7 Hz, 1H, CHPh), 5.15 (d, J = 12.1 Hz, 1H, 
OCH2aPMP), 5.03 (d, J = 12.1 Hz, 1H, OCH2bPMP), 5.03 – 4.92 (m, 2H, H-5), 4.91 – 4.83 (m, 1H, H-2), 
3.87 – 3.83 (m, 1H, CHCH3), 3.82 (s, 3H, OCH3), 2.80 (s, 3H, NCH3), 2.74 – 2.62 (m, 2H, H-3), 0.79 (d, J 
= 6.6 Hz, 3H, CHCH3).
 13C NMR (101 MHz, CDCl3) δ 169.7 (C=O), 167.9 (C=O), 159.7 (C-4’), 155.6 (C=O), 
136.4 (C-1’’), 135.3 (C-4), 130.1 (C-2’), 128.6 (C-3”), 128.2 (C-1’), 128.1 (C-2”), 127.2 (C-4”), 117.2 (C-
5), 114.0 (C-3’), 66.8 (OCH2Ph), 59.7 (OCH3), 55.4 (CHPh), 54.1 (CHCH3), 51.2 (C-2), 32.7 (C-3), 28.3 
(NCH3), 15.1 (CHCH3). 
Minor diastereomer: 1H NMR (400 MHz, CDCl3) δ 7.39 – 7.05 (m, 8H, aromatic), 6.98 – 6.66 (m, 2H, 
aromatic), 5.95 – 5.61 (m, 1H, H-4), 5.32 (d, J = 8.6 Hz, 1H, CHPh), 5.17 (d, J = 12.0 Hz, 1H, 
OCH2aPMP), 5.05 (d, J = 12.0 Hz, 1H, OCH2bPMP), 4.97 – 4.91 (m, 2H, H-5), 4.88 - 4.85 (m, 1H, H-2), 
3.94 – 3.87 (m, 1H, CHCH3), 3.83 (s, 3H, OCH3), 2.83 (s, 3H, NCH3), 2.76 – 2.67 (m, 2H, H-3), 0.80 (d, J 
= 6.6 Hz, 1H, CHCH3).
 13C NMR (101 MHz, CDCl3) δ 169.7 (C=O), 167.5 (C=O), 159.7 (C-4’), 155.6 (C=O), 
136.0 (C-1”), 134.9 (C-4), 130.0 (C-2’), 128.4 (C-3”), 128.2 (C-1’), 128.1 (C-2”) 127.2 (C-4”), 117.2 (C-
5), 114.0 (C-3’), 66.7 (OCH2Ph), 59.7 (OCH3), 55.4 (CHPh), 54.0 (CHCH3), 50.9 (C-2), 32.6 (C-3), 28.2 






Title compound 2.39c was obtained (0.847 g, 1.72 mmol, 85 %) as a viscous oil using general 
alkylating procedure from 2.38 (0.800 g, 2.02 mmol), KHMDS (0.5M, 4.85 ml, 2.42 mmol), bromo 
azide 2.54 (0.427 g, 2.42 mmol) and TBAI (0.369 g, 1.14 mmol). In this case, the reaction had to be 
warmed to 60 °C to achieve full conversion. Title product 2.39c was obtained as a 50:50 mixture of 
diastereomers, as determined by NMR spectroscopy, separable by column chromatography. 1H NMR 
(300 MHz, CDCl3) δ 7.38 – 6.87 (m, 7H, aromatic), 6.87 – 6.71 (m, 2H, aromatic), 5.24 (d, J = 3.5 Hz, 
1H, CHPh), 5.05 (d, J = 7.1 Hz, 1H, OCH2aPh), 4.96 (d, J = 7.1 Hz, 1H, OCH2bPh), 4.81 – 4.68 (m, 1H, H-
2), 3.86 – 3.75 (m, 1H, CHCH3), 3.74 (s, 3H, OCH3), 3.20 – 3.01 (m, 2H, H-6), 2.71 (s, 3H, NCH3), 1.93 – 
1.75 (m, 2H, H-3), 1.54 – 1.36 (m, 2H, H-5), 1.39 – 1.22 (m, 2H, H-4), 0.69 (d, J = 3.5 Hz, 3H, CHCH3). 
4-Methoxybenzyl 5-(benzyloxy)-2-((4S,5R)-3,4-dimethyl-2-oxo-5-phenylimidazolidine-1-
carbonyl)pentanoate (2.39d) 
           
Title compound 2.39d was obtained (0.317 g, 0.582 mmol, 97 %) as a colourless gum, using general 
alkylating procedure from 2.38 (0.200 g, 0.50 mmol), KHMDS (0.5M, 1.20 ml, 0.60 mmol) and iodide 
2.52 (0.166 g, 0.60 mmol). In this case, the reaction had to be warmed to 60 °C to achieve full 
conversion. Title product 2.39d was obtained as a 51:49 mixture of diastereomers, as determined by 
NMR spectroscopy, separable by column chromatography. HRMS (ES): m/z found 545.2609, 
C32H38N2O6 [M+H]
+ requires 545.2601; Major diastereomer: [α]𝐷
20= -20.3, (DCM, c = 0.58); IR: vmax 
(cm-1) 3063 (C-H aromatics), 2866 (C-H aliphatic), 1732 (C=O ester), 1687(C=O imide); 1H NMR (400 
MHz, CDCl3) δ 7.29 (m, 10H, aromatic), 7.12 (m, 2H, aromatic), 6.88 (m, 2H, aromatic), 5.31 (d, J = 8.7 
Hz, 1H, CHPh), 5.16 (d, J = 12.0 Hz, 1H, CH2aPhOMe), 5.04 (d, J = 12.0 Hz, 1H, CH2bPhOMe), 4.87 (t, J 
= 7.0 Hz, 1H, H-2), 4.43 (s, 2H, OCH2Ph), 3.85 – 3.81 (m, 1H, CHCH3), 3.82 (s, 3H, OCH3), 3.43 (t, J = 6.4 
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Hz, 2H, H-5), 2.78 (s, 3H, NCH3), 2.00 (m, 2H, H-3), 1.60 (m, 2H, H-4), 0.78 (d, J = 6.6 Hz, 3H, CH3CH); 
13C NMR (101 MHz, CDCl3) δ 170.1 (C=O), 168.3 (C=O), 159.7(C-4’), 155.5 (C=O) , 138.8 (C-1’’’), 
136.56 (C-1’’), 130.0 (C-2’), 128.6 (C-3’’’), 128.3 (C-3’’), 128.2 (C-1’), 128.1 (C-2’’’), 127.7 (C-4’’), 127.4 
(C-2’’), 127.0 (C-4’’’), 114.0 (C-3’) 72.7 (OCH2Ph), 69.9 (C-5), 66.7 (OCH2PhOMe), 59.6 (CHPh), 55.4 
(CHCH3), 53.9 (OCH3), 50.9 (C-2), 28.2 (NCH3), 27.6 (C-4), 25.5 (C-3), 15.0 (CHCH3). 
4-Methoxybenzyl 2-((4S,5R)-3,4-dimethyl-2-oxo-5-phenylimidazolidine-1-carbonyl)butanoate 
(2.39e) 
         
Title compound 2.39e was obtained (0.896 g, 2.11 mmol, 93 %) using general alkylating procedure 
from 2.38 (0.900 g, 2.27 mmol), KHMDS (0.5 M, 5.45 ml, 2.73 mmol) and iodoethane (0.27 ml, 3.41 
mmol) in a 51:49 ratio of diastereomers as determined by NMR spectroscopy. Crystallization of the 
diastereomeric mixture which was a colourless gum, yielded a single diastereomer as glass-like 
crystals. M.p. 91 -94 °C (CHCl3/ hexane)HRMS (ES): m/z found 425.2079, C24H29N2O5 [M+H]
+ requires 
425.2076; IR: vmax (cm
-1) 3063 (C-H aromatic), 2968 (C-H aliphatic), 1723 (C=O ester, amide), 1680 
(C=O urea); Major diastereomer 1H NMR (400 MHz, CDCl3) δ 7.20 – 7.11 (m, 5H, aromatic), 7.10 – 
7.03 (m, 2H, aromatic), 6.82 – 6.75 (m, 2H, aromatic), 5.24 (d, J = 8.7 Hz, 1H, CHPh), 5.08 (d, J = 12.1 
Hz, 1H, OCH2aPMB), 4.95 (d, J = 12.1 Hz, 1H, OCH2bPMB), 4.56 (dd, J = 8.1, 5.7 Hz, 1H, H-2), 3.89 – 
3.79 (m, 1H, CHCH3), 3.75 (s, 3H, OCH3), 2.76 (s, 3H, NCH3), 1.97 – 1.80 (m, 2H, H-3), 0.89 (t, J = 7.4 
Hz, 3H, H-4), 0.72 (d, J = 6.6 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 170.2 (C=O), 168.1 (C=O), 159.6 (C-
4’), 155.6 (C=O), 136.1 (C-1”), 130.0 (C-2’), 128.4 (C-3”), 128.2 (C-1’), 128.1 (C-2”), 127.2 (C-4”), 114.0 
(C-3’), 66.5 (OCH2Ph), 59.8 (OCH3), 55.4 (CHPh), 54.1 (CHCH3), 52.8 (C-2), 28.3 (NCH3), 22.05 (C-3), 
15.1 (CHCH3), 12.4 (C-4). 
Alkylation of α-substituted auxiliary malonates 2.39a to 2.39e with alkyl halides to generate α,α-
disubstituted auxiliary malonates 2.40a – 2.40g  
To a solution of the appropriate derivative of 2.39 (1 eq) in THF at -78 °C was added a solution of 
KHMDS (1.2 eq, 0.5 M) and the reaction contents allowed to stir at this temperature for 30 min. 
Thereafter, the appropriate alkylating agent (1.5 – 3 eq) was slowly added, the reaction contents 
allowed to slowly warm up to rt and left to stir overnight for 20 hrs. The reaction was quenched with 
sat. aqueous NH4Cl, extracted with EtOAc, the organic extracts dried over MgSO4, filtered under 
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vacuum and the organic solvent removed in vacuo. The crude residue was chromatographed using 
EtOAc / hexane mixtures to afford the derivative 2.40, which was analysed by chiral HPLC and NMR 
spectroscopy for diastereoselectivity. 
4-Methoxybenzyl (S)-2-benzyl-3-((4S,5R)-3,4-dimethyl-2-oxo-5-phenylimidazolidin-1-yl)-2-methyl-
3-oxopropanoate (2.40a) 
    
The title compound 2.40a was obtained (0.889 g, 1.78 mmol, 96 %) as a colourless solid via the 
general alkylation method using 2.39a (0.900 g, 1.85 mmol), KHMDS (0.5 M, 4.44 ml, 2.22 mmol) and 
methyl iodide (0.180 ml, 2.78 mmol, 1.5 eq). M.p. 98 - 101 °C (Chloroform/ hexane). Chiral HPLC on a 
C18 column eluting with ACN: H20 (60:40) revealed a 98:2 diastereomer ratio. Minor diastereomer 
retention time = 10.4 min; that of the major diastereomer = 11.2 min. HRMS (ES): m/z found 
501.2390, C30H33N2O5 [M+H]
+ requires 501.2369. [α]𝐷
20= -45.8, (DCM, c = 1); IR: vmax (cm
-1) 3008 (C-H 
aromatics), 2955 (C-H alkanes), 1722 (C=O ester, amide), 1669 (C=O urea); 1H NMR (400 MHz, CDCl3) 
δ 7.23 – 7.14 (m, 8H, aromatic), 7.13 – 6.95 (m, 4H, aromatic), 6.89 – 6.79 (m, 2H, aromatic), 5.13 (d, 
J = 8.5 Hz, 1H, CHPh), 5.05 (d, J = 11.9 Hz, 1H, OCH2aPMP), 4.93 (d, J = 11.9 Hz, 1H, OCH2bPMP), 3.81 
(s, 3H, OCH3), 3.80 – 3.73 (m, 1H, CH3CH), 3.39 (d, J = 13.7 Hz, 1H, CH2aPh), 3.35 (d, J = 13.7 Hz, 1H, 
CH2bPh) 2.75 (s, 3H, NCH3), 1.46 (s, 3H, CCH3), 0.73 (d, J = 6.6 Hz, 3H, CH3CH); 
13C NMR (101 MHz, 
CDCl3) δ 172.4 (C=O), 169.8 (C=O), 159.7 (C-4’), 155.3 (C=O), 137.2 (C-1’’), 136.5 (C-1’’’), 130.6 (C-2’), 
130.5 (C-3’’’), 128.5 (C-3’’), 128.2 (C-1’), 128.1 (C-2’’’), 128.0 (C-2’’), 126.9 (C-4’’’), 126.8 (C-4’’), 113.9 
(C-3’), 66.6 (OCH2Ph), 60.6 (OCH3), 56.5 (CHPh), 55.5 (C-2), 54.4 (CHCH3), 41.7 (CH2Ph), 28.2 (NCH3), 










       
The title compound 2.40b was obtained (0.762 g, 1.69 mmol, 90 %) as a viscous oil via the general 
alkylation method using 2.39b (0.820 g, 1.88 mmol), KHMDS (0.5 M, 4.51 ml, 2.26 mmol) and methyl 
iodide (0.18 ml, 2.82 mmol, 1.5 eq). Chiral HPLC on a C18 column eluting with ACN: H20 (50:50) 
revealed a 98:2 diastereomer ratio. Minor diastereomer retention time = 22.9 min; that of the major 
diastereomer = 18.8 min. [α]𝐷
20= -46.2, (DCM, c = 1); HRMS (ES): m/z found 451.2233, C26H31N2O5 
[M+H]+ requires 451.2233; IR vmax (cm
-1): 3063 (C-H aromatics), 2937 (C-H alkanes), 1723 (C=O ester, 
amide), 1676 (C=O urea); 1H NMR (400 MHz, CDCl3) δ 7.26 – 7.13 (m, 6H, aromatic), 7.07 – 7.00 (m, 
2H, aromatic), 6.91 – 6.84 (m, 2H, aromatic), 5.76 – 5.62 (m, 1H, CH2=CH), 5.23 (d, J = 8.6 Hz, 1H, 
CHPh), 5.13 (d, J = 12.0 Hz, 1H, OCH2aPh), 5. 05 (d J = 12.0 Hz, 1H, OCH2bPh), 5.02 – 4.97 (m, 2H, 
CH=CH2), 3.81 (s, 3H, OCH3), 3.80 – 3.75 (m, 1H, CH3CH), 2.73 (s, 3H, NCH3), 2.72 – 2.66 (m, 2H, 
CH2=CHCH2), 1.46 (s, 3H, CCH3), 0.73 (d, J = 6.6 Hz, 3H, CHCH3); 
13C NMR (101 MHz, CDCl3) δ 172.3 
(C=O), 170.2 (C=O), 159.7 (C-4), 155.2 (C=O), 136.6 (C-1’), 133.8 (CH2=CH), 130.5 (C-2), 128.6 (C-3’), 
128.4 (C-1’), 128.1 (C-2’), 126.9 (C-4’), 118.2 (CH2=CH), 114.0 (C-3),  66.5 (OCH2Ph), 60.4 (OCH3), 55.5 




The title compound 2.40c was obtained (0.32 g, 0.60 mmol, 95 %) as a viscous oil via the general 
alkylation method using 2.39c (0.31 g, 0.63 mmol), KHMDS (0.5 M, 1.50 ml, 0.75 mmol) and allyl 
bromide (0.06 ml, 0.75 mmol, 1.2 eq). Chiral HPLC on a C18 column eluting with ACN: H20 (70:30) 
revealed a 98:2 diastereomer ratio. Minor diastereomer retention time = 9.7 min; that of the major 
diastereomer = 6.9 min. [α]𝐷
20= -31.2°, (CHCl3, c = 1); HRMS (ES): m/z found 534.2721, C29H36N5O5 
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[M+H]+ requires 534.2716; IR vmax (cm
-1): 3055 (C-H aromatics), 2911 (C-H alkanes), 2135 (N3), 1719 
(C=O ester, amide), 1668 (C=O urea); 1H NMR (300 MHz, CDCl3) δ 7.28 – 7.06 (m, 5H, aromatic), 6.99 
(m, 2H, aromatic), 6.81 (m, 2H, aromatic), 5.36 – 5.22 (m, 1H, H-8), 5.18 (d, J = 8.7 Hz, 1H, CHPh), 
5.04 (d, J = 11.9 Hz, 1H, OCH2aPh), 4.97 (d, J = 11.9 Hz, 1H, OCH2bPh), 4.93 – 4.78 (m, 2H, H-9), 3.78 – 
3.68 (m, 4H, OCH3 and CHCH3), 3.12 (td, J = 6.8, 2.5 Hz, 2H, H-6), 2.95 – 2.84 (m, 1H, H-7a), 2.71 – 
2.61 (m, 4H, NCH3 and H-7b), 1.97 – 1.77 (m, 2H, H-5), 1.52 – 1.38 (m, 2H, H-4), 1.36 – 1.21 (m, 1H, 
H-3a), 1.14 – 0.97 (m, 1H, H-3b), 0.67 (d, J = 6.6 Hz, 3H, CHCH3).
 13C NMR (101 MHz, CDCl3) δ 171.3 
(C=O), 169.5 (C=O), 159.8 (C-4”), 155.2 (C=O), 136.5 (C-1’), 133.0 (C-8), 130.6 (C-2”), 128.5 (C-2’), 
128.2 (C-1”), 128.1 (C-3’), 127.2 (C-4’), 118.4 (C-9), 114.0 (C-3”), 66.5 (OCH2Ph), 60.5 (CHPh), 58.2 (C-





The title compound 2.40d was obtained (1.25 g, 1.97 mmol, 90 %) as a gummy solid via the general 
alkylation method using 2.39d (1.20 g, 2.20 mmol), KHMDS (0.5 M, 5.29 ml, 2.64 mmol) and benzyl 
bromide (0.32 ml, 2.64 mmol, 1.2 eq). Chiral HPLC on a C18 column eluting with ACN: H2O (70:30) 
revealed a 97:3 diastereomer ratio. Minor diastereomer retention time = 11.2 min; that of the major 
diastereomer = 13.1 min. [α]𝐷
20= -4.2°, (CHCl3, c = 1); HRMS (ES): m/z found 635.3124, C39H43N2O6 
[M+H]+ requires 635.3121; IR vmax (cm
-1): 3033 (C-H aromatics), 2891 (C-H alkanes), 1717 (C=O ester, 
amide), 1671 (C=O urea); 1H NMR (300 MHz, CDCl3) δ 7.29 – 6.92 (m, 15H, aromatic), 6.94 – 6.69 (m, 
4H, aromatic), 5.17 (d, J = 8.7 Hz, 1H, CHPh), 4.88 (d, J = 11.7 Hz, 1H, OCH2aPh), 4.77 (d, J = 11.7 Hz, 
1H, OCH2bPh), 4.42 – 4.26 (m, 2H, H-6), 3.71 (s, 3H, OCH3), 3.64 (dd, J = 8.7, 6.6 Hz, 1H, CHCH3), 3.42 
– 3.22 (m, 4H, H-7 and H-5), 2.62 (s, 3H, NCH3), 2.02 – 1.82 (m, 2H, H-3), 1.73 – 1.58 (m, 1H, H-4a), 
1.46 – 1.31 (m, 1H, H-4b), 0.65 (d, J = 6.6 Hz, 3H, CHCH3); 
13C NMR (101 MHz, CDCl3) δ 171.3 (C=O), 
169.8 (C=O), 159.9 (C-4’’’’), 155.4 (C=O), 139.1 (C-1’), 137.0 (C-1’’), 136.6 (C-1’’’), 130.8 (C-2’’’’), 130.6 
(C-3’), 128.4 (C-3’’’ and C-1’’’’), 128.0 (C-3’’), 127.9 (C-4’’’), 127.8 (C-2’’), 127.7 (C-2’), 127.5 (C-2’’’), 
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126.5 (C-4’’ and C-4’), 114.1 (C-3’’’’), 73.0 (C-6), 70.6 (C-5), 66.5 (OCH2Ph), 61.0 (CHPh), 60.0 (C-2), 
55.5 (CHCH3), 54.4 (OCH3), 40.1 (C-7), 30.6 (C-3), 28.2 (NCH3), 25.1 (C-4), 15.1 (CHCH3). 
4-Methoxybenzyl (R)-2-((4S,5R)-3,4-dimethyl-2-oxo-5-phenylimidazolidine-1-carbonyl)-2-
ethylpent-4-enoate (2.40e) 
     
The title compound 2.40e was obtained (0.997 g, 2.15 mmol, 91 %) as a viscous oil via the general 
alkylation method using 2.39e (1.00 g, 2.36 mmol), KHMDS (0.5 M, 5.66 ml, 2.83 mmol) and allyl 
bromide (0.31 ml, 3.54 mmol, 1.5 eq). Chiral HPLC on a C18 column eluting with ACN: H20 (50:50) 
revealed a 94:6 diastereomer ratio. Minor diastereomer retention time = 19.5 min; that of the major 
diastereomer = 18.0 min.  HRMS (ES): m/z found 465.2350, C27H33N2O5 [M+H]
+ requires 
465.2344; [α]𝐷
20= -53.42°, (CHCl3, c = 0.8); IR: vmax (cm
-1) 3027 (C-H aromatic), 2917 (C-H alkanes), 
1727 (C=O ester, amide), 1680 (C=O urea); 1H NMR (400 MHz, CDCl3) δ 7.30 – 7.13 (m, 5H, aromatic), 
7.05 (d, J = 6.4 Hz, 2H, aromatic), 6.92 – 6.82 (m, 2H, aromatic), 5.47 – 5.31 (m, 1H, CH2=CH), 5.25 (d, 
J = 8.6 Hz, 1H, CHPh), 5.11 (d, J = 11.9 Hz, 1H, OCH2aPh), 5.03 (d, J = 11.9, 1H, OCH2bPh) 5.00 – 4.84 
(m, 2H, CH=CH2), 3.81 (s, 3H, OCH3), 3.79 – 3.70 (m, 1H, CH3CH), 2.99 – 2.74 (m, 2H, CH2=CHCH2), 
2.72 (s, 3H, NCH3), 2.05 – 1.93 (m, 2H, CH3CH2), 0.80 (t, J = 7.6 Hz, 3H, CH2CH3), 0.73 (d, J = 6.6 Hz, 3H, 
CHCH3); 
13C NMR (101 MHz, CDCl3) δ 171.4 (C=O), 169.7 (C=O), 159.7 (C-4), 155.2 (C=O), 136.6 (C-1’), 
133.3 (CH=CH2), 130.5 (C-2), 128.5 (C-3’), 128.4 (C-1), 128.1 (C-2’), 127.2 (C-4’), 118.1 (CH2=CH), 
114.0 (C-3), 66.3 (OCH2Ph), 60.5 (OCH3), 58.8 (qC), 55.5 (CHPh), 54.3 (CHCH3), 37.6 (CH2CH=CH2), 28.2 
(NCH3), 26.3 (CH2CH3), 15.1 (CHCH3), 8.7 (CH2CH3). 
(R)-4-Methoxybenzyl 2-(3-(benzyloxy)propyl)-2-((4S,5R)-3,4-dimethyl-2-oxo-5-
phenylimidazolidine-1-carbonyl)pent-4-enoate (2.40f) 
            
The title compound 2.40f was prepared (1.771 g, 3.03 mmol, 97 %) as a thick gum via the general 
alkylation procedure using 2.39d (1.700 g, 3.12 mmol), KHMDS in toluene (0.5 M, 7.50 ml, 3.74 
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mmol) and allyl bromide (0.43 ml, 4.99 mmol). Chiral HPLC on a C18 column eluting with ACN: H20 
(50:50) revealed a 98:2 diastereomer ratio. Major diastereomer retention time = 10.3 min; that of 
the minor diastereomer = 11.4 min. HRMS (ES): m/z found 585.2971, C35H41N2O6 [M+H]
+ requires 
585.2965; [α]𝐷
20= -36.9° (DCM, c = 1); IR: vmax (cm
-1) 3033 (C-H Aromatics), 2866 (C-H alkanes), 1734 
(C=O ester), 1674 (C=O imide); 1H NMR (400 MHz, CDCl3) δ 7.35 – 7.11 (m, 10H, aromatic), 7.04 (d, J 
= 6.5 Hz, 2H, aromatic), 6.87 (d, J = 8.7 Hz, 2H, aromatic), 5.47 – 5.32 (m, 1H, CH=CH2), 5.22 (d, J = 8.6 
Hz, 1H, CHPh), 5.07 (d, J = 11.9 Hz, 1H, OCH2aPhOMe), 5.05 (d, J = 11.9 Hz, 1H, OCH2bPhOMe), 4.97 
(dd, J = 17.0, 2.1 Hz, 1H, CH=CH2a), 4.88 (dd, J = 10.1, 2.1 Hz, 1H, CH=CH2b), 4.43 (s, 2H, OCH2Ph), 
3.79 (s, 3H, OCH3), 3.75 – 3.64 (m, 1H, CHCH3), 3.49 – 3.31 (m, 2H, H-3), 2.98 – 2.85 (m, 1H, 
CH2=CHCH2), 2.80 – 2.70 (m, 1H, CH2=CHCH2), 2.67 (s, 3H, NCH3), 2.13 – 1.94 (m, 2H, H-2), 1.72 – 1.51 
(m, 1H, H-1), 1.47 – 1.29 (m, 1H, H-1), 0.70 (d, J = 6.6 Hz, 3H, CHCH3); 
13C NMR (101 MHz, CDCl3) δ 
171.16 (C=O), 169.42 (C=O), 159.6 (C-4’), 155.1 (C=O), 138.8 (C-1’’’), 136.52 (C-1’’), 133.1 (CH=CH2), 
130.5 (C-2’), 128.4 (C-3’’’), 128.4 (C-3’’), 128.3 (C-1’), 128.0 (C-2’’’), 127.7 (C-4’’), 127.5 (C-2’’), 127.1 
(C-4’’’), 118.2 (CH=CH2), 113.9 (C-3’), 72.7 (OCH2Ph), 70.3 (C-3), 66.3 (OCH2PMB), 60.4 (CHPh), 58.1 
(Cq), 55.3 (CHCH3), 54.0 (OCH3), 38.0 (CH2=CHCH2), 29.8 (NCH3), 28.01 (C-1), 24.5 (C-2), 14.9 (CHCH3). 
4-Methoxybenzyl (S)-2-benzyl-2-((4S,5R)-3,4-dimethyl-2-oxo-5-phenylimidazolidine-1-
carbonyl)pent-4-enoate (2.40g) 
         
The title compound 2.40g was obtained (0.896 g, 1.70 mmol, 92 %) as a clear oil via the general 
alkylation method using 2.39a (0.900 g, 1.85 mmol), KHMDS (0.5 M, 4.44 ml, 2.22 mmol) and allyl 
bromide (0.24 ml, 2.78 mmol, 1.5 eq). Chiral HPLC on a C18 column eluting with ACN: H20 (75:25) 
revealed a 96:4 diastereomer ratio. Minor diastereomer retention time = 4.2 min; that of the major 
diastereomer = 5.0 min. [α]𝐷
20= -25.4, (DCM, c = 1); HRMS (ES): m/z found 527.2522, C32H35N2O5 
[M+H]+ requires 527.2501; IR: vmax (cm
-1) 3067 (C-H aromatic), 2925 (C-H aliphatic), 1727 (C=O ester, 
amide), 1572 (C=O urea); 1H NMR (400 MHz, CDCl3) δ 7.26 – 7.14 (m, 10H, aromatic), 7.08 (m, 2H, 
aromatic), 6.93 – 6.87 (m, 2H, aromatic), 5.68 – 5.54 (m, 1H, CH=CH2), 5.17 (d, J = 8.6 Hz, 1H, CHPh), 
5.12 (d, J = 2.0 Hz, 1H, CH2a=CH), 5.05 (d, J = 11.9 Hz, 1H, OCH2aPh), 5.03 – 4.98 (m, 1H, CH2b=CH), 
4.93 – 4.84 (m, 1H, OCH2bPh), 3.85 (s, 3H, OCH3), 3.80 – 3.71 (m, 1H, CH3CH), 3.46 (d, J = 13.7 Hz, 1H, 
CH2aPh), 3.43 – 3.28 (m, 1H, CH2aCH=CH2), 2.97 (m, 1H, CH2bCH=CH2), 2.86 (d, J = 15.8 Hz, 1H, 
CH2bPh), 2.77 (s, 3H,NCH3), 0.77 (d, J = 6.6 Hz, 3H, CHCH3); 
13C NMR (101 MHz, CDCl3) δ 170.9 (C=O), 
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168.8 (C=O), 159.7 (C-4’), 155.2 (C=O), 137.2(C-1’’), 136.4 (C-1’’’), 133.5 (CH2=CH), 130.5 (C-2’ andC-
3’’’), 128.4 (C-3’’), 128.1 (C-2’’ and C-2’’’), 128.0(C-1’), 127.1 (C-4’’’), 126.8 (C-4’’), 118.4 (CH2=CH), 
113.9 (C-3’), 66.4 (OCH2Ph), 60.5 (OCH3), 60.2 (C-2), 55.4 (CHPh), 54.3 (CHCH3), 39.5 (CH2=CHCH2), 
39.2 (CH2Ph), 28.2 (NCH3), 15.0 (CHCH3). 
General PMB removal procedure and modified Curtius rearrangement procedure to obtain ATAs 
2.44a to 2.44f from disubstituted auxiliary PMB malonates 240a – 2.40f: 
 
The appropriate disubstituted auxiliary malonate PMB ester (1 eq) was dissolved in DCM and anisole 
(1.2 eq) was added. Trifluoroacetic acid (6 eq) was introduced slowly via syringe, and the reaction 
stirred at room temperature for 2 hours.  Solvent and excess TFA were removed on the rotary 
evaporator and the crude mixture chromatographed using ethyl acetate/hexane (70/30) to afford 
the corresponding disubstituted auxiliary acid. The quaternary acid derivative (1 eq) was dissolved in 
acetonitrile (0.01M), and Et3N (2 eq) and diphenyphosphoryl azide (1.2 eq) were successively added. 
The mixture was allowed to stir at room temperature for 3 hours after which time the solvent was 
removed in vacuo and the residue flash chromatographed with ethyl acetate/ hexane (10/90) to give 
the acyl azide as a clear gum. This was immediately committed to the next step, whereby it was 
dissolved in acetonitrile (0.01M) and refluxed at 85 °C. The rearrangement to isocyanate was 
complete within 6 hours as evidenced by TLC. The reaction was cooled to 60 °C and HCl (6M) was 
added to effect the hydrolysis (30 minutes). The reaction mixture was then cooled to RT and the 
amine isolated by extractive work up. Thus, after removal of acetonitrile, water was added and the 
mixture extracted once with diethyl ether to remove non-amine material. The aqueous layer was 
then treated with sodium hydroxide solution (5 %) until pH 10 -12 to liberate the amine from its 
hydrochloride salt and extracted with three times with ethyl acetate and once with 
chloroform/ethanol (75/25). The organic extracts were washed with brine, dried over anhydrous 




The disubstituted auxiliary malonate PMB ester 2.40a (0.620 g, 1.51 mmol) was subjected to the 
general procedure for PMB removal using anisole (0.20 ml, 1.82 mmol, 1.2 eq) and TFA (0.69 ml, 
9.06 mmol, 6 eq) to give benzyl, methyl- substituted auxiliary acid 2.41a (0.492 g, 1.43 mmol, 95 %) 
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as a clear oil. This was then committed to the general modified procedure for Curtius rearrangement 
with Et3N (0.40 ml, 2.86 mmol, 2 eq), DPPA (0.37 ml, 1.72 mmol, 1.2 eq) and HCl (5M, 2 ml) for the 
hydrolysis, yielding α-tertiary amine 2.44a (0.397 g, 1.13 mmol, 79 % from the acid) as a colourless 
liquid.  
1H NMR (400 MHz, CDCl3) δ 7.38 – 7.11 (m, 8H, aromatic), 7.05 – 6.95 (m, 2H, aromatic), 5.11 (d, J = 
8.5 Hz, 1H, CHPh), 1), 3.75 – 3.69 (m, 1H, CH3CH), 3.28 (d, J = 13.7 Hz, 1H, CH2aPh), 3.22 (d, J = 13.7 




The disubstituted auxiliary malonate PMB ester 2.40b (0.760 g, 1.69 mmol) was subjected to the 
general procedure for PMB removal using anisole (0.22 ml, 2.03 mmol, 1.2 eq) and TFA (0.77 ml, 
10.14 mmol, 6 eq) to give allyl, methyl-substituted auxiliary acid 2.41b (0.525 g, 1.59 mmol, 94 %) as 
a clear oil. All of the acid was then committed to the general modified procedure for Curtius 
rearrangement with Et3N (0.45 ml, 3.18 mmol, 2 eq), DPPA (0.40 ml, 1.87 mmol, 1.2 eq) and HCl (5M, 
3 ml) for the hydrolysis, yielding allyl, methyl-substituted auxiliary α-tertiary amine 2.44b (0.422 g, 
1.40 mmol, 88 % from the acid) as a colourless liquid. 
1H NMR (300 MHz, CDCl3) δ 7.29 – 7.19 (m, 3H, aromatic), 7.13 – 7.01 (m, 2H, aromatic), 5.80 – 5.62 
(m, 1H, H-4), 5.22 (d, J = 8.4 Hz, 1H, CHPh), 5.09 – 4.95 (m, 2H, H-5), 3.94 – 3.78 (m, 1H, CHCH3), 2.77 
(s, 3H, NCH3), 2.58 (dd, J = 13.7, 8.1 Hz, 1H, H-3a), 2.43 (dd, J = 13.7, 8.1 Hz, 1H, H-3b), 2.25 (broad s, 








 (4S,5R)-1-((R)-2-Allyl-2-amino-6-azidohexanoyl)-3,4-dimethyl-5-phenylimidazolidin-2-one (2.44c) 
 
The disubstituted auxiliary malonate PMB ester 2.40c (0.850 g, 1.59 mmol) was subjected to the 
general procedure for PMB removal using anisole (0.20 ml, 1.91 mmol, 1.2 eq) and TFA (0.72 ml, 
9.54 mmol, 6 eq) to give the disubstituted auxiliary acid 2.41c (0.566 g, 1.37 mmol, 86  %) as a clear 
oil. All of the acid was then committed to the general modified procedure for Curtius rearrangement 
with Et3N (0.39 ml, 2.72 mmol, 2 eq), DPPA (0.41 ml, 1.90 mmol, 1.2 eq) and HCl (5 M, 4 ml) for the 
hydrolysis, yielding α-tertiary amine 2.44c (0.447 g, 1.16 mmol, 85 %) as a colourless liquid. 
1H NMR (300 MHz, CDCl3) δ 7.32 – 7.15 (m, 3H, aromatic), 7.08 (m, 2H, aromatic), 5.54 – 5.33 (m, 1H, 
H-8), 5.25 (d, J = 8.5 Hz, 1H, CHPh), 5.08 – 4.85 (m, 2H, H-9), 3.87 (dt, J = 8.5, 6.6 Hz, 1H, CHCH3), 3.20 
– 3.09 (m, 2H, H-6), 2.79 (s, 2H, NH2), 2.76 (s, 3H, NCH3), 2.74 – 2.65 (m, 1H, H-7a), 2.40 (dd, J = 13.7, 
8.0 Hz, 1H, H-7b), 1.98 – 1.82 (m, 1H, H-3a), 1.79 – 1.66 (m, 1H, H-3b), 1.56 – 1.41 (m, 2H, H-5), 1.35 




The disubstituted auxiliary malonate PMB ester 2.40d (1.200 g, 1.89 mmol) was subjected to the 
general procedure for PMB removal using anisole (0.24 ml, 2.27 mmol, 1.2 eq) and TFA (0.87 ml, 
11.34 mmol, 6 eq) to give the disubstituted auxiliary acid 2.41d (0.885 g, 1.72 mmol, 91 %) as a clear 
oil. All of the acid was then committed to the general modified procedure for Curtius rearrangement 
with Et3N (0.49 ml, 3.44 mmol, 2 eq), DPPA (0.44 ml, 2.06 mmol, 1.2 eq) and HCl (5M, 5 ml) for the 




1H NMR (300 MHz, CDCl3) δ 7.31 – 7.16 (m, 10H, aromatic), 7.12 – 6.98 (m, 5H, aromatic), 5.20 (d, J = 
8.4 Hz, 1H, CHPh), 4.37 (s, 2H,H-6), 3.93 – 3.78 (m, 1H, CHCH3), 3.45 (d, J = 13.3 Hz, 1H, H-7a), 3.40 – 
3.26 (m, 2H, H-5), 2.79 (d, J = 13.3 Hz, 1H, H-7b), 2.76 (s, 3H, NCH3), 2.40 (broad s, 2H, NH2), 2.05 – 
1.90 (m, 1H, H-3a), 1.75 – 1.44 (m, 3H, H-3b and H-4), 0.72 (d, J = 6.6 Hz, 3H, CHCH3). 
 (4S,5R)-1-((R)-2-Amino-2-ethylpent-4-enoyl)-3,4-dimethyl-5-phenylimidazolidin-2-one (2.44e) 
 
The disubstituted auxiliary malonate PMB ester 2.40e (0.700 g, 1.51 mmol) was subjected to the 
general procedure for PMB removal using anisole (0.20 ml, 1.82 mmol, 1.2 eq) and TFA (0.69 ml, 
9.06 mmol, 6 eq) to give ethyl, allyl- substituted auxiliary acid 2.41e (0.492 g, 1.43 mmol, 95 %) as a 
clear oil. This was then committed to the general modified procedure for Curtius rearrangement 
with Et3N (0.40 ml, 2.86 mmol, 2 eq), DPPA (0.37 ml, 1.72 mmol, 1.2 eq) and HCl (5M, 2 ml) for the 
hydrolysis, yielding α-tertiary amine 2.44e (0.366 g, 1.16 mmol, 81 % from the acid) as a colourless 
liquid.  
1H NMR (400 MHz, CDCl3) δ 7.60 – 7.50 (m, 2H, aromatic), 7.36 – 7.26 (m, 3H, aromatic), 5.53 – 5.39 
(m, 1H, CH2=CH), 5.14 – 4.91 (m, 2H, CH=CH2), 4.87 (d, J = 8.9 Hz, 1H, CHPh), 4.11 – 3.98 (dq, J = 10.6, 
6.3 Hz, 1H, CH3CH), 2.35 – 2.29 (m, 2H, CH3CH2), 2.34 (s, 3H, NCH3), 1.80 (m, 1H, CH2=CHCH2a), 1.58 
(m, 1H, CH2=CHCH2b), 1.26 (broad s, 2H, NH2), 1.18 (d, J = 6.3 Hz, 3H, CHCH3), 0.64 (t, J = 7.4 Hz, 3H, 
CH2CH3); 
13C NMR (101 MHz, CDCl3) δ 175.8 (C=O), 156.9 (C=O), 137.5 (Arq), 130.4 (CH=CH2), 129.1 
(Ar), 128.9 (Ar), 128.6 (Ar), 120.9 (CH=CH2), 65.1 (Cq), 60.7 (CHPh), 53.1 (CHCH3), 41.5 (CH2CH=CH2), 










4-enoic acid (2.41f) 
          
The title acid 2.41f was prepared (0.389 g, 0.838 mmol, 98 %) as a colourless oil via the general 
procedure for PMB removal from the disubstituted auxiliary malonate derivative 2.40f (0.500 g, 0.86 
mmol), with anisole (0.11 ml, 1.03 mmol, 1.2 eq) and TFA (0.40 ml, 5.13 mmol, 6 equivalents).  
HRMS (ES): m/z found 465.2332, C27H33N2O5 [M+H]
+ requires 465.2345; [α]𝐷
20= -45.7° (DCM, c= 1);  
IR: vmax (cm
-1) 3431 (OH), 3056 (C-H aromatics), 2978 (C-H alkanes), 1732 (C=O carboxylic acid), 1677 
(C=O imide); 1H NMR (400 MHz, CDCl3) δ 7.35 – 7.21 (m, 10H, aromatic), 5.44 – 5.35 (m, 1H, 
CH=CH2), 5.31 (d, J = 8.7 Hz, 1H, CHPh), 5.05 – 4.86 (m, 2H, CH=CH2), 4.44 (s, 2H, OCH2Ph), 3.99 – 
3.82 (m, 1H, CHCH3), 3.51 – 3.30 (m, 2H, H-3), 3.11 – 2.96 (m, 1H, CH2=CHCH2a), 2.73 (s, 3H, NCH3), 
2.82 – 2.60 (m, 1H, H-1a), 2.04 – 1.94 (m, 2H, H-1b + CH2=CHCH2b), 1.74 – 1.59 (m, 1H, H-2a), 1.56 – 
1.42 (m, 1H, H-2b), 0.75 (d, J = 6.5 Hz, 3H, CHCH3); 
13C NMR (101 MHz, CDCl3) δ 173.2 (C=O), 166.8 
(C=O), 137.5 (C-1’’), 136.3 (C-1’), 133.1 (CH=CH2), 128.5 (C-3’’), 127.9 (C-3’) 127.7 (C-2’’), 127.4 (C-2’), 
127.2 (C-4’), 127.0 (C-4’’), 119.6 (CH2=CH), 73.5 (OCH2Ph), 72.9 (C-3), 60.6 (CHPh), 58.7 (Cq), 54.2 




The disubstituted auxiliary acid 2.41f (0.100 g, 0.215 mmol) was dissolved in acetonitrile (50 ml) and 
triethylamine (0.06 ml, 0.43 mmol, 2 eq) and DPPA (0.056 ml, 0.258 mmol, 1.2 eq) were added 
successively. The mixture was allowed to stir at room temperature for 3 hours, following which the 
solvent was evaporated and the residue chromatographed using EtOAc/ hexanes (10/90), yielding 
the acyl azide product 2.42f (0.097g, 0.198 mmol, 92 %). Acyl azide 2.42f was re-dissolved in CH3CN 
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and refluxed for 4 hours. Once concentrated, the residue was chromatographed with EtOAc/hexane 
(15/85) giving the isocyanate 2.43f (0.082 g, 0.178 mmol, 90 %) as a colourless crystalline solid. M. p. 
84 – 86 °C (DCM/hexane); HRMS (ES): m/z found 462.2396 [M+H]+ for C27H31N3O4 requires 462.2393; 
[α]𝐷
20 = -38.5° (DCM, c = 1); IR: vmax (cm
-1) 3033 (C-H aromatic), 2909 (C-H aliphatic), 2253 (NCO), 
1731 (C=O), 1692 (C=O imide); 1H NMR (400 MHz, CDCl3) δ 7.39 – 7.10 (m, 10H, aromatic), 5.81 – 
5.53 (m, 1H, CH=CH2), 5.25 (d, J = 8.3 Hz, 1H, CHPh), 5.15 – 4.92 (m, 2H, CH=CH2), 4.39 (s, 2H, 
OCH2Ph), 3.86 (dq, J = 8.3, 6.6 Hz, 1H, CHCH3), 3.41 – 3.32 (m, 2H, H-3), 3.31 – 3.23 (m, 1H, 
CH2=CHCH2a), 2.75 (s, 3H, NCH3), 2.75 – 2.70 (m, 1H, H-1a), 2.55 -2.46 (m, 1H, CH2=CHCH2b), 1.96 (m, 
1H, H-1b), 1.70 – 1.58 (m, 1H, H-2a), 1.40 – 1.21 (m, 1H, H-2b), 0.79 (d, J = 6.6 Hz, 3H, CHCH3); 
13C 
NMR (101 MHz, CDCl3) δ 170.1 (C=O), 154.1 (C=O), 138.5 (C-1’’), 136.1 (C-1’), 132.5 (CH=CH2), 128.3 
(C-3’’), 128.1 (C-3’ and C-2’’), 127.3 (C-2’), 127.2 (C-4’), 126.9 (C-4’’), 125.3 (NC=O), 119.0 (CH2=CH), 
72.5 (OCH2Ph), 72.4 (C-3), 69.6 (CNCO), 62.0 (CHPh), 53.8 (CHCH3), 40.9 (CH2=CHCH2), 33.1 (C-1), 28.1 
(NCH3), 24.4 (C-2), 14.6 (CHCH3). 
(4S,5R)-1-((R)-2-Amino-2-(3-(benzyloxy)propyl)pent-4-enoyl)-3,4-dimethyl-5-phenylimidazolidin-2-
one (2.44f) 
       
The disubstituted auxiliary malonate derivative 2.40f (0.500 g, 0.86 mmol), was  subjected to the 
general procedure for PMB removal using anisole (0.11 ml, 1.03 mmol, 1.2 eq) and TFA (0.40 ml, 
5.13 mmol, 6 equivalents) to deliver the quaternary acid 2.41f (0.389 g, 0.84 mmol, 98 %) as a 
colourless oil. This was then committed to the general modified Curtius rearrangement procedure 
using Et3N (0.22 ml, 1.68 mmol, 2 eq), DPPA (0.20 ml, 1.68 mmol, 1.2 eq) and HCl (6 M, 5.00 ml) in 
the hydrolysis step to give the α-tertiary amine 2.44f (0.300 g, 0.69 mmol, 82 %) as a light yellow oil. 
HRMS (ES): m/z found 436.2612 [M+H]+ for C26H34N3O3 requires 436.2600; [α]𝐷
20= -23.2° (DCM, c = 1); 
IR: vmax (cm
-1) 3392 (NH), 3054 (C-H aromatic), 2987 (C-H alkanes), 1716  (C=O), 1671 (C=O imide); 1H 
NMR (400 MHz, CDCl3) δ 7.29 – 7.16 (m, 8H, aromatic), 7.09 – 7.06 (m, 2H, aromatic), 5.54 – 5.39 (m, 
1H, CH2=CH), 5.24 (d, J = 8.5 Hz, 1H, CHPh), 5.03 – 4.96 (m, 2H, CH2=CH), 4.41 (s, 2H, OCH2Ph), 3.83 
(dq, J = 8.5, 6.6 Hz, 1H, CHCH3), 3.46 – 3.33 (m, 2H, H-3), 2.74 (s, 3H, NCH3), 2.70 (dd, J = 14.0, 7.9 Hz, 
1H, CH2=CHCH2a), 2.46 (dd, J = 14.0, 7.9, 1H, CH2=CHCH2b), 2.17 (broad s, 2H, NH2), 1.94 – 1.76 (m, 
2H, H-1), 1.63 – 1.45 (m, 2H, H-2), 0.74 (d, J = 6.6 Hz, 3H, CHCH3); 
13C NMR (101 MHz, CDCl3) δ 175.9 
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(C=O), 155.8 (C=O), 138.9 (C-1’’), 137.1 (C-1’), 133.8 (CH=CH2), 128.6 (C-3’’), 128.42 (C-3’), 128.1 (C-
2’’), 127.7 (C-2’), 127.5 (C-4’), 127.0 (C-4’’), 118.7 (CH2=CH), 72.9 (OCH2Ph), 70.8 (C-3) , 62.6 (CHPh), 
61.5 (CNH2),  54.2 (CHCH3), 42.4 (CH2=CHCH2), 34.0 (C-1), 28.5 (NCH3), 24.5 (C-2), 15.2 (CHCH3).   
Methanolysis procedure for conversion of derivatives 2.44a – 2.44d to give methyl ester amino acid 
derivatives 2.46a to 2.46d 
The appropriate ATA was placed in anhydrous MeOH (50 ml), and NaOMe (1M, 1.1 eq) was 
introduced via dropwise addition. The reaction was stirred for 1 hour after which time water (10 ml) 
was added and the methanol removed on a rotary evaporator. The aqueous mixture was extracted 
with ethyl acetate (2 x 20 ml) and once with chloroform/ ethanol (75/25, 20 ml) and the pooled 
organic fractions were dried with anhydrous MgSO4, filtered and concentrated. Chromatographic 
purification of products was carried out using MeOH/ DCM (5/95 to 10/90).  
Methyl (S)-2-amino-2-methyl-3-phenylpropanoate (2.46a)  
 
Amino acid methyl ester 2.46a was obtained (0.195 g, 1.01 mmol, 79 %) as a viscous oil via the 
general methanolysis procedure from ATA 2.44a (0.450 g, 1.28 mmol) and NaOMe (1.40 ml) as a 
clear gum. Auxiliary (-)-2.29 was also recovered (0.249 g, 1.31 mmol, 95 %) as tan needle-like 
crystals. Chiral HPLC on an AD column eluting with IPA: Hex (10:90) revealed a 97:3 enantiomeric 
ratio. Minor enantiomer retention time = 10.1 min; that of the major enantiomer = 11.3 min. HRMS 
(ES): m/z found 194.1175, C11H16NO2 [M+H]
+ requires 194.1172; [α]𝐷
20= -8.2°, (CHCl3, c = 0.67), [lit. 
[α]𝐷
20= -14.1° (CHCl3, c = 1.6)]
151; IR: vmax (cm
-1) 3374 (NH2), 3027 (C-H aromatics), 2956 (C-H alkanes), 
1731 (C=O), 1601 (NH bend); 1H NMR (400 MHz, CDCl3) δ 7.21 – 7.12 (m, 3H, aromatic), 7.08 – 7.03 
(m, 2H, aromatic), 3.61 (s, 3H, OCH3), 3.04 (d, J = 13.2 Hz, 1H, CH2aPh), 2.72 (d, J = 13.2 Hz, 1H, 
CH2bPh), 1.63 (broad s, 2H, NH2), 1.30 (s, 3H, CCH3); 
13C NMR (101 MHz, CDCl3) δ 177.6 (C=O), 136.7 






Methyl (S)-2-benzamido-2-methylpent-4-enoate (2.47) 
 
The general methanolysis procedure using ATA 2.44b (0.400 g, 1.33 mmol) and NaOMe (1M, 1.46 
ml) furnished the α-allyl alanine methyl ester 2.46b (0.144, 1.01 mmol, 76 %) as a light yellow gum 
which was then taken up in DCM (20 ml) and anhydrous pyridine (0.12 ml, 1.46 mmol, 1.2 eq) was 
added followed by benzoyl chloride (0.17 ml, 1.46 mmol, 1.2 eq) and the reaction was left to stir for 
6 hours. No work-up was performed; after removal of DCM on the rotary evaporator the residue was 
chromatographed with ethyl acetate/ hexane (40/60) giving N-benzoyl α-allyl alanine methyl ester 
2.47 (0.230 g, 0.929 mmol, 92 %) as a light-yellow gum. Auxiliary (-)-2.29 was recovered (0.240 g, 
1.26 mmol, 90 %) as yellowish needle-like crystals from the methanolysis reaction. Chiral HPLC on an 
AD column eluting with IPA: Hex (10:90) revealed a 98:2 enantiomeric ratio. Minor enantiomer 
retention time 6.3 min; that of the major enantiomer 7.1 min HRMS (ES): m/z found 248.1291, 
C14H18NO3 [M+H]
+ requires 248.1287;[α]𝐷
20= +9.80°, (CHCl3, c = 1), [lit.[α]𝐷
20
 = +9.74° (CHCl3, c = 
1.0)];150 IR: vmax (cm
-1) 3346 (NH), 3067 (C-H aromatics), 2929 (C-H alkanes), 1731 (C=O), 1640 (C=O); 
1H NMR (400 MHz, CDCl3) δ 7.82 – 7.68 (m, 2H, aromatic), 7.51 – 7.34 (m, 3H, aromatic), 6.92 (s, 1H, 
NH), 5.81 – 5.59 (m, 1H, CH2=CH), 5.23 – 5.06 (m, 2H, CH=CH2), 3.80 (s, 3H, OCH3), 3.20 – 2.99 (m, 
1H, CH2=CHCH2a), 2.68 (m, 1H, CH2=CHCH2b), 1.73 (s, 3H, CCH3); 
13C NMR (101 MHz, CDCl3) δ 174.8 
(C=O), 166.6 (C=O), 135.0 (Arq), 132.6 (CH=CH2), 131.7 (Ar), 128.7 (Ar), 127.0 (Ar), 119.7 (CH=CH2), 
60.4 (Cq), 52.9 (OCH3), 40.9 (CH2CH=CH2), 23.1 (CH3). 
Methyl (R)-2-allyl-6-azido-2-benzamidohexanoate (2.49) 
  
The general methanolysis procedure using ATA 2.44c (0.400 g, 1.04 mmol) and NaOMe (1M, 1.25 ml) 
furnished the quaternary amino acid methyl ester 2.46c (0.185 g, 0.822 mmol, 78 %) as a gummy 
solid which was then taken up in DCM (20 ml) and anhydrous pyridine (0.16 ml, 2.06 mmol, 2.5 eq) 
was added followed by benzoyl chloride (0.110 ml, 0.986 mmol, 1.2 eq) and the reaction was left to 
167 
 
stir for 6 hours. No work-up was performed; after removal of DCM on the rotary evaporator the 
residue was chromatographed with ethyl acetate/ hexane (40/60) giving N-benzoyl ester 2.49 (0.239 
g, 0.723 mmol, 88 %) as a light-yellow gum. Auxiliary (-)-2.29 was recovered (0.180 g, 0.946 mmol, 
91 %) as yellowish needle-like crystals from the methanolysis reaction. Chiral HPLC on an AD column 
eluting with IPA: Hex (10:90) revealed a 98:2 enantiomeric ratio. Minor enantiomer retention time = 
9.1 min; that of the major enantiomer = 8.1 min HRMS (ES): m/z found 331.1771, C17H23N4O3 [M+H]
+ 
requires 331.1770 ;[α]𝐷
20= -15.75°, (CHCl3, c = 1); IR: vmax (cm
-1) 3329 (NH), 3071 (C-H aromatics), 
2945 (C-H alkanes), 2090 (N3) 1728 (C=O), 1654 (C=O) 
1H NMR (400 MHz, CDCl3) δ 7.83 – 7.71 (m, 2H, 
aromatic), 7.61 – 7.36 (m, 3H, aromatic), 7.15 (broad s, 1H, NH), 5.70 – 5.51 (m, 1H, H-8), 5.13 – 5.01 
(m, 2H, H-9), 3.83 (s, 3H, OCH3), 3.39 (dd, J = 13.9, 7.3 Hz, 1H, H-7a), 3.30 – 3.14 (m, 2H, H-6), 2.70 
(ddd, J = 13.6, 12.0, 4.6 Hz, 1H, H-3a), 2.57 (dd, J = 13.9, 7.3 Hz, 1H, H-7b), 1.90 (ddd, J = 13.6, 12.0, 
4.6 Hz, 1H, H-3b), 1.64 – 1.50 (m, 2H, H-5), 1.48 – 1.29 (m, 1H, H-4a), 1.23 – 1.04 (m, 1H, H-4b); 13C 
NMR (101 MHz, CDCl3) δ 174.4 (C=O), 166.4 (C=O), 135.1 (Arq), 132.3 (C-8), 131.7 (Ar), 128.8 (Ar), 
127.0 (Ar), 119.3 (C-9), 65.3 (C-2), 53.1 (C-6), 51.2 (OCH3), 39.7 (C-7), 34.5 (C-3), 28.7 (C-5), 21.7 (C-4). 
Methyl (R)-2-amino-2-benzyl-5-(benzyloxy)pentanoate (2.46d) 
 
Title quaternary amino acid methyl ester 2.46d was obtained (0.140 g, 0.43 mmol, 73 %) as a clear 
oil via the general methanolysis procedure from ATA 2.44d (0.300 g, 0.59 mmol) and NaOMe (1M, 
0.71 ml). Auxiliary (-)-2.29 was also recovered (0.098 g, 0.52 mmol, 88 %) as tan needle-like crystals. 
1H NMR (300 MHz, CDCl3) δ 7.34 – 7.14 (m, 8H, aromatic), 7.12 – 6.98 (m, 2H, aromatic), 4.42 (s, 2H, 
H-6), 3.62 (s, 3H, OCH3), 3.41 (t, J = 6.3 Hz, 2H, H-5), 3.11 (d, J = 13.2 Hz, 1H, H-7a), 2.73 (d, J = 13.2 
Hz, 1H, H-7b), 2.00 – 1.88 (m, 1H, H-3a), 1.85 (broad s, 2H, NH2), 1.65 (m, 1H, H-3b), 1.54 – 1.39 (m, 






Synthesis of quaternary lysine derivative 
Methyl (R)-2-allyl-2-benzamido-6-((tert-butoxycarbonyl)amino)hexanoate (2.50) 
 
Quaternary amino acid methyl ester 2.49 (0.065 g, 0.196 mmol) and PPh3 (0.103 g, 0.393 mmol, 2 
equivalents) were dissolved in THF/H20 (6/1, 30 ml) and stirred at rt for 9 hours, followed by the 
addition of Boc2O (0.085 g, 0.393 mmol, 2 equivalents) in THF (5 ml). The protection step was 
complete within 15 minutes as indicated by tlc, following which the THF was removed on the rotary 
evaporator and water (5 ml) and EtOAc (15 ml) were added. The aqueous layer was extracted with 
EtOAc (3 x 10 ml) and the combined organic fractions dried over MgSO4, filtered and concentrated 
under reduced pressure.  The resultant residue was chromatographed using EtOAc/ hexanes (15/85) 
delivering the title quaternary lysine amino acid methyl ester derivative 2.50 (0.046 g, 0.149 mmol, 
76 %) as a light-yellow thick oil. Chiral HPLC on an AD column eluting with IPA: Hex (10:90) revealed 
a 98:2 enantiomeric ratio. Minor enantiomer retention time = 12.8 min; that of the major 
enantiomer = 9.9 min HRMS (ES): m/z found 405.2389,  C22H33N2O5 [M+H]
+ requires 405.2380; [α]𝐷
20= 
-12.8°, (CHCl3, c = 1); IR: vmax (cm
-1): 3407 (NH), 3339 (NH) 3071 (C-H aromatics), 2929 (C-H alkanes), 
1733 (C=O ester), 1686 (C=O) 1654 (C=O);1H NMR (300 MHz, CDCl3) δ 7.78 – 7.66 (m, 2H, aromatic), 
7.57 – 7.27 (m, 3H, aromatic), 7.08 (s, 1H, NHBz), 5.69 – 5.36 (m, 1H, H-8), 5.06 – 4.78 (m, 2H, H-9), 
4.49 (broad s, 1H, NHBoc), 3.74 (s, 3H, OCH3), 3.28 (dd, J = 13.9, 7.3 Hz, 1H, H-7a), 3.01 – 2.86 (m, 2H, 
H-6), 2.68 – 2.54 (m, 1H, H-3a), 2.51 (dd, J = 13.9, 7.3 Hz, 1H, H-7b), 1.88 – 1.72 (m, 1H, H-3b), 1.47 – 
1.36 (m, 2H, H-5), 1.33 (s, 9H, tBu), 1.29 – 1.22 (m, 1H, H-4a), 1.10 – 0.87 (m, 1H, H-4b); 13C NMR 
(101 MHz, CDCl3) δ 174.4 (C=O), 166.4 (C=O), 156.1 (C=O), 135.1 (Arq), 132.4 (C-8), 131.6 (Ar), 128.7 
(Ar), 127.0 (Ar), 119.2 (Ar), 79.2 (Cq t-Bu), 65.2 (C-2), 53.0 (OCH3), 40.2 (C-6), 39.7 (C-7), 34.6 (C-3), 







Synthesis of quaternary proline derivative 
Methyl (R)-2-benzyl-5-(benzyloxy)-2-((tert-butoxycarbonyl)amino)pentanoate (2.53) 
 
Quaternary amino acid methyl ester 2.46d (0.170 g, 0.519 mmol) was dissolved in t-BuOH (60 ml) 
and to this was added Boc2O (0.170 g, 0.779 mmol, 1.5 equivalents) and the mixture allowed to stir 
overnight at rt. No work-up was performed and following removal of t-BuOH on the rotary 
evaporator, the residue was chromatographed using EtOAc/ hexanes (10/90) furnishing the Boc- 
protected amino acid methyl ester 2.53 (0.169 g, 0.395 mmol, 76 %) as a gummy liquid. Chiral HPLC 
on an AD column eluting with IPA: Hex (10:90) revealed a 96:4 enantiomeric ratio. Minor enantiomer 
retention time = 12.1 min; that of the major enantiomer = 10.7 min HRMS (ES): m/z found 428.2440,  
C25H34NO5 [M+H]
+ requires 428.2437 ;[α]𝐷
20= -42.5°, (CHCl3, c = 1); IR: vmax (cm
-1) 3332 (NH), 2955 (C-H 
aromatics), 2919 (C-H alkanes), 1733 (C=O), 1670 (C=O); 1H NMR (300 MHz, CDCl3) δ 7.24 – 7.10 (m, 
8H, aromatic), 7.03 – 6.91 (m, 2H, aromatic), 5.30 (broad s, 1H, NH), 4.40 (s, 2H, H-6), 3.66 (s, 3H, 
OCH3), 3.52 (d, J = 13.3 Hz, 1H, H-7a), 3.45 – 3.31 (m, 2H, H-5), 3.03 (d, J = 13.3 Hz, 1H, H-7b), 2.47 – 
2.29 (m, 1H, H-3a), 1.95 – 1.83 (m, 1H, H-3b), 1.65 – 1.50 (m, 1H, H-4a), 1.39 (s, 9H, t-Bu), 1.36 – 1.26 
(m, 1H, H-4b). 13C NMR (101 MHz, CDCl3) δ 173.6 (C=O), 154.2 (C=O), 138.7 (C-1’), 136.7 (C-1”), 130.0 
(C-3’), 128.6 (C-3”), 128.3 (C-2’), 127.7 (C-2”), 127.6 (C-4”), 126.9 (C-4’), 79.3 (Cq t-Bu), 72.9 (C-6), 
70.0 (C-5), 65.0 (C-2), 52.6 (OCH3), 41.2 (C-7), 32.5 (C-3), 28.6 (t-Bu), 24.8 (C-4). 
Methyl (R)-2-benzyl-2-((tert-butoxycarbonyl)amino)-5-hydroxypentanoate (2.54) 
 
Boc-protected amino acid ester 2.53 (0.150 g, 0.351 mmol) was dissolved in deoxygenated methanol 
(50 ml) and to this was carefully added Pd/C (0.037 g, 10 wt %, 10 mol %) under a nitrogen 
atmosphere. The reaction was placed under a hydrogen atmosphere and stirred vigorously for 2 
hours. Filtration through Celite, followed by concentration on the rotary evaporator yielded a 
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colourless gum, which was purified by column chromatography using EtOAc/hexane (30/70) to 
furnish alcohol 2.54 (0.116 g, 0.344 mmol, 98 %). 
1H NMR (300 MHz, CDCl3) δ 7.29 – 7.08 (m, 3H, aromatic), 6.72 – 6.98 (m, 2H, aromatic), 5.32 (broad 
s, 1H, NH), 3.68 (s, 3H, OCH3), 3.59 – 3.44 (m, 3H, H-7a, H-5), 3.01 (d, J = 13.5 Hz, 1H, H-7b), 2.49 – 
2.41 (m, 1H, H-3a), 1.95 – 1.88 (m, 1H, H-3b), 1.65 – 1.45 (m, 2H, OH, H-4a), 1.40 (s, 9H, t-Bu), 1.36 – 
1.20 (m, 1H, H-4b). 
Methyl (R)-2-benzyl-2-((tert-butoxycarbonyl)amino)-5-((methylsulfonyl)oxy)pentanoate (2.55) 
 
The alcohol 2.54 (0.060 g, 0.177 mmol) was dissolved in DCM (20 ml) and to this was added pyridine 
(0.30 ml, 0.354 mmol, 2 equivalents), DMAP (0.011 g, 0.09 mmol, 0.5 equivalents) and mesyl 
chloride (0.030 ml, 0.354 mmol, 2 equivalents) and the reaction stirred at rt for 4 hours. The mixture 
was transferred to a separating funnel and washed with aqueous saturated sodium bicarbonate (15 
ml) and the aqueous layer was extracted with DCM (3 x 20 ml). Pooled organic fractions were dried 
over anhydrous MgSO4, filtered and concentrated in vacuo and the residue was committed to flash 
chromatography using EtOAc/ hexanes (10/90) to yield the title quaternary amino acid methyl ester 
2.55 (0.068 g, 0.163 mmol, 92 %) as a colourless gum.  
1H NMR (300 MHz, CDCl3) δ 7.25 – 7.10 (m, 3H, aromatic), 7.09 – 6.82 (m, 2H, aromatic), 5.31 (broad 
s, 1H, NH), 4.25 – 4.04 (m, 2H, H-5), 3.70 (s, 3H, OCH3), 3.53 (d, J = 13.5 Hz, 1H, H-7a), 2.99 (d, J = 
13.5 Hz, 1H, H-7b), 2.94 (s, 3H, SCH3), 2.59 – 2.45 (m, 1H, H-3a), 2.03 – 1.89 (m, 1H, H-3b), 1.81 – 
1.62 (m, 1H, H-4a), 1.55 – 1.45 (m, 1H, H-4b), 1.41 (s, 9H, t-Bu). 
Methyl (S)-2-benzylpyrrolidine-2-carboxylate (2.56) 
 
Boc-protected quaternary amino acid methyl ester 2.55 (0.080 g, 0.193 mmol) was dissolved in DCM 
(40 ml) and cooled to 0 °C followed by the addition of TFA (0.08 ml, 1.01 mmol, 5.5 equivalents). 
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Stirring was continued at this temperature for 2 hours, after which time tlc analysis indicated 
complete deprotection of the starting material. The intermediate free amine was not isolated and 
the reaction mixture was concentrated in vacuo to remove solvent and TFA. The yellowish liquid was 
re-taken up in THF (30 ml) followed by the addition of triethylamine (0.25 ml, 1.93 mmol, 10 
equivalents) and the solution was stirred at rt for an hour. Following THF removal on the rotary 
evaporator, water (15 ml) and EtOAc (40 ml) were added and the aqueous layer extracted with 
EtOAc (3 x 30 ml). Combined organic fractions were dried over anhydrous MgSO4, filtered, 
concentrated and the resultant residue was chromatographed using EtOAc/ hexanes (20/80) to 
furnish the α-benzyl quaternary proline derivative 2.56 (0.032 g, 0.145 mmol, 75 %) as a clear 
viscous liquid. Chiral HPLC on an AD column eluting with IPA: Hex (10:90) revealed a 98:2 
enantiomeric ratio. Minor enantiomer retention time = 6.2 min; that of the major enantiomer 4.4 
min HRMS (ES): m/z found 220.1338, C13H18NO2 [M+H]
+ requires 220.1338; [α]𝐷
20= -10.0°, (CHCl3, c = 
1); IR: vmax (cm
-1) 3349 (NH), 3029 (C-H aromatics), 2950 (C-H alkanes), 1733 (C=O); 1H NMR (300 
MHz, CDCl3) δ 7.26 – 7.01 (m, 5H, aromatic), 3.58 (s, 3H, OCH3), 3.10 (d, J = 13.1 Hz, 1H, CH2aPh), 
3.00 – 2.83 (m, 2H, H-5), 2.80 (d, J = 13.1 Hz, 1H, CH2bPh), 2.06 (broad s, 1H, NH), 1.85 – 1.70 (m, 1H, 
H-3a), 1.72 – 1.56 (m, 1H, H-3b) 1.44 – 1.40 (m, 2H, H-4); 13C NMR (101 MHz, CDCl3) δ 177.0 (C=O), 
137.6 (Arq), 129.8 (Ar), 128.3 (Ar), 126.8 (Ar), 70.7 (C-2), 52.1 (OCH3),  46.1 (C-5), 45.5 (CH2Ph), 35.8 
(C-3), 24.5 (C-4). 
Synthesis of OPMB, OTBDPS tether156 




Borane-dimethylsulfide complex (22.8 ml, 0.232l, 3.2 eq) and trimethyl borate (25.0 mL, 0.22 mol, 3 
eq) were stirred for 15 minutes in THF (300 ml) at 0 °C. (S)-malic acid (10.00 g, 0.0746 mol) was then 
added and the reaction was left to stir at room temperature overnight. Methanol (60 ml) was 
carefully introduced at 0 °C, followed by removal of the solvent in vacuo and filtration of the 
resultant residue through a short pad of silica, eluting with methanol/dichloromethane (20/80). 
Evaporation of the solvent afforded the triol 2.63 (7.44 g, 70.1 mmol, 94 %) as a colourless oil, which 







To a stirred mixture of the triol 2.63 (6.50 g, 61.25 mmol) and p-methoxybenzaldehyde 
dimethylacetal (20.7 ml, 121.6 mmol) in dichloromethane (250 ml), was added CSA (1.43 g, 6.14 
mmol, 10 mol %) and the reaction left to stir overnight. Triethylamine (ca 2ml) was then added and 
the solvent evaporated. The residue was subjected to column chromatography using EtOAc/ hexane 
(50/50) to furnish the title PMP acetal alcohol 2.64 (10.58 g, 47.16 mmol, 77 %) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ 7.01 (d, J = 8.1 Hz, 2H, aromatic), 6.89 (d, J = 8.1 Hz, 2H, aromatic), 5.50 
(s, 1H, H-5), 4.29 (dd, J = 11.5, 5.1 Hz, 1H, H-4a), 4.01 – 3.94 (m, 2H, H-4b + H-2), 3.89 (s, 3H, OCH3), 






A solution of imidazole (1.46 g, 21.41 mmol, 1.2 eq) and t-butylchlorodiphenylsilane (5.90 mL, 21.41 
mmol, 1.2 eq) in acetonitrile (200 mL) was cooled to 0 °C and to this was added PMP acetal-alcohol 
2.64 (4.00 g, 17.84 mmol) dissolved in acetonitrile (30 mL). The reaction mixture was left to stir at 
room temperature for 5 h, after which time it was cooled to 0 °C and quenched with water (20 ml). It 
was then extracted with ethyl acetate (3 x 100 ml), and the combined organic fractions were washed 
with water (50 ml) then brine (50 ml), dried over anhydrous MgSO4 and filtered. Upon removal of 
the solvent, column chromatography with EtOAc/hexane (10/90) was performed on the residue, 
yielding the TBDPS ether 2.65 (7.08 g, 15.30 mmol, 86 %) as a colourless gum.  
1H NMR (400 MHz, CDCl3) δ 7.79 – 7.70 (m, 4H, aromatic), 7.55 – 7.35 (m, 8H, aromatic), 6.90 – 6.83 
(m, 2H, aromatic), 5.48 (s, 1H, H-5), 4.38 (dd, J = 11.5, 5.1 Hz, 1H, H-4a), 4.09  – 3.95 (m, 2H, H2 + 
H1a),  3.90 – 3.86 (m,  1H, H-1b), 3.81 (s, 3H, OCH3), 3.71 – 3.61 (m, 1H, H-4b), 1.98 – 1.83 (m, 1H, H-









A solution of acetal 2.65 (2.80 g, 6.05 mmol) in toluene (150 ml) was cooled to -78 °C and to this was 
added DIBAL (1.5 M in toluene, 16.14 ml, 24.21 mmol, 4 eq). Stirring was continued at -78 °C for a 
further 3 h, following which, methanol (17 ml) was added slowly. Once the mixture reached room 
temperature, saturated aqueous potassium sodium tartrate (80 ml) was added and stirring was 
continued for a further 15 minutes. The layers were separated and the aqueous layer was extracted 
with DCM (3 x 100 ml). Pooled organic fractions were washed with brine (100 ml), dried over 
anhydrous MgSO4 and concentrated to a thick oil. Purification by column chromatography eluting 
with EtOAc/hexane (30/70) afforded the alcohol 2.66 as a clear oil (2.67 g, 5.75 mmol, 95 %). 
1H NMR (300 MHz, CDCl3) δ 7.76 – 7.62 (m, 4H, aromatic), 7.50 – 7.34 (m, 6H, aromatic), 7.21 (d, J = 
8.7 Hz, 2H, aromatic), 6.86 (d, J = 8.7 Hz, 2H, aromatic), 4.60 (d, J = 11.3 Hz, 1H, OCH2aPh), 4.42 (d, J = 
11.3 Hz, 1H, OCH2bPh), 3.80 (s, 3H, OCH3), 3.77 (m, 1H, H-3), 3.76 – 3.65 (m, 4H, H-4 and H-1), 2.09 





Alcohol 2.66 (2.00 g, 4.30 mmol) was placed in dry toluene (200 ml). Imidazole (0.47 g, 6.88 mmol, 
1.6 equivalents), PPh3 (1.81g, 6.88 mmol, 1.6 equivalents) and iodine (1.42 g, 5.59 mmol, 1.3 
equivalents) were added successively to the stirring mixture. The reaction was left to stir at room 
temperature for 4 hours and then saturated sodium thiosulphate solution (100 ml) was added. The 
aqueous layer was extracted with diethyl ether (3 x 10 ml) and washed with saturated sodium 
bicarbonate (100 ml) followed by brine (100 ml). It was then concentrated and subjected to flash 
chromatography using EtOAc/ hexanes (5/95) to afford the iodide 2.67 (2.27 g, 3.95 mmol, 92 %) as 
a clear liquid.  
1H NMR (300 MHz, CDCl3) δ 7.78 – 7.65 (m, 4H, aromatic), 7.49 – 7.28 (m, 6H, aromatic), 7.25 – 7.23 
(m, 2H, aromatic), 6.88 – 6.85 (m, 2H, aromatic), 4.55 (d, J = 10.5 Hz, 1H, OCH2aPh), 4.41 (d, J = 10.5 
Hz, 1H, OCH2bPh), 3.95 – 3.83 (m, 1H, H-1a), 3.81 (s, 3H, OCH3), 3.77 – 3.61 (m, 1H, H-2), 3.72 – 3.60 




1-Allyl 3-ethyl 2-((S)-4-((tert-butyldiphenylsilyl)oxy)-3-((4-methoxybenzyl)oxy)butyl)malonate 
(2.70) 
 
Ethyl allyl malonate 2.69 (2.00 ml, 13.20 mmol) was slowly added to a stirred suspension of NaH (60 
% dispersion in oil, 0.53 g, 13.20 mmol) in tetrahydrofuran (100 ml) at 0 °C. The anion was allowed to 
form by vigorous stirring at room temperature for a further 45 minutes. A solution of the iodide 2.67 
(7.61 g, 13.20 mmol) in THF (50 ml) was added in one portion to the clear anion solution.  The 
reaction was stirred at room temperature for an hour then slowly brought up to 60 °C. After 8 hours, 
it was cooled and quenched with saturated ammonium chloride solution (50 ml) and extracted with 
ethyl acetate (3 x 100 ml). The organic extracts were washed with brine (50 ml), dried over 
anhydrous MgSO4, filtered and evaporated to give the crude product.  Column chromatography 
using EtOAc/hexane (20/80) gave the alkylated malonate product 2.70 (7.59 g, 12.28 mmol, 93 %) as 
a thick oil in a 50:50 ratio of diastereomers as determined by 1H NMR spectroscopy. HRMS (ES): m/z 
found 619.3055, C36H47O7Si [M+H]
+ requires 619.3048; IR: vmax (cm
-1) 3068 (C-H aromatics), 2933 (C-H 
aliphatic), 1748 (C=O), 1729 (C=O); 1H NMR (400 MHz, CDCl3) δ 7.76 – 7.65 (m, 4H, aromatic), 7.49 – 
7.38 (m, 6H, aromatic), 7.25 (d, J = 6.6 Hz, 2H, aromatic), 6.88 (d, J = 8.7 Hz, 2H, aromatic), 6.05 – 
5.82 (m, 1H, CH2=CH), 5.39 – 5.22 (m, 2H, CH=CH2), 4.68 – 4.63 (m, 2H, CH2=CHCH2), 4.59 (d, J = 11.3 
Hz, 1H, OCH2aPh), 4.45 (d, J = 11.3 Hz, 1H, OCH2bPh), 4.25 – 4.17 (m, 2H, CH2CH3), 3.83 (s, 3H, OCH3), 
3.77 (dd, J = 10.6, 5.2 Hz, 1H, H-4’a), 3.66 (dd, J = 10.6, 5.5 Hz, 1H, H-4’b), 3.56 – 3.49 (m, 1H, H-3’), 
3.36 (t, J = 7.6 Hz, 1H, H-2), 2.13 – 1.90 (m, 2H, H-1’), 1.73 – 1.56 (m, 2H, H-2’), 1.28 (t, J = 7.1, 3H, 
CH2CH3), 1.10 (s, 9H, t-Bu); 
13C NMR (101 MHz, CDCl3) δ 169.4 (C=O) 169.2 (C=O,), 159.3 (ArPMB), 
135.8 (2 x ArSi), 133.7 (ArqSi), 133.6 (ArqSi), 131.9 (ArqPMB), 131.0 (ArSi), 129.8 (ArSi), 129.4 (ArPMB), 127.9 
(ArSi), 127.8 (Arsi), 118.6 (CH=CH2), 113.9 (ArPMB), 78.9 (C-3’), 71.9 (OCH2Ph), 66.1 (C-4’), 65.9 
(CH2=CHCH2), 61.5 (CH2CH3), 55.4 (OCH3), 52.1 (C-2), 29.5 (C(CH3)3), 27.0 (C(CH3)3, 24.9 (C-2’), 19.4 (C-








To a solution of mono-alkylated allyl ethyl malonate 2.70 (6.00 g 9.70 mmol) in EtOH (200 mL) at 0 °C 
was added dropwise a solution of KOH (2.5 M in EtOH, 5.80 ml, 14.5 mmol, 1.5 eq) and the ice-bath 
removed. Since tlc analysis indicated incomplete hydrolysis after stirring at rt overnight, a further 
equivalent of KOH was added and stirring continued for a further 3 hours, after which time the EtOH 
was removed under reduced pressure and the concentrate diluted with water (100 mL) and 
extracted with DCM (3 x 100 ml) to remove unreacted starting material. The aqueous layer was then 
acidified with conc. HCl to pH = 3 and then re-extracted with DCM (1 x 300 and 2 × 150 ml), the 
organic extracts combined, dried over MgSO4, filtered, and concentrated in vacuo to obtain the half-
acid 2.71 (4.10 g, 7.08 mmol, 73 %) as a colourless oil in a diastereomeric ratio of 50:50 as 
determined by 1H NMR spectroscopy. HRMS (ES): m/z found 579.2733, C33H43O7Si [M+H]
+ requires 
579.2731; IR: vmax (cm
-1) 3457 (OH), 3073 (C-H aromatic), 2957 (C-H alkenes), 1734 (C=O). 
Diastereomer 1: 
1H NMR (300 MHz, CDCl3) δ 8.01 (broad s, COOH), 7.69 – 7.62 (m, 4H, aromatic), 7.45 – 7.30 (m, 6H, 
aromatic), 7.19 (d, J = 8.5 Hz, 2H, aromatic), 6.82 (d, J = 8.5 Hz, 2H, aromatic), 4.54 (d, J = 11.3 Hz, 1H, 
OCH2aPh), 4.40 (d, J = 11.3 Hz, 1H, OCH2bPh), 4.23 – 4.09 (m, 2H, CH2CH3), 3.76 (s, 3H, OCH3), 3.73 
(dd, J = 10.6, 5.4 Hz, 1H, H-6), 3.64 – 3.56 (m 1H, H-6), 3.52 – 3.43 (m, 1H, H-5), 3.31 (t, J = 7.5, 1H, H-
2), 2.07 – 1.85 (m, 2H, H-3), 1.72 – 1.49 (m, 2H, H-4), 1.24 (t, J = 7.2, 3H, CH2CH3), 1.05 (s, 9H, tBu Hs); 
13C NMR (101 MHz, CDCl3) δ 173.4 (C=O), 169.8 (C=O), 159.3 (ArPMB), 135.7 (ArSi), 135.6 (ArSi), 133.5 
(ArqSi), 133.4 (ArqSi), 131.9 (ArqPMB), 131.0 (ArSi), 129.8 (ArSi), 129.5 (ArPMB), 127.9 (ArSi), 127.6 (ArSi), 
113.6 (ArPMB), 78.8 (C-5), 71.9 (OCH2Ph), 65.9 (C-6), 61.8 (CH2CH3), 55.4 (OCH3), 51.5 (C-2), 29.3 (SiC), 
27.0 (C(CH3)3), 25.1 (C-4), 19.3 (C-3), 14.2 (CH2CH3). 
Diastereomer 2: 
1H NMR (300 MHz, CDCl3) δ 8.01 (broad s, COOH), 7.69 – 7.62 (m, 4H, aromatic), 7.45 – 7.30 (m, 6H, 
aromatic), 7.19 (d, J = 8.5 Hz, 2H, aromatic), 6.82 (d, J = 8.5 Hz, 2H, aromatic), 4.54 (d, J = 11.3 Hz, 1H, 
OCH2aPh), 4.40 (d, J = 11.3 Hz, 1H, OCH2bPh), 4.23 – 4.09 (m, 2H, CH2CH3), 3.76 (s, 3H, OCH3), 3.73 
(dd, J = 10.6, 5.4 Hz, 1H, H-6), 3.64 – 3.56 (m 1H, H-6), 3.52 – 3.43 (m, 1H, H-5), 3.34 (t, J = 7.5, 1H, H-
2), 2.07 – 1.85 (m, 2H, H-3), 1.72 – 1.49 (m, 2H, H-4), 1.27 (t, J = 7.2, 3H, CH2CH3), 1.05 (s, 9H, tBu Hs); 
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13C NMR (101 MHz, CDCl3) δ 173.5 (C=O), 169.7 (C=O), 159.3 (ArPMB), 135.6 (ArSi), 135.5 (ArSi), 133.5 
(ArqSi), 133.4 (ArqSi), 131.7 (ArqPMB), 131.0 (ArSi), 129.7 (ArSi), 129.4 (ArPMB), 127.7 (ArSi), 127.6 (Arsi), 
113.8 (ArPMB), 78.8 (C-5), 71.9 (OCH2Ph), 65.0 (C-6), 61.9 (CH2CH3), 55.6 (OCH3), 51.5 (C-2), 29.9 (SiC), 





To a solution of 1-chlorobenzotriazole (0.689 g, 4.50 mmol, 1.3 eq) in acetonitrile (200 ml) was 
added PPh3 (1.26 g, 4.50 mmol, 1.3 eq) at 0 °C and the mixture stirred for 10 minutes. The alkylated 
mono-acid 2.71 (2.00 g, 3.46 mmol, 1 eq) in acetonitrile (50 ml) was then syringed in and the 
reaction left to warm up to room temperature. Over the next 20 minutes, the reaction colour 
changed from mauve to bright yellow, at which point auxiliary (+)-2.29 (0.861 g, 4.50 mmol, 1.3 eq) 
was introduced and the reaction refluxed overnight. Once cooled, saturated aqueous sodium 
bicarbonate solution (80 ml) was added and the mixture vigorously stirred at 50 °C for 2 hours. Next, 
the organic layer was isolated and extracted with saturated aqueous sodium bicarbonate (50 ml), 
washed with brine and dried over anhydrous MgSO4, then filtered and concentrated under reduced 
pressure. The crude product was chromatographed using EtOAc/ hexanes (20/80) to give the 
auxiliary-alkylated malonate 2.72 (1.71 g, 2.28 mmol, 66 %) as a thick, colourless gum in a 50:50 ratio 
of diastereomers as determined by 1H NMR spectroscopy. HRMS (ES): m/z found 751.3740, 
C44H55N2O7Si [M+H]
+ requires 751.3735; [α]𝐷
20= -44.4°, (DCM, c = 1); IR: vmax (cm
-1) 3033 (C-H 
aromatic), 2901 (C-H alkanes), 1730 (C=O ester, amide), 1685 (C=O urea). 
Diastereomer 1: 
1H NMR (300 MHz, CDCl3) δ 7.76 – 7.55 (m, 4H, aromatic), 7.50 – 7.15 (m, 11H, aromatic), 7.13 – 7.06 
(m, 2H, aromatic), 6.89 – 6.84 (m, 2H, aromatic), 5.34 (d, J = 8.6 Hz, 1H, CHPh), 4.76 (dd, J = 8.7, 5.2 
Hz, 1H, H-2), 4.53 (d, J = 11.2 Hz, 1H, OCH2aPh), 4.43 (d, J = 11.2 Hz, 1H, OCH2bPh), 4.26 – 4.11 (m, 2H, 
CH3CH2), 3.91 (dq, J = 8.6, 6.6 Hz, 1H, CHCH3), 3.78 (s, 3H, OCH3), 3.67 – 3.51 (m, 2H, H-6), 3.50 – 3.41 
(m, 1H, H-5), 2.79 (s, 3H,NCH3), 2.02 – 1.83 (m, 2H, H-3), 1.51 – 1.39 (m, 1H, H-4), 1.28 – 1.18 (m, 3H, 
CH2CH3), 1.03 (s, 9H, t-Bu), 0.78 (d, J = 6.6 Hz, 3H, CHCH3); 
13C NMR (75 MHz, CDCl3) δ 170.3 (C=O), 
168.1 (C=O), 159.1 (ArqPMB), 155.6 (C=O), 136.0 (Arq), 135.6 (ArSi), 135.5 (ArSi), 133.7 (ArqSi), 133.6 
177 
 
(ArqSi), 131.2 (ArqPMB), 129.7 (Ar), 129.6 (ArPMB), 129.2 (2 x ArSi), 128.0 (Ar), 127.8 (ArSi), 127.6 (ArSi), 
127.1 (Ar), 113.7 (ArPMB), 79.5 (C-5), 71.9 (OCH2Ph), 66.3 (C-6), 61.1 (CH2CH3), 59.8 (CHPh), 55.4 
(OCH3), 54.1 (CHCH3), 51.1 (C-2), 29.9 (NCH3), 28.3 (C(CH3)3), 27.0 (C(CH3)3), 24.7 (C-4),  19.4 (C-3), 
15.2 (CHCH3), 14.3 (CH3CH2). 
Diastereomer 2: 
1H NMR (300 MHz, CDCl3) δ 7.71 – 7.64 (m, 4H, aromatic), 7.45 – 7.10 (m, 13H, aromatic), 6.88 – 6.76 
(m, 2H, aromatic), 5.25 (d, J = 8.6 Hz, 1H, CHPh), 4.68 (dd, J = 8.7, 5.2 Hz, 1H, H-2), 4.55 (d, J = 11.2 
Hz, 1H, OCH2aPh), 4.43 (d, J = 11.1 Hz, 1H, OCH2bPh), 4.20 – 4.05 (m, 2H, CH3CH2), 3.79 (s, 3H, OCH3), 
3.77 – 3.72 (m, 1H, CHCH3), 3.75 – 3.66 (m, 1H, H-6a), 3.66 – 3.58 (m, 1H, H-6b), 3.55 – 3.43 (m, 1H, 
H-5), 2.80 (s, 3H, NCH3), 2.17 – 2.06 (m, 1H, H-3a), 1.99 – 1.81 (m, 1H, H-3b), 1.77 – 1.63 (m, 2H, H-





A solution of 2.72 (1.50 g, 2.00 mmol, 1 eq) in THF (200 ml) was cooled to -78 °C followed by the 
dropwise addition of KHMDS in toluene (0.5 M, 4.8 ml, 2.40 mmol, 1.2 eq) and stirring at this 
temperature was continued for a further 30 minutes after which time allyl bromide (0.26 ml, 3.00 
mmol, 1.5 eq) was added in one portion to the anion solution. The reaction was slowly warmed to 
room temperature and allowed to stir overnight. It was then quenched with saturated aqueous 
ammonium chloride solution (100 ml), the THF removed on the rotary evaporator and the mixture 
and extracted with EtOAc (1 x 200 and 2 x 100 ml). The combined organic extracts were dried over 
anhydrous MgSO4 and evaporated to give the crude product which was chromatographed using 
EtOAc/ hexanes (15/85) to give the title quaternary auxiliary malonate 2.73 (1.55 g, 1.96 mmol, 98 
%) as a thick colourless gum, in a diastereomeric ratio of 97:3 as determined by 1H NMR 
spectroscopy.  
HRMS (ES): m/z found 791.4046, C47H59N2O7Si [M+H]
+  requires 791.4040; IR: vmax (cm
-1) 3029 (C-H 
aromatic), 2921 (C-H alkanes), 1727 (C=O ester, amide), 1679 (C=O urea); 1H NMR (300 MHz,CDCl3) δ 
7.69 – 7.60 (m, 4H, aromatic), 7.45 – 7.14 (m, 13H, aromatic), 6.82 (m, 2H, aromatic), 5.51 – 5.33 (m, 
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1H, CH=CH2), 5.24 (d, J = 8.5 Hz, 1H, CHPh), 4.99 – 4.84 (m, 2H, CH2=CH), 4.48 (d, J = 11.2 Hz, 1H, 
OCH2aPh), 4.40 (d, J = 11.2 Hz, 1H, OCH2bPh), 4.24 – 4.07 (m, 2H, CH2CH3), 3.79 (s, 3H, OCH3), 3.76 – 
3.65 (m, 2H, H-6a and CHCH3), 3.62 – 3.50 (m, 1H, H-6b), 3.46 – 3.32 (m, 1H, H-5), 2.90 – 2.76 (m, 
2H, CH2=CHCH2), 2.70 (s, 3H, NCH3), 2.19 – 1.95 (m, 2H, H-3), 1.57 – 1.38 (m, 2H, H-4), 1.25 (t, J = 7.2 
Hz, 3H, CH2CH3), 1.05 (s, 9H, t-Bu), 0.73 (d, J = 6.6 Hz, 3H CHCH3); 
13C NMR (75 MHz, CDCl3) δ 171.4 
(C=O), 169.7 (C=O), 159.1 (ArqPMB), 155.2 (C=O), 136.7 (Arq), 135.8 (ArSi), 135.7 (ArSi), 133.8 (ArqSi), 
133.7 (ArqSi), 133.3 (CH=CH2), 131.3 (ArqPMB), 129.8 (Ar), 129.3 (ArPMB), 129.2 (ArSi), 128.5 (ArSi), 128.1 
(Ar), 127.8 (ArSi), 127.2 (ArSi), 127.0 (Ar), 118.1 (CH=CH2), 113.8 (ArPMB), 79.9 (C-5), 71.9 (OCH2Ph), 
66.1 (C-6), 60.6 (CH2CH3), 58.3 (CHPh), 55.4 (OCH3), 54.3 (CHCH3), 53.1 (C-2), 37.9 (CH2=CHCH2), 28.7 
(NMe), 28.2 (C(CH3)3), 27.0 (C(CH3)3), 26.1 (C-4), 19.4 (C-3), 15.1 (CHCH3), 14.4 (CH2CH3). 
(R)-2-Amino-2-(3-(benzyloxy)propyl)pent-4-en-1-ol (2.74) 
 
To a cooled suspension of lithium borohydride (0.030 g, 1.38 mmol, 2.5 eq) in diethyl ether (5 ml) at 
0 °C was added a solution of α-tertiary amine 2.44f (0.240 g, 0.55 mmol) in diethyl ether (60 ml) and 
the reaction allowed to warm up to 10 °C over the next 3 hours. Next, the reaction was diluted with 
diethyl ether (5 ml) and water (0.1 ml) and NaOH (15 %, 0.2 ml) were slowly added. Stirring was 
continued for a further 15 minutes at room temperature followed by the addition of anhydrous 
MgSO4. Thereafter, the mixture was filtered, the solvent removed under reduced pressure, and the 
residue chromatographed with methanol/dichloromethane (10/90) to give the pure amino alcohol 
2.74 (0.104 g, 0.42 mmol, 76 %) as a clear liquid. Auxiliary # was also recovered (0.068 g, 0.36 mmol 
65 %) as colourless needle-like crystals. HRMS (ES): m/z found 250.1814, C15H24NO2 [M+H]
+ requires 
250.1807; [α]𝐷
20-1.2° (DCM, c = 1); IR: vmax (cm
-1) 3693 (OH), 3444 (NH2), 3054 (C-H aromatic), 2927 
(C-H alkanes), 1552 (NH bend); 1H NMR (400 MHz, CDCl3) δ 7.37 – 7.08 (m, 5H, aromatic), 5.88 – 5.55 
(m, 1H, H-4), 5.13 – 4.96 (m, 2H, H-5), 4.43 (s, 2H, OCH2Ph), 3.40 (t, J = 6.3 Hz, 2H, H-3’), 3.28 (s, 2H, 
H-1), 2.14 – 1.91 (m, 2H, H-3), 2.04 - 1.99 (broad s, 3H, NH2 and OH), 1.64 – 1.50 (m, 2H, H-1’), 1.47 – 
1.33 (m, 2H, H-2’); 13C NMR (100 MHz, CDCl3)  138.3 (Arq), 133.1 (C-4), 128.4 (Ar), 127.7 (Ar), 127.6 





(R)-tert-Butyl (7-(benzyloxy)-4-(hydroxymethyl)hept-1-en-4-yl)carbamate (2.75) 
 
To a solution of amino alcohol 2.74 (0.080 g, 0.321 mmol) in dichloromethane (20 ml) was added 
Boc2O (0.084 g, 0.385 mmol, 1.2 eq).  The reaction was refluxed for 8 hours after which time it was 
cooled, washed with water (20 ml) and the organic layer concentrated. The residue was purified by 
flash chromatography using EtOAc/hexane (40/60) to give the Boc-protected amino alcohol 2.75 
(0.098 g, 0.282 mmol, 88 %) as a slightly yellow oil. HRMS (ES): m/z found 350.2291, C20H32NO4 
[M+H]+ requires 350.2284; [α]𝐷
20-2.2° (DCM, c = 1); IR: vmax (cm
-1) 3426 (NH), 3086 (C-H aromatic), 
2933 (C-H alkanes), 1689 (C=O); 1H NMR (400 MHz, CDCl3) δ 7.27 – 7.25 (m, 5H, aromatic), 5.81 – 
5.75 (m, 1H, H-2), 5.19 – 5.13 (m, 2H, H-1), 4.82 (broad s, 1H, NH), 4.52 (s, 2H, OCH2Ph), 4.20 (broad 
s 1H, OH), 3.75 – 3.66 (m, 2H, H-7), 3.50 (t, J = 5.1 Hz, 2H,CH2OH), 2.38 (m, 2H, H-3), 1.65 (m, 4H, H-5, 
H-6), 1.42 (s, 9H, t-Bu); 13C NMR (101 MHz, CDCl3) δ 156.5 (C=O), 138.5 (Arq), 133.2 (C-2), 129.7 (Ar), 
128.5 (Ar), 127.8 (Ar), 119.3 (C-1), 80.0 (C(CH3)3), 73.2 (OCH2Ph), 70.5 (C-7), 68.1 (CH2OH), 58.8 (C-4), 
39.3 (C-3) 31.5 (C-5), 28.5 (C(CH3)3), 23.8 (C-6). 
 (R)-tert-Butyl (7-(benzyloxy)-4-formylhept-1-en-4-yl)carbamate (2.76) 
 
Dess-Martin periodinane (0.175 g, 0.412 mmol, 1.2 eq) was placed in dichloromethane (20 ml) and 
cooled to 0 °C. The boc-protected amino alcohol 2.75 (0.120 g, 0.343 mmol) was then introduced 
and the reaction left to warm up to room temperature and stirred for 2 hours. Upon completion, 
sodium hydroxide solution (1 M, 3.00 ml) was slowly added and the mixture left to stir a further 10 
minutes. Extraction with dichloromethane (3 x 40 ml) followed and the combined organic layers 
were washed with brine (30 ml), dried over anhydrous MgSO4 and concentrated. The residue was 
flash chromatographed with EtOAc/hexane (10/90) to give aldehyde 2.76 (0.110 g, 0.316 mmol, 92 
%) HRMS (ES): m/z found 348.2133, C20H22NO4 [M+H]
+ requires 348.2131; [α]𝐷
20-2.5° (DCM, c = 1); IR: 
vmax (cm
-1) 3423 (NH), 3055 (C-H aromatics), 2987 (C-H alkanes), 1736 (C=O aldehyde), 1712 (C=O 
Boc); 1H NMR (400 MHz, CDCl3) δ 9.33 (s, 1H, HCO), 7.53 – 6.84 (m, 5H, aromatic), 5.71 – 5.49 (m, 1H, 
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H-2), 5.30 (broad s, 1H, NH), 5.11 (m, 2H, H-1), 4.47 (s, 2H, OCH2Ph), 3.43 (t, J = 6.0 Hz, 2H, H-7), 2.82 
(m, 1H,H-3a), 2.50 (m, 1H,H-3b), 2.05 – 1.99 (m, 1H, H-5a), 1.80 -1.75 (m, 1H, H-5b), 1.72 – 1.51 (m, 
2H, H-6), 1.44 (s, 9H, t-Bu); 13C NMR (101 MHz, CDCl3) δ 200.6 (HC=O), 154.6 (C=O), 138.5 (Arq), 131.7 
(C-2), 128.5 (Ar), 127.8 (Ar), 127.8 (Ar) 119.7 (C-1), 73.0 (OCH2Ph), 69.8 (C-7), 65.2 (C(CH3)3), 53.4 (C-
4), 37.4 (C-3), 29.8 (C-5), 28.5 (t-Bu), 23.9 (C-6). 
tert-Butyl ((4R)-4-(3-(benzyloxy)propyl)-5-hydroxyocta-1,7-dien-4-yl)carbamate (2.77) 
 
To a solution of aldehyde 2.76 (0.100 g, 0.288 mmol) in THF (50 ml) was added allylmagnesium 
chloride (1 M solution in THF, 0.35 ml, 0.35 mmol, 1.2 eq) via a syringe at -78 °C. Stirring was 
continued at this temperature for 2 hours then warmed up to -20 °C and stirred for a further 4 hours 
after which time the reaction was quenched by the addition of  water (5 ml) followed by HCl (1 M, 1 
ml) and warmed up to room temperature. It was then diluted and extracted with ethyl acetate (3 x 
30 ml) and the organic extracts washed with saturated sodium bicarbonate solution (10 ml) and 
brine (20 ml), then dried over anhydrous MgSO4, filtered and concentrated. The crude product was 
purified by column chromatography using EtOAc/ hexane (30/70) to give the allylated product 2.77 
(0.107 g, 0.274 mmol, 95 %) as a colourless oil, as a 4:1 ratio of diastereomers as determined by 1H 
NMR spectroscopy. HRMS (ES): m/z found 390.2631, C23H36NO4 [M+H]
+ requires 390.2644; [α]𝐷
20-2.1° 
(DCM, c = 1); IR: vmax (cm
-1) 3415 (OH), 3073 (C-H aromatic), 2978 (C-H alkane), 1712 (C=O Boc). 
Major diastereomer 
1H NMR (400 MHz, CDCl3) δ 7.45 – 7.16 (m, 5H, aromatic), 6.07 – 5.92 (m, 1H, H-7), 5.88 – 5.75 (m, 
1H, H-2), 5.21 – 5.16 (m, 1H, H-8), 5.15 – 5.11 (m, 1H, H-8), 5.10 – 5.05 (m, 2H, H-1), 4.75 (broad s, 
1H, NH), 4.56 (broad s, 1H, OH), 4.50 (s, 2H, OCH2Ph), 3.68 – 3.53 (m, 1H, H-5), 3.54 – 3.40 (m, 2H, H-
3’), 2.39 – 2.33 (m, 1H, H-6a), 2.32 – 2.28 (m, 2H, H-1’), 2.17 – 2.06 (m, 1H, H-6b), 2.00 – 1.90 (m, 1H, 
H-3a), 1.85 – 1.71 (m, 1H, H-3b), 1.69 – 1.54 (m, 2H, H-2’), 1.45 - 1.40 (m, 9H, t-Bu); 13C NMR (101 
MHz, CDCl3) δ 156.6 (C=O), 138.7 (Arq), 136.6 (C-2), 132.9 (C-7), 128.3 (Ar) 127.6 (Ar), 127.5 (Ar), 
119.7 (C-1), 116.4 (C-8), 80.0 (C(CH3)3), 75.3 (OCH2Ph), 72.9 (C-5), 70.6 (C-3’), 60.8 (C-4), 39.1 (C-3), 




13C NMR (101 MHz, CDCl3) δ 156.6 (C=O), 138.7 (C-1”), 133.5 (C-2), 129.8 (C-7), 128.3 (C-3”), 127.6 
(C-4”), 127.5 (C-2”), 118.2 (C-1), 116.4 (C-8), 83.1 (C(CH3)3), 75.6 (OCH2Ph), 73.0 (C-5), 69.3 (C-3’), 
60.8 (C-4), 39.1 (C-3), 37.0 (C-6), 31.5 (C-1’), 28.3 (t-Bu), 23.8 (C-2’).  
 
tert-Butyl ((1R)-1-(3-(benzyloxy)propyl)-6-hydroxycyclohex-3-en-1-yl)carbamate (2.78) 
 
The diallyl compound 2.77 (0.130 g, 0.334 mmol) was dissolved in deoxygenated dichloromethane 
(10 ml) and Grubbs first-generation catalyst (0.027 g, 0.033 mmol, 10 mol %) was added. The 
reaction was refluxed for 3 hours during which the colour changed from purple to black. The solvent 
was removed via rotary evaporation and the residue columned with EtOAc/ hexane (30/70) to yield 
the title compound 2.78 (0.104 g, 0.287 mmol, 86 %) as a colourless solid. Recrystallization from 
chloroform/ hexane afforded the major diastereomer as fine needle-like crystals. Major 
diastereomer: Melting point: 91 – 94 °C (chloroform/ hexane). HRMS (ES): m/z found362.2329, 
C21H32NO4 [M+H]
+ requires 362.2331; [α]𝐷
20= +28.8, (DCM, c = 1); IR: vmax (cm
-1) 3428 (OH), 3055 (C-H 
aromatic), 2978 (C-H aliphatic), 1685 (C=O Boc); 1H NMR (400 MHz, CDCl3) δ 7.44 – 7.18 (m, 5H, 
aromatic), 5.71 – 5.01 (m, 1H, H-4), 5.51 – 5.39 (m, 1H, H-3), 5.22 (broad s, 1H, OH), 4.63 (s, 1H, NH), 
4.50 (s, 2H, OCH2Ph), 3.79 – 3.68 (m, 1H, H-6), 3.60 – 3.44 (m, 2H, H-3’), 2.43 – 2.32 (m, 1H, H-5a), 
2.27 – 2.19 (m, 2H, H-5b and H-2a), 2.16 – 2.01 (m, 1H, H-2b), 2.06 (m, 1H, H-2’a), 1.83 – 1.68 (m, 2H, 
H-2’b and H-1’a), 1.66 – 1.54 (m, 1H, H-1’b), 1.42 (s, 9H, t-Bu); 13C NMR (101 MHz, CDCl3) 157.6 
(C=O), 138.7 (C-1’’), 128.5 (C-3’’), 127.8 (C-2’’), 127.6 (C-4’’), 127.0 (C-4), 122.6 (C-3), 80.3 (C(CH3)3), 
73.1 (OCH2Ph), 72.8 (C-1), 70.8 (C-3’), 58.3 (C-6), 37.5 (C-2), 32.8 (C-5), 30.7 (C-1’), 28.4 ((CH3)3), 23.9 
(C-2’). 
tert-Butyl ((1S)-2-hydroxy-1-(3-hydroxypropyl)cyclohexyl)carbamate (2.79) 
 
Cyclohexene 2.78 (0. 65 g, 1.80 mmol) was dissolved in deoxygenated ethanol (10 ml) and to this 
was carefully added Pd/C (10 % wt, 0.192 g, 10 mol%) under a nitrogen atmosphere. The mixture 
was placed under a hydrogen atmosphere and stirred vigorously for 5 hours. Filtration through 
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Celite, followed by concentration yielded a yellow gum which was purified by column 
chromatography using EtOAc/ hexane (30/70) to furnish the cyclohexanol product 2.79 (0.453 g, 
1.66 mmol, 92 %) as a clear gum.  
1H NMR (300 MHz, CDCl3) δ 4.92 (broad s, 1H, CHOH), 4.65 (s, 1H, NH), 3.76 – 3.57 (m, 2H, H-3’), 3.55 
– 3.46 (m, 1H, H-2), 2.28 (broad s, 1H, CH2OH), 2.14 – 1.99 (m, 1H, H-3a), 2.00 – 1.86 (m, 1H, H-6a), 
1.85 – 1.64 (m, 3H, H-4a, H-5a, H-6b), 1.66 – 1.50 (m, 3H, H-3b, H-2’), 1.50 – 1.44 (m, 1H, H-5b), 1.42 
(s, 9H, t-Bu), 1.37 – 1.23 (m, 3H, H-3, H-4b). WHERE ARE THE H-1 ’protons?? 
(3aS)-3a-(3-((tert-Butyldiphenylsilyl)oxy)propyl)hexahydrobenzo[d]oxazol-2(3H)-one (2.80) 
 
The diol 2.79 (0.100 g, 0.37 mmol, 1 eq) was dissolved in THF (60 ml) and cooled to 0 °C. To this was 
added NaH (60 % dispersion in oil, 0.015 g, 0.37 mmol, 1 eq) and stirring was continued for 15 
minutes after which time TBDPSCl 0.11 ml, (0.41 mmol, 1.1 eq) was syringed in. The reaction was left 
at 10 °C for a further hour, following which water (20 ml) was added and the THF was removed on 
the rotary evaporator, followed by extraction with DCM (3 x 50 ml). The combined organic extracts 
were washed with brine, dried over MgSO4, filtered and concentrated in vacuo. Column 
chromatography using EtOAc/ hexanes (15/85) furnished the oxazolidinone 2.80 (0.099 g, 0.23 
mmol, 61 %) as a viscous oil. HRMS (ES): m/z found 438.2455, C26H36NO3Si [M+H]
+ requires 438.2464; 
[α]𝐷
20= -11.3°, (DCM, c = 1); IR: vmax (cm
-1) 3422 (NH), 3071 (C-H aromatics), 2940 (C-H alkanes), 1748 
(C=O); 1H NMR (400 MHz, CDCl3) δ 7.00 – 7.60 (m, 4H, aromatic), 7.52 – 7.33 (m, 6H, aromatic), 5.11 
(broad s, 1H, NH), 4.24 (t, J = 4.0 Hz, 1H, H-3), 3.69 (t, J = 5.5 Hz, 2H, H-3’), 2.06 – 1.89 (m, 1H, H-1’a), 
1.73 – 1.26 (m, 11H, 5xCH2, H-1’b), 1.06 (s, 9H, t-Bu); 
13C NMR (101 MHz, CDCl3) δ 159.3 (C=O), 135.7 
(Arq x 2), 133.8 (Ar x 2), 129.8 (Ar x 2), 127.9 (Ar x2 ), 80.6 (C-3), 63.8 (C-3a), 59.1 (C-3’), 34.3 (C-4’’), 







tert-Butyl (R)-(1-(3-(benzyloxy)propyl)-6-oxocyclohex-3-en-1-yl)carbamate (2.81) 
 
DMSO (0.47 ml, 6.65 mmol, 2.4 eq) was added to a solution of oxalyl chloride (0.28 ml, 3.32 mmol, 
1.2 eq) in dichloromethane (20 ml) at -78 °C and the mixture was left to stir for 20 minutes. 
Cyclohexenol 2.78 (1.00 g, 2.77 mmol) in DCM (50 ml) was then syringed in and stirring of this 
mixture was continued for a further 30 minutes at -78 °C.  Triethylamine (1.42 ml, 11.08 mmol, 4 eq) 
was then added and the reaction allowed to warm up to room temperature. Once the components 
were concentrated in vacuo, flash chromatography was carried out using EtOAc/ hexane (10/90) to 
furnish the cyclohexenone product 2.81 (0.896 g, 2.49 mmol, 90 %)as a thick, colorless gum. HRMS 
(ES): m/z found 360.1985, C21H30NO4 [M+H]
+ requires 360.1980; [α]𝐷
20= +2.1, (DCM, c = 1); IR: vmax 
(cm-1) 3407 (NH), 3054 (C-H aromatic), 2982 (C-H alkanes), 1708  (C=O ketone) 1701 (C=O Boc); 1H 
NMR (400 MHz, CDCl3) δ 7.37 – 7.26 (m, 5H, aromatic), 5.97 (broad s, 1H, NH), 5.75 – 5.66 (m, 1H, H-
4), 5.67 – 5.58 (m, 1H, H-3), 4.47 (s, 2H, OCH2Ph), 3.51 – 3.36 (m, 2H, H-3’), 3.28 (d, J = 16.2 Hz, 1H, 
H-2a), 3.08 (ddd, J = 21.1, 5.5, 2.8 Hz, 1H, H-5a), 2.93 (d, J = 21.1 Hz, 1H, H-5b), 2.55-2.48 (m, 1H, H-
1’a), 2.41 – 2.28 (m, 1H, H-2b), 2.19 – 2.06 (m, 1H, H-1’b), 1.66 – 1.50 (m, 2H, H-2’), 1.43 (s, 9H, t-Bu); 
13C NMR (101 MHz, CDCl3) δ 207.6 (C=O), 154.4 (C=O), 138.6 (Arq), 128.5 (Ar), 127.7 (Ar), 125.3 (Ar), 
124.6 (C-4), 123.3 (C-3), 81.6 (C(CH3)3), 73.0 (C-1), 69.9 (OCH2Ph), 63.6 (C-3’), 39.6 (C-5), 38.3 (C-2), 
30.3 (C-1’), 28.5 (C(CH3)3), 24.4 (C-2’). 
tert-Butyl (S)-(1-(3-hydroxypropyl)-2-oxocyclohexyl)carbamate (2.82) 
 
Cyclohexenone 2.81 (0.650 g, 1.81 mmol) was dissolved in deoxygenated ethanol (100 ml) and to 
this was carefully added Pd/C (0.192 g, 10 wt %, 10 mol %) under a nitrogen atmosphere. The 
reaction was placed under a hydrogen atmosphere and stirred vigorously for 4 hours. Filtration 
through Celite, followed by concentration on the rotary evaporator yielded a yellow gum, which was 
purified by column chromatography using EtOAc/hexane (30/70) to furnish the cyclohexanone 
product 2.82 (0.476 g, 1.75 mmol, 97 %) as a colourless solid, which recrystallized to delicate 





20= -1.4, (DCM, c = 1); IR: vmax (cm
-1) 3581 (OH), 3424 (NH), 3054 (C-H 
aromatic), 2947 (C-H alkane), 1712 (C=O ketone), 1681 (C=O Boc); 1H NMR (400 MHz, CDCl3) δ 4.91 
(broad s, 1H, NH), 4.14 – 3.95 (m, 1H, H-3’a), 3.65 – 3.51 (m, 1H, H-3’b), 2.56 – 2.25 (m, 2H, H-3), 
2.14 – 1.96 (m, 2H, H-6), 1.95 – 1.69 (m, 5H, H-4, H-1’ and OH), 1.64 – 1.47 (m, 4H, H-5 and H-2’), 
1.45 (s, 9H, t-Bu); 13C NMR (101 MHz, CDCl3) δ 211.1 (C=O), 156.0 (C=O), 79.7 (C(CH3)3), 62.4 (Cq), 
60.8 (C-3’), 38.0 (C-3), 35.9 (C-6), 33.9 (C-4), 28.6 (CCH3)3), 22.9 (C-2’), 22.5 (C-1’), 20.9 (C-5). 
tert-Butyl (S)-(1-(3-((tert-butyldiphenylsilyl)oxy)propyl)-2-oxocyclohexyl)carbamate (2.83) 
 
Alcohol 2.82 (0.350 g, 1.29 mmol) was dissolved in dichloromethane (100 ml) and cooled to 0 °C. To 
this solution was added NaH (0.057 g, 1.42 mmol, 1.1 eq), followed by TBDPSCl (0.40 ml, 1.55 mmol, 
1.2 eq). The reaction was warmed to room temperature and left to stir for 3 hours, after which time 
water (30 ml) was slowly added and the mixture extracted with dichloromethane (3 x 60 ml). 
Combined organic extracts were dried over anhydrous MgSO4, filtered and concentrated in vacuo. 
The residue was subjected to column chromatography using EtOAc/ hexanes (10/90) to deliver the 
title cyclohexanone 2.83 (0.585 g, 1.15 mmol, 89 %) as an opaque gum.  HRMS (ES): m/z found 
510.3046, C30H44NO4Si [M+H]
+ requires 510.3040; [α]𝐷
20= +25.6, (DCM, c = 1); IR: vmax (cm
-1) 3400 
(NH), 3073 (C-H aromatic) 2933 (C-H alkane), 1703 (C=O ketone), 1701 (C=O Boc); 1H NMR (400 MHz, 
CDCl3) δ 7.77 – 7.57 (m, 4H, aromatic), 7.47 – 7.32 (m, 6H, aromatic), 5.90 (broad s, 1H, NH), 3.78 – 
3.44 (m, 2H, H-3’), 2.84 – 2.65 (m, 1H, H-3a), 2.57 – 2.22 (m, 3H, H-6 and H-1’a), 2.23 – 2.07 (m, 1H, 
H-1’b), 2.05 – 1.96 (m, 1H, H-3b), 1.74 – 1.62 (m, 4H, H-4 and H-5), 1.56 – 1.43 (m, 1H, H-2’a), 1.41 (s, 
9H, t-Bu Boc), 1.19 – 1.09 (m, 1H, H-2’b), 1.04 (s, 9H, t-BuSi); 13C NMR (101 MHz, CDCl3) δ 209.9 
(C=O), 154.9 (C=O), 135.7 (Arq), 135.0 (2 x Ar), 129.8 (2 x Ar), 127.8 (2 x Ar), 79.1 (OC(CH3)3), 65.0 (Cq), 
63.6 (C-3’), 39.1 (C-3), 38.0 (C-6), 29.7 (SiC(CH3)3), 28.6 (OC(CH3)3), 28.1 (C-4), 27.0 (SiC(CH3)3), 26.7 










To a freshly prepared solution of MgBr(CH2)3OBn (1 M in THF, 0.34 ml, 0.392 mmol, 2 eq) at 0 °C was 
added a solution of the cyclohexanone 2.83 (0.100 g, 0.196 mmol) in THF (20 ml) and the reaction 
was allowed to warm up to rt and stirred for a further hour. Upon completion, the mixture was 
cooled to 0 °C and water (10 ml), followed by HCl (1 M, 10 ml) were added and stirring was 
continued for another 15 minutes. The mixture was then extracted with EtOAc (1 x 80 ml and 2 x 60 
ml) and the combined organic fractions were washed with saturated sodium bicarbonate (100 ml), 
dried over anhydrous MgSO4, filtered and concentrated on the rotary evaporator. Purification by 
column chromatography using EtOAc/hexanes (10/90) furnished the Grignard adduct 2.84 (0.102 g, 
0.155 mmol, 79 %) as a gummy liquid in a 14:1 ratio of diastereomers as determined by NMR 
spectroscopy. HRMS (ES): m/z found 660.4076, C40H58NO5Si [M+H]
+ requires 660.4084; [α]𝐷
20= +16.7, 
(DCM, c = 1); IR: vmax (cm
-1) 3407 (broad, OH), 3056 (C-H aromatics), 2930 (C-H alkanes), 1708 (C=O); 
1H NMR (400 MHz, CDCl3) δ 7.81 – 7.56 (m, 4H, aromatic), 7.43 – 7.27 (m, 11H, aromatic), 5.42 
(broad s, 1H, NH), 4.52 (s, 2H, CH2Ph), 4.26 (broad s, 1H, OH), 3.79 – 3.61 (m, 2H, H-3”), 3.61 – 3.39 
(m, 2H, H-3’), 2.46 – 2.32 (m 1H, H-3a), 1.94 – 1.79 (m, 1H, H-3b), 1.73-1.50 (m, 8H, H-1’, H-1”, H6, H-
4), 1.49 – 1.42 (m, 2H, H-2”), 1.40 (s, 9H, Boc t-Bu), 1.21 (m, 4H, H-2’ and H-5), 1.06 (s, 9H, Si-t-Bu); 
13C NMR (101 MHz, CDCl3) δ 156.7 (C=O), 139.0 (C-1”’), 135.8 (C-2””), 134.3 (C-1””), 129.7 (C-4””), 
128.5 (C-3”’), 127.8 (C-3””), 127.5 (C-2”’), 126.0 (C-4”’), 80.2 (OC(CH3)3), 76.1 (C-2), 72.8  (OCH2Ph), 
71.6 (C-3’), 64.5 (C-3”), 62.9 (C-1), 32.9 (C-3), 31.8 (SiC(CH3)3), 30.9 (C-6), 28.5 (OC(CH3)3), 27.1, 
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